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ABSTRACT 
 
Long lasting calcium (Ca2+) oscillations are necessary and sufficient for mammalian egg 
activation and early embryological development. In mammals, phospholipase C zeta 
(PLCζ) has been identified as the likely endogenous trigger of Ca2+ oscillations at 
fertilization.  Some cases of male factor infertility have been associated with the 
absence / reduced or presence a mutant form of PLCζ. In these cases sperm fails to 
activate eggs after intra-cytoplasmic sperm injection (ICSI). Artificial egg activation is 
the potential way to trigger Ca2+ oscillations and egg activation. Strontium (Sr2+) is the 
main artificial agent for this purpose in rodent eggs. The work in this Thesis aims to 
examine the mechanism of PLCζ or Sr2+ ions to trigger Ca2+ oscillations in mammalian 
eggs. It was not clear how Sr2+ causes Ca2+ oscillations and why it is only effective in 
rodents but not human eggs or domestic animals. My studies show that Sr2+ is effective 
in causing Ca2+ oscillations in mouse eggs over a range of concentrations, but that its 
actions are influenced by the osmolarity of the medium. Low osmolarity enhances the 
ability of low concentrations of Sr2+ to cause Ca2+ oscillations. Further investigation 
revealed that Sr2+ influx is mainly through the reverse mode of the Na+/Ca2+ exchange 
protein (NCX) which can be controlled by the membrane potential and Na+ gradient 
across the plasma membrane. Preliminary studies investigated the ability of a modified 
Sr2+ media that maximizes reverse mode NCX to trigger Ca2+ changes in human eggs.   
In other studies, various PLCζ-luciferase cRNAs were injected into mouse and human 
eggs. PLCζ expression in mouse eggs was measured by imaging light due to luciferase 
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activity, and Ca2+-oscillations were monitored with Ca2+ sensitive fluorescent dye. 
Aspects of the structure of PLCζ and the effects and the recent discovery of PLCζ 
sequence mutations were investigated.  Preliminary studies were also carried out to test 
the ability of recombinant PLCζ protein to cause Ca2+ oscillations in mammalian eggs.  It 
is hoped that these studies might open up new therapies for some male factor infertility 
couples that acconts 1-5% of failed ICSI.  
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1.1  Pre-embryonic development 
 
 A new life starts with the fusion of gametes of haploid chromosomes to create a diploid 
number of chromosomes and to triggers a series of molecular transitions within the egg 
to re-enter the cell cycle and begin embryonic development (Leguia and Wessel, 2007). 
The cell cycle stage at which the egg is held until it is fertilized is species specific, for 
example; G1 of the first mitosis in sea urchins and second meiotic metaphase in 
mammals (Stricker, 1999). Fertilization is the end-point of multiple molecular cascades 
that enable ejaculated spermatozoa to find and attach to the zona pellucida (ZP) 
(Tulsiani et al., 1998) (Fig. 1.1)  
Egg cytoplasm
Zona pellucida
Egg’s plasma 
membrane
spermatozoa
Acrosomal 
reaction
Gamete membrane fusion
 
Figure  1.1 Descriptive diagram showing sperm-egg fusion in the fertilization process.  
1.1.1 Oogenesis 
 
In the human ovary, at 6-8 weeks gestation, rapid mitotic multiplication of primordial 
germ cells (PMGCs) gives rise to oogonia. In female embryos, during the pre-follicular 
stage between 7 and 9 gestational weeks, the oogonia (female germ cells) and 
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granulosa cells start arranging in cords and sheet patterns (Gondos, 1985). 
Subsequently, the oogonia undergo multiple mitotic divisions resulting in increases in 
their population. At the end of which and through these divisions at 11-12 weeks 
gestation, some oogonia stop and exit mitosis and reach the primary oocyte stage and 
enter the prophase of the first meiotic division (Stoop et al., 2005), which takes place in 
the ovaries and continues into the second trimester (Rabinovici and Jaffe, 1990) see 
(Fig. 1. 2). 
Meiotic Events
n
2
n
2
n
2
n
2
n
n
Oogonium (stem cell)
Primary oocyte
Primary oocyte arrested in 
prophase I present at birth
From puberty to 
menopause monthly
Ovary (inactive)Childhood
Mitosis
Growth
Before birth
Follicle Development
in Ovary
Follicle cells Oocyte
Primordial Follicle
Primordial Follicle
Sperm
Primary oocyte still 
arrested in prophase I
Primary Follicle
Growing Follicle
Vesicular 
(Graafian)
Follicle
Spindle
n
Meiosis I completed 
by one primary oocyte
each month
2nd PB
1st PB
Secondary oocyte 
Arrested in metaphase II
Ovulation
Zygote
Ovulated 
Secondary
oocyte
Meiosis II completed 
(occur only if sperm penetrated)
n
  
Figure  1.2 Schematic diagram illustrating oogenesis and fertilization processes. 
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The onset of folliculogenesis (the occurrence of primordial follicles) takes place between 
16 and 21 weeks of gestation (Konishi et al., 1986).  Each primary oocyte (oogonia) is 
contained within a primordial follicle surrounded by layers of follicle cells (Fig. 1.2). 
Significant fluctuations in the population of germ cells are seen during follicular 
maturation. This is basically due to the continuous proliferation of premeiotic oogonia 
and the elimination process in the form of apoptosis, which occurs in both oogonia and 
germ cells at different stages of folliculogenesis (De Poll et al., 1997). Physiologically, 
the destruction of singular or groups of cells appears to be a step of vital importance 
during embryonic and postnatal development in this count reduction (Raff et al., 1993). 
This takes place by the activation of a specific self-destruction programme, which 
involves many changes in form cellular activity such as cutting the DNA into 
oligonucleosomes by endonucleases (Peitsch et al., 1993). The primordial follicles 
undergo a stage of growth and during this time the primary oocytes are able to undergo 
a remarkable enlargement since no more mitosis occurs at this stage (Fig. 1.2). The ZP 
is formed while the egg is growing and passing through a stage called germinal vesicle 
(GV) stage which is characterised by a large nucleus (Fig. 1.3).  
 
Figure  1.3 Egg in germinal vesicle stage. Prominent nucleolus in the nucleus (black arrow).  
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GV eggs are arrested at prophase I (PI arrest) of meiosis I. PI arrest is regulated by 3, 5 
cyclic adenosine monophosphate (cAMP) levels within the oocyte (Conti et al., 2002). 
The production of cAMP is either from the egg, or transferred into the egg through gap 
junctions from granulosa cells. The cAMP holds the oocytes at PI arrest by inactivating 
maturation promoting factor (MPF) see later (Pirino et al., 2009).   
During meiotic prophase in humans, the condensation of DNA occurs followed by the 
alignment of homologous chromosomes parallel to each other forming 23 bivalent pairs 
(each pair has twice the required DNA). Then each chromosome splits longitudinally 
except at the centromeres. Subsequently, cells are arrested in metaphase I (Fig. 1.4) 
before entering meiotic metaphase which lasts from birth until after puberty when 
ovulation start to occur. 
  At the onset of puberty in humans the total number of eggs falls to 300,000 and this 
reduction is mainly due to cell death through apoptosis (follicular atresia) (Billig et al., 
1996). Roughly around 400 eggs are destined for ovulation. Resumption of meiosis 
occurs before ovulation, at the time of the LH surge (Pirino et al., 2009) while the egg is 
still a primary egg. Chromosomes in the germinal vesicle nucleus become short and 
thick and the first stage of meiosis is completed to enter the Metaphase I (MI) stage. In 
this stage, the homologous chromosomes are separated into two equal sets of 
chromosomes, each containing twice the necessary chromatin ‘meiosis I end’ (Fig. 1.4) 
see next page.  
To enter Metaphase II (MII), one of the chromosomes sets pinches off into a small cell 
in the perivitelline space (to make a polar body containing one chromosome set with 
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double amount of chromatin) producing the secondary egg (mature egg = MII) which is 
haploid but containing twice necessary chromatin (Fig. 1.5 left). MII eggs are identified 
by the presence of an extruded first polar body and have their diploid complement of 
chromosomes delicately arranged on the metaphase plate near the polar body (Peter et 
al., 1997) (see the schematic diagram) (Fig. 1.5 right). MII arrested eggs subsequently 
undergo ovulation in expectation of fertilisation. 
 
Meiosis IMeiosis II
(After fertilisation)
oogoniumPrimary oocyte
secondary oocyte
Polar body
Polar body
Polar body
Polar body
Zygote
sperm
M II 
M I 
 
Figure  1.4  Schematic diagram illustrating meiotic processes and zygote formation. Note the metaphase I 
stage with metaphase plate. 
Cumulus cells
1st Polar body
Metaphase plate
Perivetalline space
Oolemma
Ooplasm
Zona pellucida
 
Figure  1.5 Mature secondary human egg with cumulus cells and a schematic illustration showing the 
structural components of the MII egg.                   
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1.1.2 Spermatogenesis  
 
Spermatogenesis is the process of sperm production from the embryonic precursors the 
primordial germ cells (PMGCs) (Donovan, 1998). Germ cells are the only cells that 
undergo meiosis. Spermatozoa have unique functional properties and morphology. In 
humans the PMGCs can be detected by the end of the 3rd week of gestation in the 
extra-embryonic mesoderm during early embryonic development. By 5 to 6 weeks they 
migrate by amoeboid movement to the genital ridge areas via hindgut and dorsal 
mesentery (Makabe et al., 1991). PMGCs multiply during the migration process, and 
show no sex determination by this time (Stoop et al., 2005). A week later, the gonads 
and the sex establishment takes place. In male embryos, and under the effect of Sertoli 
cell precursors, the seminiferous tubules form (Falin, 1969). In the testis, PMGCs 
proliferate to gonocytes until third month of gestation when spermatogonia (the multi-
potent stem cells of the germ line) are seen (Hiromitsu et al., 2007).  Normal 
spermatogenesis is directed by genes on the Y chromosome, although many regulating 
proteins are derived from autosomal chromosomes, hormones, growth factors and 
vitamins act on the testis to regulate spermatogenesis (Skaletsky et al., 2003). The role 
of sex chromosomes in the premeiotic period has great importance for the sex 
differentiation processes; the ovarian egg of XY karyotype is differentiated whereas the 
testicular sperm of XX karyotype cannot differentiate (Isotani et al., 2005).  
    Spermatogenesis is the process of sperm differentiation in the testis. This systematic 
process is supported by Sertoli cells and by Leydig cells (interstitial cells of the testes).  
The functioning of these cell types is regulated by testosterone, which secreted by 
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leydig cells under control of LH stimulation (Hiromitsu et al., 2007). FSH (secretion from 
the pituitary gland) together with testosterone stimulates spermatogenesis by binding of 
FSH to Sertoli cells and producing several androgen binding proteins (ABP). These 
proteins bind to testosterone in the tubular lumen and stimulate spermatogenesis. 
Inhibin secreted from Sertoli cells suppresses FSH secretion; however, activin secreted 
from Sertoli, peritubular and Leydig cells opposes inhibin by inducing FSH production 
(Hiromitsu et al., 2007). 
  Spermatogenesis begins with the mitotic division of spermatogonia to produce diploid 
primary spermatocytes (46XY) (Stoop et al., 2005). These cells undergo first meiotic 
divisions into two haploid cells (23X or 23Y) called secondary spermatocytes, 
consequently the second meiotic division occurs and spermatids are formed (containing 
23 single half chromosomes). 
 In the postmeiotic period and during spermatogenesis the rounded spermatids convert 
to normal spermatozoa by significant morphological changes; the nucleus becomes 
compacted, the DNA condensed, the mitochondria gather and form an axoneme, the tail 
emerges by elongation of one of cellular centrioles and the acrosomal cap is created 
from the Golgi apparatus that surrounds the nucleus. This takes about 5–6 week to 
complete (Heller and Clermont, 1963). By the completion of the first sperm cell in the 
testis, the three different stages are arranged in the seminiferous tubules in a 
systematic pattern; the spermatogonia set in the tubular walls, the spermatids at the 
tubular lumens and the spermatocytes in the middle (Fig. 1.6) see next page.  
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Figure  1.6 Diagrammatic illustration of spermatogenesis and germ cell arrangement in the tubule. 
(http://faculty.sunydutchess.edu/Scala/Bio102/PDF/Spermatogeneses.jpg)  
 
During adulthood this process occurs in the seminiferous tubules which results in a 
large sperm counts and takes more than 2 months (Dym, 1994). Spermatogenesis itself 
is not sufficient to produce male gametes capable of fertilisation. Once sperm have 
completed their morphogenesis they detach from the seminiferous epithelium and are 
transported after passing through the rete testis to the cauda epididymis in testicular 
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fluid by peristaltic contractions. Sperm  production needs approximately  65 - 74 days 
(Dym, 1994) in humans, 50 days of which are spent in the seminiferous tubule and the 
rest taken in travelling to the epididymis where sperm acquire motility and become 
capable of fertilization. In  comparison to mouse only 34.5 days are sufficient for sperm 
formation (Reijo et al., 1995). In human testicles 100 million sperm are made per day 
and each ejaculation releases 200 million sperm from the vas deferens through the 
epididymal caput (Reijo et al., 1995).   
Morphologically the sperm head is species specific; flattened rounded in man and 
domesticated animals such as the dog and hook shaped in mice and rodents to help 
each other to reach the ovulated egg. The dimensions of human sperm head is about 5 
μm long, 2.5 μm wide and 1.5 μm thick (Austin and Short, 1982). In all mammals the 
sperm head contains a highly condensed DNA-protein mass called chromatin linked 
with protamines (Austin and Short, 1982) which are replaced by histone during 
fertilisation. The sperm tail is divided into a mid-piece and an end piece (Fig. 1.7). The 
mid-piece contains the mitochondrial helix and the end piece is mainly responsible for 
the sperm motility (Austin and Short, 1982). 
Tail                                     
Acrosome
Nucleus
Centriole
Mitochondria
Axoneme
End-piece  Mid-pieceHead Neck  
Figure  1.7 Schematic diagram of spermatozoa structural components. 
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1.1.3 Fertilization process 
 
 Fertilization is the process where the two different gametes (highly specialized cells) 
the egg and the sperm, unite to form a new individual (zygote) (Leguia and Wessel, 
2007) that contains a genetic material derived from both parents.  
  Millions of sperm per ejaculate are released into the female reproductive tract. Only 
capacitated sperm are competent to initiate fertilisation, as they must penetrate both the 
cumulus masses and the ZP respectively. In humans, the metaphase II stage ovum 
(haploid) with its cumulus cells, is picked-up by the fimbrial end of the fallopian tube, 
and survives for about 18-24 hours waiting for sperm in the ampulla to initiate 
fertilization process. The activated sperm reach this area and the fertilization process 
starts. However, if fertilization does not occur, the ovum undergoes apoptosis and finally 
eliminated by the tube (Naokazu et al., 2005). 
As early as sperm penetrates the cumulus mass and the zona by means of chemical 
and mechanical cascades (acrosomal reaction see below), the remaining chromosome 
splits longitudinally and half the chromatin pinches off to form the second polar body 
(Naokazu et al., 2005), and the second meiotic division of the ovum is completed (Fig. 
1.4).  Eventually, the nuclear contents of the sperm will enter the ooplasm, and then the 
haploid egg that contains correct amount of its chromatin will receive a similar amount 
of male chromatin from the penetrated sperm (haploid). Subsequently, the two haploid 
female and male pronuclei (PN) move toward the centre of the egg to form the zygote 
(Fig. 1.8) with the establishment of the diploid number of chromosomes. During this 
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migration event, DNA replication takes place and eventually the first mitotic division of 
newly formed organism is started (Abou-Haila and Tulsiani, 2000).   
 
Figure  1.8 Schematic diagram of fertilized human egg.   
 
The paternal DNA is required for normal embryonic development and must be 
remodelled at fertilisation since the DNA of the mature sperm is compacted and 
transcriptionally inactive (McLay and Clarke, 2003). The remodelling process involves 
replacing the major basic protein found in the nuclei of mature sperm cells (protamines) 
with histones. In mammals, fertilization involves several sequential steps. These 
include, capacitation of sperm in the female genital tract, binding of capacitated sperm 
to the ZP, sperm activation (acrosome reaction), ZP penetration and sperm-egg 
membrane fusion (Fig. 1.1) (Abou-Haila and Tulsiani, 2000; Naokazu  et al., 2005) 
subsequently egg activation events and re-entering the cell cycle. 
1.1.3.1 Capacitation 
 
Immediately after ejaculation mammalian spermatozoa are unable to fertilise the egg. 
Throughout testicular spermatogenesis, epididymal maturation, and capacitation in the 
female reproductive tract, sperm undergo a series of biochemical modifications. In the 
female reproductive tract, spermatozoa can survive for an average of 48 hours and they 
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have to travel from the vagina to the tubal ampullary portion to meet the ovulated ovum 
where only one sperm is needed to penetrate the ZP for normal fertilization. During this 
journey the sperms undergo a sequence of complex events known as capacitation 
process (Baldi et al., 1996). This process increases the sperm activity and mobility. 
However, in IVF the collected sperm can undergo this capacitation by leaving them in a 
suitable media in the incubator that optimized with appropriate temperature 37C and 
5% CO2 levels.  
1.1.3.2 Acrosomal reaction 
 
The acrosome reaction is the process of normal fertilization, just before egg penetration, 
when the sperm is activated after capacitation (Fig. 1.1). It often involves the release of 
enzymes and exposure of surface antigens as a part of the cell ruptures (Naokazu et 
al., 2005). It can be defined as a sequence of complex cellular and molecular incidents 
including changes of the sperm surface, oscillations in the intracellular Ca2+ 
concentration, cyclic nucleotides and protein de/phosphorylation reactions (Baldi, et al., 
1996). The acrosomal reaction in mammalian sperm is believed to be started in vivo by 
sperm binding to the ZP, the egg’s extracellular matrix (Fukami et al., 2010). Therefore 
ZP binding is restricted only to capacitated sperm undergoing the acrosome reaction 
(Tulsiani et al., 1998). That means only sperm that have completed the acrosome 
reaction can penetrate the ZP and fuse with the egg plasma membrane (Wassarman et 
al., 2001). Reactive oxygen species (ROS) have been suggested to have an important 
role in capacitation-related phosphorylation of several proteins in human (Aitken, 1989). 
Interestingly, Ca2+ has been reported to play a primary role in execution of the 
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acrosome reaction in sperm (Breitbart, 2002). However, recent studies have questioned 
the site at which the acrosome reaction occurs. A recent study used fluorescence 
microscopy was able to detect the onset of the acrosome reaction under experimental 
condition, and found out that most fertilizing spermatozoa underwent the acrosome 
reaction before reaching the ZP of cumulus-enclosed oocytes (Jin et al., 2011). 
1.1.3.3 Sperm-egg interaction and fusion 
 
During fertilization, the interaction between egg’s ZP and spermatozoa is a relatively 
species-specific incident (Swenson and Dunbar, 1982 and Abou-Haila and Tulsiani, 
2000). Sperm-egg membrane fusion is thought to take place shortly after the sperm 
reaches the plasma membrane of the egg. The sperm fuses with microvilli on the egg 
surface. In other words, the capacitated sperm surface-receptors bind to their ligands on 
the ZP. Subsequently, the sperm plasma and the acrosomal outer membranes undergo 
multiple fenestrations, fusion and exocytosis of acrosomal contents. The surface over 
the equatorial part of the spermatozoon is prepared for the fusion step (Yanagimachi, 
1994).  It is a prerequisite step that enables the acrosome reacted sperm to penetrate 
the ZP and fertilize the egg. Hydrolytic enzymes with the hyperactivated flagellar motility 
of sperm tail play a major role in the ZP penetration and fertilization process (Tulsiani  et 
al., 2007). Once the sperm and egg membranes have fused, the sperm releases its 
content into the egg cytoplasm and in just a few minutes after fusion, the egg undergoes 
the first Ca2+ transient which begins the process of egg activation (Lawrence et al., 
1997).  
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1.1.4 Egg activation events 
 
The fertilization and egg activation processes appears to be similar in many mammals. 
The similarity between human and mouse egg in some maturation aspects has made 
the mouse egg as an acceptable model to study the human egg maturation process. 
Since both exhibit meiotic arrest at metaphase II before ovulation and undergo ZP 
reaction to protect against polyspermy during fertilisation (Ducibella et al., 1990). After 
sperm egg binding and fusion a sequential critical events took place in the egg towards 
the normal activation through specific biochemical pathways within the egg (Ben-Yosef 
and Shalgi, 1998). Amongst these events, characteristic increases in free cytosolic Ca2+ 
levels within the egg has been recognized by researchers to be the key stimulus  and 
the universal feature for the egg-activation process (Runft et al., 2002). These increases 
in Ca2+ level can lead to a series of events that are important steps towards embryo 
formation. These include; cortical granule (CG) exocytosis, and the resumption of the 
cell cycle by the completion of meiosis and expulsion of the second polar body. By the 
completion time of these events, both the formation of pronuclei and the synthesis of 
DNA will have started (Raz and Shalgi, 1998). These all help lead to the completion of 
the first cell cycle that initiates the early embryonic mitotic divisions (Yanagimachi, 1994; 
Ben-Yosef and Shalgi, 1998; Stricker 1999; Swann and Parrington, 1999). 
1.1.4.1 Exocytosis 
 
Following sperm penetration, one of the early characteristic and key events in the egg 
activation process takes place namely CG exocytosis (Raz and Shalgi, 1998). The 
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mammalian CGs are membrane-bound small specialized organelles within the cortex 
that contain enzymes such as proteinases and glycosidases. They are found in oocytes 
and eggs of all mammals (Leguia and Wessel, 2007), and in response to cytoplasmic 
Ca2+ transients undergo exocytosis into the perivitelline space (Ducibella et al., 1990; 
Ducibella, 1991; Yanagimachi, 1994; Raz and Shalgi, 1998). The physiological function 
of exocytosis is mediated through a zona modification reaction which protects against 
polyspermic fertilization (Ducibella, 1991; Ben-Yosef and Shalgi, 1998). The maximal 
release of CGs takes place at the meitic metaphase II stage (Ducibella et al., 1990).This 
kind of polyspermic protection has been reported in all mammalian species including 
human oocytes (Sathananthan and Trounson, 1985).  
 
1.1.4.2 Role of Ca2+ in egg activation 
 
It has been known that all forms of life during their resting state create a difference in 
Ca2+ concentration between the inside cytoplasmic free Ca2+ (50-100 nM) which is  
approximate of 10,000 fold lower than the outside extracellular Ca2+ concentration  (1-2 
mM). One consequence is that even the most primitive cells use Ca2+ as a messenger 
for sending signals from outside to inside the cell (Fukami et al., 2010).  Under 
fertilization event, the free cytoplasmic Ca2+ elevates to reach up to 1-10µM (Taylor et 
al., 1993; Pepperell et al., 1999). In general, a Ca2+ increase is important in cellular 
events such as in fertilization and cell division, and as well as in physiological events in 
cells such as in neurons, cardiac muscle, secretary cells (Stephanie et al., 2008). 
Importantly, Ca2+ is a double-edged sword, because a suitable Ca2+ increase is good 
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signal transducer for various physiological functions (Fukami et al., 2010), but high 
cytoplasmic free Ca2+ levels can also be toxic.  
 For decades, the physiological importance of Ca2+-oscillations in egg activation has 
been an issue of importance. In all examined species the pivotal signal in fertilization is 
the rise in Ca2+. As we know today that Ca2+ is a cell regulatory key ions and during 
fertilization its release is a prerequisite step for egg activation, releasing MII egg from 
the resting stage (meiotic arrest) (Miyazaki et al., 2006) that all mammalian eggs are 
arrested at.  The first clear role of Ca2+ was shown in 1974 when it as found  that 
parthenogenic activation of star-fish, sea urchin and hamster eggs occurred with Ca2+ 
ionophore A23187 (Steinhardt et al., 1974). Similar findings have been reported in fish 
(Ridgway et al., 1977). Later on, different pathenogenetic activation protocols for eggs, 
such as ethanol (7%) and strontium (Sr2+), were all shown to cause free cytoplasmic 
Ca2+ increases which eventually led to egg activation (Stricker, 1999; Saunders et al., 
2002; Miyazaki et al., 2006). On the other hand, introduction of the Ca2+ chelating agent, 
EGTA, into the ooplasm was shown to have the opposite effect by stopping the egg 
activation at fertilization (Whitaker et al., 1982 and Kline and Kline, 1992). All this 
extensive research lead to the conclusion, that Ca2+ release is necessary and sufficient 
for egg activation in mammals (Stricker, 1999; Miyazaki et al., 2006). In fact, the first 
few Ca2+ spikes are essential for egg activation (Kline and Kline, 1992), whereas a long 
lasting Ca2+ rises are necessary for early embryo developments (Swann and Ozil, 
1994).  
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1.1.4.3 Ca2+-oscillations in mammals 
 
An increase in intracellular Ca2+ is responsible for activating eggs of all species. The 
Ca2+ increases occur in two forms depending on species type, either as a single rise as 
seen in sea urchin, fish and frog eggs (Gilkey et al., 1978; Jaffe, 1985 and Stricker, 
1999), or as multiple transients as in ascidians and mammalian eggs (Swann and Ozil, 
1994). These multiple transients are called Ca2+-oscillations and in mammals take 
several hours to cease and they are characterized by larger amplitude and low frequent 
Ca2+ rises in compare to the ascidians (Swann and Yu, 2008). In mammals, the Ca2+ 
spikes’ number, the amplitude and the frequency appear to be a species dependent and 
may have a direct impact on the developmental progression (Faure et al., 1999), from 
events of egg activation to events associated with further  embryogenesis (Runft et al., 
2002; Miyazaki and Ito, 2006).  During normal mammalian fertilization repeated 
increases of the free Ca2+ level in egg cytoplasm from 1.0nM and reach up to 1.0 µM 
(Stricker, 1999; Runft et al., 2002).  
The frequency of oscillations at fertilization appears to vary within mammals, from 20 - 
30 spikes per hour in hamster eggs (Miyazaki et al., 1986), from 5 -30 spikes per hour in 
mouse eggs (Kline and Kline, 1992; Faure et al., 1999), to about 6 spikes in rabbit 
(Fissore and Robl, 1993),  3 spikes in pig (Sun et al., 1992), and as low as 2 spikes per 
hour in bovine eggs (Sun et al., 1994; Faure et al., 1999). There are several factors that 
may affect on the Ca2+ oscillations frequency. For example, in mouse eggs the 
extracellular Ca2+ concentration (Igusa and Miyazaki, 1983), the age of the eggs (Faure 
et al., 1999), all appear to be responsible for the variability in the frequency of Ca2+ 
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oscillations. There is also variability in the first Ca2+ spike in mammalian eggs, which is 
generally of longer duration with small mini spikes on the top of the main increase. This 
tends to be followed by a series of shorter Ca2+ spikes without mini spikes (Fig. 1.9). 
Normally, the frequency and amplitude of Ca2+-oscillations declines with time until they 
stop around the time of pronuclear formation.  
15min
SpermRelative Ca2+
(Fluorescence ratio, 
Fura-red)
 
Figure  1.9 Ca
2+
-oscillations initiated by sperm during IVF in a mouse eggs. 
 
1.1.4.4 The importance of Ca2+-oscillations during fertilization in 
mammals 
 
In general, Ca2+ increase is important in cellular events such as in fertilization and cell 
division, and is involved as well as in many physiological events in cells (Stephanie et 
al., 2008). It has been recognized that Ca2+ is the most known fundamental factor of egg 
activation (Loren and Lacham-Kaplan, 2006). It has been established that an increase 
in the intracellular free Ca2+ concentration is necessary for egg activation at fertilization 
in animals (Stricker et al., 1999). These Ca2+ changes in mammals, occur as a 
prolonged series of oscillations after sperm-egg fusion which shown to be essential for 
egg activation and early embryonic development in mice (Kline and Kline 1992; Stricker 
et al., 1999; Ducibella et al., 2008). These oscillations are cell cycle dependent (Jones 
et al., 1995). The eggs in pre-fertilization state are held in meiotic arrest by maturation 
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promoting factor (MPF). The triggered Ca2+ oscillations act by destroying MPF via cyclin 
B destruction and activate several protein kinases as part of downstream Ca2+ 
signalling. These include calmodulin-dependent protein kinase II, CaMKII, which seems 
to be critical to trigger meiotic resumption and early development in mouse eggs 
(Madgwick et al., 2005; Ducibella et al., 2006; Knott et al., 2006; Ducibella et al., 2008) 
by stimulation of ubiquitin-dependent degradation of cyclin B by the proteosome (Lorca 
et al., 1993). These Ca2+-oscillations have also been reported in human eggs during IVF 
(Taylor et al., 1993) and ICSI (Tesarik et al., 1994).  
 
1.1.4.5 Ca2+-waves  
 
 Each individual rise in the intracellular free Ca2+ in egg’s cytoplasm in species such as 
frog and sea urchin moves from one pole to the other. They start from the point of 
sperm egg fusion and travels across the whole egg in a wave like pattern (Miyazaki et 
al., 2006) (Fig. 1.10).  
0.1mm 
Oocyte diameter 
2 seconds sperm 
 
Figure  1.10  Schematic diagram representing the progression of Ca
2+
-wave across the egg. 
 
The first image of a Ca2+ wave was described by Gilkey and his colleagues in medaka 
fish eggs (Gilkey et al., 1978), and it travels at a speed of 5-50 micrometer/seconds 
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(Whitaker et al., 1993). It was shown that these waves are not affected by external Ca2+ 
confirming that Ca2+ rise comes from the intracellular source (Gilkey et al., 1978). 
However, in mammals the situation is more complex due to the occurrence of the 
recurrent elevations of free Ca2+ levels (Swann. et al., 1994; Swann et al., 1999; 
Miyazaki et al., 2006). These transients are a result of releasing of Ca2+ from 
intracellular stores into all portions of ooplasm (Swann et al., 1999). In mammals the 
average size of the eggs is around 0.1mm and Ca2+-waves take around 2 seconds to 
cross the whole egg (Whitaker, 2006) (Fig 1.10). As mentioned previously the first Ca2+ 
wave start from sperm-egg fusion site, however the subsequent Ca2+-waves initiate 
from different parts in the egg (vegetal hemisphere) which are rich in ER irrespective of 
sperm-egg fusion site (Stricker, 1999; Miyazaki et al., 2006). 
1.1.4.6 Cell cycle & Ca2+-oscillations  
 
At fertilization, the increased intracellular Ca2+ is needed only for short periods of time; 
since prolonged elevated Ca2+ levels, in most cases, results in cell death by activating 
DNA-fragmenting enzymes and proteases (Guerini, 1998). At mammalian fertilization 
the increases in Ca2+ levels lead to the completion of meiosis. In addition, it causes 
other egg activation events; e.g. CG exocytosis, which puts in place a mechanical block 
to polyspermy (Zucker and Steinhardt, 1978; Kline, 1988; Kline and Kline, 1992). 
MPF is a protein complex that consists of a catalytic subunit cdk1 and a regulatory 
protein cyclin B1. MPF is responsible for transition from interphase into meiosis/mitosis 
(Nurse, 1990). In mature metaphase II eggs both cdk1, cyclinB and MAP kinase are 
required to stabilizing MPF activity (Palmer and Nebreda, 2000). Before fertilisation 
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MPF remains in highest level, however, Ca2+ transients at fertilization trigger cyclin B 
destruction via the activation of CaMKII that phosphorylates Emi2 and targets it for 
degradation (Doree and Hunt, 2002). This is  followed by proteolysis of cyclin B by the 
proteasome and the MPF level then drops down to a  minimal level as seen during 
interphase (Doree and Hunt, 2002; Jones, 2004). Subsequently, the fertilized egg 
completes meiosis by expulsion of the second polar body which is after 1.5 - 2 hrs after 
the start of fertilization. However, Ca2+-oscillations continue beyond polar body 
formation to stop by the time of pronucleus formation around 2 hrs later, when the MAP 
kinase pathway is inactivated (Moos et al., 1996). 
The application of the spindle disrupting drug nocodazole leads to a block of cell cycle 
protein changes and to the inhibition of pronucleus formation, and this has shown to 
facilitate the continuation of Ca2+-oscillations hours after the usual cessation time. This 
indicates a relationship between Ca2+ signals and the cell cycle. Most significantly it 
appears that Ca2+ transients stop when proneucleur formation occurs (Jones et al., 
1995). Additionally, Ca2+ released by different stimuli such as InsP3 and Sr2+, all 
dramatically diminished after certain time (hours) in one-cell embryos which also 
signifies that the completion of meiosis II, as progress  towards the first mitotic division 
is linked directly to the Ca2+ releasing ability (Carroll, 2001). Furthermore, Ca2+-
oscillations have been reported in different stages of cell cycle, as it they have been 
detected in fertilized mouse embryos 16 - 18 hrs after fertilization, which is around the 
time of nuclear envelope breakdown (NEBD) of the first mitotic division (Kono et al., 
1996).  
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1.1.5 Parthenogenetic activation 
 
Parthenogenesis is the process by which an egg is activated without sperm or any 
contribution from the male genome (Swann and Ozil, 1994). There are three different 
procedures have been established to stimulate mammalian egg activation artificially, 
namely; electrical, mechanical, and chemical (Yamano et al., 2000). The electrical 
stimulation depends on the Ca2+ influx through pore formation in the plasma membrane 
(Nasr-Esfahani et al., 2010). It has been shown that long-lasting Ca2+ transients 
triggered by repetitive electric pulses not only enhance pronucleus formation but it can 
also facilitate later embryonic development, even in eggs who are resistant to 
parthenogenetic activation (Swann and Ozil, 1994; Ozil and Swann, 1995). The 
effectiveness of this procedure relays on medium ionic content, pore size and cell type. 
This method has been reported successfully on bovine and human oocytes (Zhang et 
al., 1999; Yanagida et al., 1999). However, it can also induce the reactive oxygen 
species (Nasr-Esfahani et al., 2010).  
The mechanical methods involve breaking the oocytes plasma membranes using a 
microneedle to facilitate the influx of Ca2+, or involve by a direct microinjection of Ca2+ 
into the egg. The activation events have been observed on pig and human oocytes 
using this procedure (Mach’aty et al., 1996; Dirican et al., 2008). However neither the 
electrical nor mechanical methods are commonly used in clinical practice (Nasr-
Esfahani et al., 2010). 
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The third type and the most commonly used in clinical practice is the chemical method. 
This can involve different compounds such as 7% ethanol (Presice and Yang, 1994), 
Ca2+ ionophore A213187 (Kline and Kline, 1992; Perry et al., 1999; Ahmady and 
Michael, 2007), cycloheximide (Moses and Kline, 1995), thimerosal (Fissore and Robl, 
1993), and strontium “Sr2+” (Kline and Kline, 1992; John et al., 2003; Yanagida et al., 
2006; Ducibella and Fissore, 2008). However, the chemical method has been limited 
mainly to the experimental animal models and a few case reports on human eggs 
(Borges et al., 2009; Nasr-Esfahani et al., 2010). The chemical compounds act by Ca2+ 
releases from the intracellular stores, mainly the ER, this subsequently leads to the 
depletion of Ca2+ in ER which in turn promotes the extracellular Ca2+ influx (Nasr-
Esfahani et al., 2010). Interestingly, these agents could potentially be used to treat 
some cases of male factor infertility where the sperm is not able to activate the egg 
(Borges et al., 2009; Nasr-Esfahani et al., 2010). It has been found that couples with 
repeated failed ICSI could achieve pregnancy by artificial egg activation using Ca2+ 
ionophores (Perry et al., 1999) and delivery of a healthy baby (Ahmady and Michael, 
2007). Noteworthy, most chemical stimulators can only cause a single Ca2+ rise, such 
as with Ca2+ ionophores, and it is possible that such a single short Ca2+ rise fails to 
trigger the whole activation events (Sutovsky and Schatten, 1997). Similarly, 7% ethanol 
can only causes single large Ca2+ increase (Swann and Ozil, 1994). In contrast, others 
such as Sr2+ can triggers prolonged Ca2+-oscillations that look similar to that seen in 
fertilization (Fig. 1.11 see next page). Sr2+ is known to be the most successful and 
efficient agent for causing mouse egg activation artificially (Kline and Kline, 1992; John 
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et al., 2003; Rogers et al., 2004). Some reports show that parthenogenetic mouse 
embryos may implant but with severe growth retardation because the absence of the 
paternal chromosomes. This leads to a defect in the formation of extraembryonic tissue. 
Hence most embryos die before birth ( Surani et al., 1984; McGrath and Solter, 1984). 
From these findings, and other, it is clear that full embryogenesis needs one set of 
chromosomes from both parents that have undergone the appropriate imprinting. 
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Figure  1.11 Ca
2+
-oscillations patterns after IVF and Sr
2+
 activation. 
 A) Shows Ca
2+
-oscillations initiated by sperm during IVF in a mouse egg. B) Shows the Ca
2+
-oscillations 
in a mouse egg in response to 10mM Sr
2+.
 
 
1.1.5.1 Strontium (Sr2+)  
 
Media containing Sr2+ is widely used in research labs as an egg activator in rodents. 
Normal mice offspring have been reported after ICSI (intra-cytoplasmic sperm injection) 
in combination with Sr2+ activation (Suganuma et al., 2005).  Treating mouse eggs with 
Sr2+-triggers Ca2+-oscillations that look similar to the normal pattern at fertilization (Kono 
et al., 1996). It has been claimed that IP3Rs is the mediator for Sr
2+ action to trigger 
Ca2+ release and oscillations (Zhang et al., 2005) (Fig. 1.12). In humans, several 
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published reports have claimed live births using a combination of ICSI and Sr2+ (10mM) 
exposure for 60 minutes, in cases of repeated ICSI failure (Yanagida et al., 2006; Kyono 
et al., 2008; Chen et al., 2010). However, other studies have failed to show Ca2+ 
transients in human oocytes treated with 10 mM Sr2+ (Rogers et al., 2004) and no other 
groups are using Sr2+ to activate human, pig or cow eggs.      
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Figure  1.12  Schematic diagram showing the mechanism of how Sr
2+ 
releases Ca
2+ 
through IP3R 
stimulation.  Note, released Ca
2+ 
has a stimulatory and inhibitory feedback effect on IP3R. 
 
IP3Rs are thought to be present in all mammalian eggs. However, it is unclear why Sr
2+ 
works reliably in rodent eggs, but not in eggs of other species including human. It is also 
unclear why the effective concentration of Sr2+ for activation of mouse eggs varies from 
1.7mM to 20mM (Bos-Mikich et al., 1995; Zhang et al., 2005; Kishigami et al., 2007). 
Based on the previous questions, part of my research project will be trying to answer 
these questions.  
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1.2 Human eggs 
 
During fertilization in human, spermatozoa activate MII egg via a series of cellular 
events. These events started by series of rises in the free cytoplasmic Ca2+ in the first 
few minutes after gametes membranes fusion, originated from the sperm entry point 
(Lawrence et al., 1997). Taylor and his colleagues (Taylor et al., 1993) were able to 
show increases in cytoplasmic free Ca2+ in human eggs (Fig. 1.13). Aequorin was 
injected into human eggs as Ca2+ indicator; two groups of human eggs with and without 
zona were exposed overnight to capacitated sperm. Data analysis showed dramatic 
intracellular Ca2+ transients were recorded using a photomultiplier system. Interestingly, 
the amplitude, duration and frequency of these transients were similar in zona-intact 
and zona-free eggs. This was the first ever recorded Ca2+ oscillations in human eggs 
during IVF (Taylor et al., 1993).  
 
Figure  1.13 Representative figure of Ca
2+
-oscillations in human eggs after IVF. (Taylor et al., 1993) 
 
Ca2+ oscillations play a regulatory role on activation events as well as the 
developmental events (Ozil, 1990; Ducibella et al., 2002). Ca2+-oscillations have also 
been reported after ICSI on human oocyte using confocal microscope (Tesarik et al., 
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1994). They found that after sperm injection a single non-oscillatory free intracellular 
Ca2+ rise recorded and that did not provoke the activation. This was also obtained after 
the injection of medium without spermatozoa. However after lag period of 4-12 hrs 
recording, the oscillatory pattern of Ca2+ changes was recorded and that provoke the 
human egg activation (Tesarik et al., 1994). These oscillations were similar to the 
changes accompanying normal fertilization in mammalian. The interesting point here is 
the starting time point of Ca2+-oscillations which delays from half to several hours after 
ICSI (Nagy et al., 1994). However, these Ca2+ oscillations have been reported to start 
sooner if the sperm is damaged (Yanagida et al. 2001).   
Similar to other mammals such as rodents, Ca2+-oscillations at fertilizations of the 
human egg is induced by inositol trisphosphate (IP3), the catalytic product of 
phosphatidylinositol (4,5)-bisphosphate (PIP2) by phospholipase C (PLC). These 
oscillations initiate a series of cellular events within the egg, that is along with 
exocytosis for monospermia (Raz and Shalgi, 1998), the egg re-enters cell cycle by 
resuming meiosis, sperm nucleus de-condensation, maternal RNA recruitment, 
formation of pronuclei and initiation of DNA synthesis before the cleavage step (Nasr-
Esfahani et al., 2010). 
Regarding the parthenogenetic activation, both fresh and aged human eggs have also 
been reported to be activated parthenogenetically by various stimuli that increase 
intracellular Ca2+ level, such as calcium ionophores (A23187) (Winston et al. 1991; 
Borges et al., 2009; Nasr-Esfahani et al., 2010), and repeated electrical stimuli (Zhang 
et al., 1999). However, despite the several published reports which claimed that human 
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oocyte can be activated artificially in patient with repeated failed IVF and/or ICSI (Zhang 
et al., 1999; Yanagida et al., 1999; Perry AC et al., 1999; Rogers et al., 2002; Yanagida 
et al., 2006; Ahmady and Michael, 2007; Dirican et al., 2008). There is as yet no clear 
evidence showing Ca2+-oscillations triggered by artificial methods in human eggs. 
Notably, all these reported cases were reported in the combination with ICSI. This 
means that the activators of mammalian eggs have often not been shown to have the 
ability to induce any Ca2+ increase by themselves in human eggs. However, the use of 
combinations of these activators can be shown to improve the activation rates. Some of 
these combination protocols have shown better activation results, but with low success 
rates of subsequent preimplantation development in rabbits eggs (Nakagawa et al., 
2001). Attempts have been made to improve the parthenogenetic activation and the 
subsequent preimplantation developments in human eggs.  However, injecting 
complementary RNA (cRNA) encoding for human phospholipase C zeta (hPLCζ) is the 
only parthenogenetic activator that can triggers Ca2+-oscillations in human oocytes (Cox 
et al., 2002) (for a full details on this see later in PLCζ sections). In addition, cRNA 
possess the ability to enhance embryo development up to the blastocyst stage (Rogers 
et al., 2004). However there are a few limitations in the way of the clinical PLCζ 
application (see general discussion chapter). 
 
1.3 Ca
2+
-pumps and Ca
2+
-Channels 
 
The viability of cells, including eggs requires a tight control and regulation of 
cytoplasmic free Ca2+ concentrations (Pepperell et al., 1999). Intracellular Ca2+ levels 
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are maintained mainly by different type of ion transporters or channels. Ca2+ ions shuttle 
across endoplasmic reticulum (ER), mitochondrial and plasma membranes and 
regulated by channels, exchangers and pumps into and out of the cytosol (Cahalan, 
2009). Normally in cells, a low level cytoplasmic Ca2+ is maintained by different 
mechanisms in organelle’s and in plasma membranes. Ca2+ is removed from cytoplasm 
against its chemical gradient by ATP-driven systems into the SR/ER or extracellular 
space (Machaty et al., 2002a). Among those in the plasma membrane are Na+/Ca2+ 
exchanger, and the Ca2+-ATPase (Pepperell et al., 1999), both which play a keystone 
role in Ca2+ homeostasis process (Blaustein and Lederer, 1999). Interestingly, Ca2+ 
regulates wide range of cellular events such as cytoskeleton remodelling or release of 
vesicle contents, transcriptional changes and egg activation events (Machaty et al., 
2002a).  
 
1.3.1 STIM and Orai 
 
Ca2+ oscillations are mediated by the release of ER stores of Ca2+ and by external influx 
of Ca2+ (Igusa and Miyazaki, 1983) which involves a mechanism called store-operated 
calcium entry (SOCE), In this the depletion of intracellular stores of Ca2+ leads to Ca2+ 
influx (Berridge, 1995; Machaty et al., 2002a). This is relevant to mouse eggs since a 
decrease in the extracellular Ca2+ inhibits oscillations, and completely blocking 
extracellular Ca2+ influx by Ca2+ channel blocker such as Lanthanum blocks oscillations 
(Machaty et al., 2002a).  
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The sophisticated correlation between the ER and plasma membrane was established 
to show that the decrease in the Ca2+ content of ER, regardless of the cytosolic Ca2+ 
level, induces Ca2+ influx through the plasma membrane Ca2+ channels via SOCE 
feedback mechanism (Parekh and Putney, 2005). The exact molecular mechanism has 
been clarified by the identification of two proteins; STIM and Orai, both are a 
fundamental part of the calcium release activation channel (CRAC) activity. STIM1 is 
the Ca2+ sensor responsible for the molecular link between the ER Ca2+ store depletion, 
SOCE and the activation of CRAC channel in the plasma membrane i.e. stimulates 
SOCE but does not make the CRAC channel. Orai1 is the channel protein or the CRAC 
channel pore-forming subunit (Cahalan, 2009).   
In mammals and some other species there are two homologues of STIM proteins; 1 and 
2. STIM1 appears to be the primary sensor of Ca2+ in intracellular stores in mammalian 
cells (Roos et al., 2005). It compromise of two proteins separated by single membrane, 
the N-terminus is predicted to be within the ER lumen and contains negative charges 
typical of an EF-hand with Ca2+-binding domain The presence of an EF-hand motif in 
the ER lumen, suggests its role in sensing ER Ca2+. When the ER store is full the Ca2+ 
binds to the EF-hand domain of STIM. However, once the ER Ca2+ is depleted the STIM 
releases the bound Ca2+ and triggers CRAC channel activation (Cahalan, 2009). 
Knocking down STIM1 has shown a complete loss of SOCE and CRAC activity 
following Ca2+-store depletion. 
The other component of the CRAC channel in mammals is Orai1. The co-expression of 
Orai1 and STIM1 dramatically improves CRAC and SOCE activity (Mercer et al., 2006). 
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However, the co-expressed Orai1 and STIM1 gives electrophysiological features that do  
not match those originally described for CRAC since the CRAC activity declines upon  
substituting Ca2+ with other divalent cations such as Sr2+ or Ba2+. This suggests that 
STMI and Orai mechanism for Ca2+ influx may not be the only mechanism and implies 
that additional molecules might be involved (Smyth et al., 2006). 
1.3.2 Transient receptor potential channel 
 
There are a number of channels that can conduct Ca2+ into cells in response to store 
depletion; generally named as SOCEs. The transient receptor potential channel (TRP) 
is a gene product in Drosophila photoreceptors (Hardie and Minke, 1993) which 
includes seven related subfamilies: TRPC, TRPM, TRPV, TRPA, TRPP, TRPML, and 
TRPN (Estacion et al., 2001; Hardie, 2007). Initially, the canonical (TRPC) was  
regarded as the best candidate for SOCE, because TRPC show a remarkable similarity 
to the voltage-gated Ca2+ channels, except it lacks the voltage sensor of the latter 
(Machaty et al., 2002a). TRP was previously described only in non-mammalian species; 
however it has been expressed in mammals as well (Machaty et al., 2002a&b). Hence, 
after the cloning of the Drosophila TRP gene it has been reported that the TRP 
homologues are  expressed in mammals such as mouse where six related TRP genes 
identified (Zhu et al., 1996), They are also found in  rat (Funayama et al., 1996) and 
human tissue such as ovary, testis, heart, and brain (Zhu et al., 1995). Emptying 
internal stores either by IP3 or thapsigargin has been shown to have a triggering effect 
on some TRPC channel proteins like TRPC1, TRPC4 and TRPC5 which all share a 
similar structure and function as store-operated channels (Strubing et al., 2001; Beech, 
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2007; Hong-Tao Ma et al., 2008). In contrast, TRPC3 which acts as a Ca2+-activated 
non-selective cation channel, TRPC6, and TRPC7 appear to be activated primarily by 
DAG rather than store depletion (Hofmann et al., 1999). In addition to Ca2+ permeability, 
the TRPC channels can also conduct a divalent cations such Sr2+ and Ba2+. However, 
TRPC channel proteins appear dissimilar to CRAC electrophysiologicaly because 
CRAC channels have a lower conductance and are more specific than the TRP 
channels (Plant and Schaefer, 2003; Berridge, 1995). 
Interestingly, some studies show there might be a relation between TRPC channels and 
STIM1 and Orai1, which facilitate Ca2+ influx by modifying channel properties (Yuan et 
al., 2007). For example, STIM1 interacts with TRPC1, TRPC4, and TRPC5 and 
regulates their activities (Yuan et al., 2007). Furthermore, STIM1 with both TRPC1 and 
Orai1 localised together and regulates SOCE. More surprisingly, the co-expression of 
Orai1 with TRPC3 and TRPC6 appears to change TRPC3 and TRPC6 function from 
receptor-activated, non-store dependent channels to a store-dependent manner (Liao et 
al., 2007). The over-expression or knock down of TRPC, Orai1, and STIM1, studies 
have shown that TRPC5 supports a higher influx of Sr2+ than Ca2+ (Hong-Tao Ma et al., 
2008). In the contrary, a recent report has revealed no effect of either STIM1 or Orai1 
on TRPC channels function (DeHaven et al., 2009).  
The expression of TRP homologue in mammalian eggs has been reported. It was 
shown that the cDNA TRP sequences from pig eggs are 92.0% and 96.2% homolgous 
to mouse and human TRP sequences respectively (Machaty et al., 2002a). 
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1.3.3 Ca
2+
/Na
+
 exchange (NCX) 
 
There are three genes have been identified in mammals that code for the Na+/Ca2+ 
exchangers (NCX1, NCX2, and NCX3). However, the dominant in mammals is the 
NCX1 gene. All have similar sequential and functional properties: they have intracellular 
and extracellular surfaces with a relatively higher intracellular Ca2+ binding affinity 
(Machaty et al., 2002a). The NCX is driven by electrochemical gradient of Na+ across 
the PM (Carroll, 2000). The NCX is an ion transport protein located in plasma 
membrane, and it acts by translocating Ca2+ ions across PM in an exchange process of 
3 Na+ ions for one Ca2+ ion (Philipson and Nicoll, 1992; Carroll, 2000; Machaty et al., 
2002a). The continuation of this exchange process leads to the accumulation of the 
positive charges within the egg. This leads to the initiation of the efflux of Na+ by Na+/K+ 
pump and activation of the reverse action of NCX (Fig. 1.14). 
Ca2+ 3 Na+
Ca2+ 
3 Na+
Normal Na+/Ca2+ 
exchanger
Reverse Na+/Ca2+ 
exchanger
 
Figure  1.14 Schematic diagram show the direction of action of both normal and reverse modes of 
Na
+
/Ca
2+
 exchanger. The big arrow indicates the switch from forward to the reverse mode.   
 
In normal circumstances, the usual function of the NCX is to expel Ca2+ out and 
introduce Na+ in. However, in different conditions such as decreased extracellular Na+ 
or increased intracellular Na+, a reverse mode of action occurs, i.e. the NCX brings  
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Ca2+ into the cell rather than extruding it from the cell (Blaustein & Lederer, 1999). This 
takes place when the exchanger reversal potential is similar to the resting membrane 
potential (Carroll, 2000). The reversal potential is the value of membrane potential at 
which the NCX is reverses its action to the reverse mode. 
The NCX appears to expressed in the PM in a variety of animal cells including oocytes 
such as in hamster eggs in which the recovery of a Ca2+-dependent hyperpolarization 
was delayed in Na+ free medium (Igusa and Miyazaki, 1983), and mouse eggs 
(Pepperell et al., 1999) and in porcine eggs (Machaty et al., 2002b). 
In mouse and pig eggs functional evidence for NCX comes from studies which show 
Ca2+ extrusion is induced when Na+ was made rapidly available to the egg, after 
depletion, which means that NCX is activated. This concludes that NCX protein might 
contribute largely in Ca2+-haemostasis during the fertilization process (Pepperell et al., 
1999; Machaty et al., 2002a).  
The NCX is driven by a Na+ gradient and based on previous study we can calculate the 
reversal potential of the exchanger precisely using this equation (Carroll, 2000) 
(1) ER = (nENa
+ – 2ECa2+) /(n – 2)                        
(2) ENa+ = 61 log [Na+]out /[Na
+]in  &  (3) ECa
2+ = (61/2) log [Ca2+]out /[Ca
2+]in  
ER is the reversal potential, n = 3 (number of Na
+ ions exchanged for each Ca2+ ion)                                                                 
Both 2 and 3 were calculated assuming a temperature of 37C 
Replacing the known values for [Na+]in = 8 mmol l0
-1, [Na+ ]out =120 mmol l0
-1, [Ca2+]in = 
100 nmol l0-1 and [Ca2+]out = 1.7 mmol l0
-1 into equations (2) and (3) and then into (1), 
the ER results will be – 40 mV.  
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Although, the (– 40mV) value of ER is an estimated value, it is quite close to the oocytes 
resting membrane potential in mouse (Carroll, 2000) and in human eggs~ (-30 mV) 
(Feichtinger et al., 1988). This suggests that the NCX could be close to working in either 
direction in mammalian eggs. 
The [Na+]in value is the critical value that ER depends on, because in the literature it 
ranges from 4 to 12 mmol l-1, which were taken from different observations in a variety 
of cell types (Sonn and Lee, 1988; Johnson et al., 1991). Similar to the TRPC channel, 
it has been observed in cardiac myocytes studies that NCX can transport Sr2+ out of and 
into the cytosol (Sheu and Blaustein, 1986; Niggli, 1989).  
 
1.3.4 Ca
2+
-channels on endoplasmic reticulum 
 
There are several Ca2+ mediated channels in the endoplasmic reticulum (ER) 
membrane have been identified such as the inositol trisphosphate receptor (IP3Rs) and 
ryanodine receptors in mammalian eggs (Miyazaki, 1991). The major Ca2+ release 
channel in all eggs studied to date is the IP3R and its activity depends on the IP3 
production by PLC. IP3R act as a receptor to bind IP3 as well as a Ca
2+ releasing 
channel. The binding of the IP3 to the IP3Rs is an early event in the fertilization process 
that triggers a conformational change in the IP3Rs that allows Ca
2+ to be released from 
the ER lumen and enter into the egg cytosol (Leguia and Wessel, 2007). The role of the 
IP3 pathway in Ca
2+ release has been examined by microinjecting IP3 into the egg that 
showing the induction of Ca2+ release (Swann and Whitaker, 1986; Miyazaki, 1988; Wu 
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et al., 1997). On the other hand, injecting IP3 antagonist or IP3R antibody inhibits Ca
2+ 
release at fertilization (Miyazaki et al., 1992; Miyazaki et al., 1993). 
The other type of Ca2+ release channel that specifically triggered by ryanodine, hence 
named ryanodine receptors (RyRs) has also been identified in mammalian cells (Lai et 
al., 1989). There are several other small molecules, such as nitric oxide (NO), cGMP 
and cyclic ADP ribose (cADPR) that have been shown to some extent to have the ability 
to release Ca2+ from the ER mediated by other Ca2+ releasing channels that are also 
located in the ER membrane. Protein kinase G (PKG) is proposed to phosphorylate and 
activate nitric oxide synthases (NOS) which converts the L-arginine amino acid into NO 
(Leguia and Wessel, 2007). The latter triggers the RyRs on ER membrane to release 
Ca2+ (Fig. 1.15). The NO pathway seems to be necessary and sufficient to triggers Ca2+ 
release in sea urchins egg (Kuo et al., 2000) but not in vertebrates which include 
mammals (Hyslop et al., 2001). Although, some reports show the existence of RyRs in 
mouse eggs (Swann, 1992). However, their role in Ca2+ oscillations triggered by 
fertilization is minimal. It could be because that the NO pathway is a late event in 
fertilization process (Leckie et al., 2003). 
 
1.3.5 Intracellular Ca
2+
-homeostasis  
In mammalian fertilisation, the Ca2+-transients continue for 3 - 4 hours, and stop by the 
pronuclei stage (Marangos et al., 2003; Dumollard et al., 2004). The Ca2+ releases from 
the ER that cause cytosolic Ca2+ increases are either pumped back into the ER by 
sarco/endoplasmic reticulum Ca2+ ATPases (SERCAs) or extruded out of the egg by 
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plasma membrane Ca2+ ATPases (PMCAs) (Carroll, 2001) (Figure 1.15). In mammalian 
eggs and embryos, the most prominent organelles are the mitochondria, ER and CG 
(Sathananthan and Trounson, 2000). The key regulator of intracellular Ca2+ 
homeostasis during fertilization, egg activation and early development is the ER. There 
are structural junctions between ER and mitochondria in mouse, hamster (Yang et al., 
1989) and human eggs (Motta et al., 2000) which may suggest some functional 
association in Ca2+ signalling between them. 
Na+/Ca2+ exchanger (3:1)Ca
2+
Ca2+
Ca2+
Ca2+
3Na+
3Na+
Ca2+
ATP- dependent Ca2+ pump (1/molecule)
IP3R
ER/SR
Ryanodine receptor  (RyR)
  
Figure  1.15 This is an illustrative diagram showing how cells/eggs precisely maintain its Ca
2+
-
homeostasis using different kinds of Ca
2+
-channels/pumps. 
Egg derived immature mitochondria are the precursors of mitochondria in all cell types 
in mammals (Carroll, 2000). Furthermore, any disruption of Ca2+ signalling due to 
dysfunctional mitochondria ends with apoptosis i.e. the mitochondria protects eggs from 
persistent rise in Ca2+ which lead to death (Liu et al., 2001). Mammalian eggs show low 
metabolic rates and after fertilization as eggs develop the metabolic rate increases and 
mitochondria progress to maturity (Downs and Utecht, 1999) with changes in its 
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morphology to form cristae to cope with the increasing ATP requirement and oxygen 
consumption (Liu et al., 2001).  
1.3.6 IP3 production  
Cell membrane has a different forms of phospholipids such as phosphoinositide 
PI(3,4,5)P3 (PIP3) and phosphatidylinositol (4,5)-bisphosphate (PIP2). The former is the 
phosphorylation product of PIP2 by the class I phosphoinositide 3-kinases (PI 3-kinases) 
(Whitman et al., 1988). During the resting state in cells, the level of PIP3 is undetectable. 
However, it produced immediately upon cell stimulation. In contrast PIP2 level is 
relatively high in resting cells which counters 0.5 -1% from the total phospholipids. The 
importance of PIP2 comes from the changes in the PIP2 level by hydrolysis and 
synthesis in restricted areas (Fukami et al., 2010). 
There are two main types of Ca2+ release channels on the ER membrane. Ca2+ release 
is blocked by the inhibition of these channels IP3Rs and RyRs (Galione et al., 1993). In 
mammals, Ca2+-oscillations are mediated by IP3 induced calcium release (IICR) via the 
activation of IP3 receptors on the ER (Miyazaki et al., 1993; Carroll, 2001), which is 
known to be a major source for Ca2+ in mammalian eggs (Kline, 2000). The contribution 
from the extracellular Ca2+ during oscillations is probably to refill the IP3-sensitive Ca
2+ 
stores (ER) (Igusa and Miyazaki, 1983; Kline and Kline, 1992; Shirakawa and Miyazaki, 
1995). Before the novel discovery of PLCζ it was unclear exactly how the sperm triggers 
IP3 production in eggs in order to release Ca
2+  (Saunders et al., 2002; Yoda et al., 
2004). We now think that during fertilisation and just after sperm-egg fusion, the sperm 
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releases its content that contains PLC. The latter hydrolyse PIP2 to generate IP3 and 
diacyl glycerol (DAG). Raised levels of IP3 stimulate IP3Rs and Ca
2+-oscillations start. In 
fertilized mammalian oocytes, repetitive Ca2+ release from the ER causes Ca2+-
oscillations (Miyazaki et al., 1992, Miyazaki et al., 1993; Shiraishi et al., 1995). The 
released Ca2+ enhances the PLC activity (Swann et al., 1994), which in turn hydrolyses 
more PIP2 to generate extra IP3 within the egg which triggers IP3R and release more 
Ca2+ and this cycle repeated for several hours (Whitaker et al., 1993; Swann et al., 
1994; Fissore et al., 1998; Swann et al., 1999; Coward et al., 2003).  
IP3Rs down-regulation can be achieved by injection adenophostin A or  B, which are 
potent non-metabolizable fungal product (Shiraishi et al., 1995) and agonists of IP3Rs 
(Takahashi et al., 1993) with higher binding affinity to IP3Rs than IP3. Such down-
regulation  has shown inhibition of Ca2+ release in mouse eggs at fertilization  (Brind et 
al., 2000; Jellerette et al., 2000), including antibodies against IP3Rs (Miyazaki et al., 
1992; Miyazaki et al., 1993).  
 
1.4 Overview on Intracellular Ca
2+
 changes detection 
 
Today we know that Ca2+ signals is the key element in egg activation and embryo 
development (Stricker, 1999; Swann et al., 1999). Ca2+ is a key factor for maintenance 
of long lasting Ca2+-oscillations. Ca2+ is the main second messenger that controls the 
activation events (Miyazaki et al., 2006). However, it is worth reflecting upon the 
historical back ground of Ca2+ measurement in relation to egg activation and 
development.  
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  In the second decade of 20th century a US researcher team led by Jacques Loeb came 
up with the concept that, during fertilization, the sperm introduces a signal into egg and 
that this message may regarded as the key stimulus for egg activation and early embryo 
development (Sardet et al., 2006). Additionally, this team was the first who has 
discovered the process of artificial activation of sea urchin eggs (parthenogenic 
activation) i.e. without sperm involvement, by modifying the chemical components of the 
culturing media (sea water) or by exposing eggs to ultraviolet rays (Loeb, 1914). 
Between 1930 and early 1950s it was believed that Ca2+ ions play an important role in 
cell regulation processes in living bodies (Epel et al., 1998).  Some tried to establish this 
idea experimentally, and it was Daniel Mazia who carried out most of his research on 
fertilization in sea urchins.  He measured  the differences in Ca2+ content between the 
extracts of fertilized and unfertilized eggs and found that that Ca2+ increases by 10 -100 
fold in fertilized eggs (Mazia, 1937). 
   After the Second World War a group of scientists discovered a new chemiluminescent 
protein named aequorin (Shimomura et al., 1963). Aequorin is the first photoprotein 
discovered that is Ca2+ sensitive and emits blue light (~ 480nm) in the presence of Ca2+ 
ions, even in the absence of oxygen. Later during the extraction process of the aequorin 
from glowing Jelly fish via the column chromatography, another green fluorescent 
protein was eluted before aequorin, which then purified and named green fluorescent 
protein (GFP) (Shimomura et al., 1963). 
This started a new era in the monitoring of Ca2+ changes within cells by relaying on its 
sensitivity to aequorin. Using aequorin as a Ca2+ indicator in 1967 it was experimentally 
  60 
proven that Ca2+ is involved directly in the muscles contraction process. It was shown 
that the free Ca2+ levels rises in muscle cells just before the force increases and Ca2+ 
falls just before the force declines (Ridgway and Ashley, 1967; Ridgway and Gordon, 
1984; Shimomura, 2006).   
 
1.4.1 Fluorescent Ca
2+
-dyes 
 
Using aequorin requires specialist equipment, so in the early 1980s a newer generation 
of Ca2+ indicators (fluorescent dyes) were introduced such as quin-2, Fura-2 and indo-1. 
These were developed from the Ca2+ chelator BAPTA (fluorescent 1,2-bis-(2-
aminophenoxy)-N,N,N',N'-tetraacetic acid) (Cobbold and Rink, 1987). Henceforth, Ca2+ 
oscillations began to be observed in all other species studied (Jaffe, 1985; Stricker, 
1999) including plants (Dumas et al., 2006).  
With the introduction of the fluorescent dyes the intracellular free Ca2+ changes become 
relatively easy to measure, however these dyes were hydrophilic and did not cross the 
plasma membrane. To overcome this dilemma, a trick was used to turn them into 
lipophilic membrane permeable derivatives using acetoxymethyl (AM) esters. The 
complex is then cleaved by cytosolic esterases to release free dye in cytosol. However, 
this technique also faces a problem; for example, fura-2-AM accumulates in the 
intracellular organelles and can this give a false impression on Ca2+ levels (Cobbold and 
Rink, 1987). To get around this some of the Ca2+ indicators were conjugated to dextrans 
(long-chain polysaccharides of high molecular weight). These so called dextran-
conjugated Ca2+ indicators appear particularly promising for Ca2+ measurements at 
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physiological temperatures for prolonged periods (Beierlein et al., 2004). Currently, this 
class of indicators is widely used as the preferable Ca2+ dyes in large cells such as 
eggs. The ones I used in my Theses are oregon green bapta dextran (OGBD) (494-
523nm) and Rhod Dextran (RhD) (550-580nm) and in only IVF experiments I used 
Fura-Red (488-660nm). 
1.4.1.1 Measuring Ca2+ in eggs  
 
It was impossible to monitor Ca2+-oscillations in eggs until the availability of two good 
methods for Ca2+ measurement (calcium dyes and aequorin). Once scientists were able 
to measure cytoplasmic Ca2+ changes in eggs, they used aequorin to show that there is 
a large wave-like  Ca2+ increase at fertilization in medaka fish eggs and (Ridgway et al., 
1977) and sea urchin eggs (Steinhardt et al., 1977). Later aequorin was used show 
Ca2+-oscillations in fertilizing mouse and hamster eggs (Miyazaki et al., 1986).  Later still 
fura2 and dextran derivatives were also used show Ca2+ increases at fertilization in sea 
urchin eggs, and Ca2+-oscillations in fertilizing eggs of various mammalian species 
(Hafner et al., 1988; Harrison et al., 2002) respectively.  
    
1.4.2 Bioluminescence (Chemiluminescence) 
 
Bioluminescence is a natural process that occurs in living organisms in which they give 
off visible light from chemical energy. It is also a powerful in vivo imaging tool. The 
sensitivity ranges from 10nM to1mM with a very high efficient signal to noise detection 
level even with ~ 1-100 photons/sec. Bioluminescence has been used to monitor ATP 
(Dumollard et al., 2004) and Ca2+ changes (Ridgway et al., 1977) in cells and eggs. 
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1.4.2.1 The luciferase-luciferin system  
 
Newton Harvey first discovered luciferin and an enzyme called luciferase from Cypridina 
(a small crustacean) (Harvey, 1926). He found that these two substances are produce 
strong bright blue luminescence (peak emission wavelength 482 nm) when mixed 
together in aqueous solution (Harvey, 1926) in an oxygen-dependent bioluminescent 
reaction (The luciferase-luciferin system). However, the luciferase is closely associated 
with green fluorescent protein (GFP). Therefore, in the presence of GFP a green light 
luminescence is released (peak emission wavelength 510 nm) (Shimomura, 1985). 
Luciferin has been extracted, purified, and crystallized from dried Cypridina. Similarly 
luciferase has also been extracted and purified (Shimomura, 2006). 
The most common types of the living organisms that are bioluminescent are beetles e.g. 
click beetles and fireflies (Wilson and Hastings, 1998) that emit light flashes in a range 
of colours from green to yellow (550-580 nm) (Fig 1.16). Studies on North American 
firefly have shown that luciferase is located in organelles called peroxisomes in the 
photocytes that located on the ventral surface of the sixth and seventh abdominal 
segments (Wilson and Hastings, 1998).  
There are several factors that augment luciferase-luciferin signals such as the pH , 
temperature (Seliger and Mc, 1960), ionic strength (Denburg and McElroy, 1970), 
protein concentration (Allue et al., 1996) and chloride concentration (Ugarova et al., 
1981). On the other hand, luciferase-luciferin signals was also shown to be inhibited by 
high concentrations of oxyluciferin (Gandelman et al., 1994). The optimal luciferin 
concentration in media has been suggested to be 100 μM for luminescent recordings 
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(Gandelman et al., 1994). Firefly luciferase is a protein dimer of around 100 kDa. The 
luciferin-luciferase reaction takes place in 2 steps; first formation of adenosine 
monophosphate (AMP)-luciferin, followed by its oxidation to form oxyluciferin (excited 
state) (Fig. 1.16). Throughout my study I will use the luciferase developed from a North 
American firefly (Photinus pyralis) to measure the protein expression via a luciferin-
luciferase reaction (Steghens et al., 1998). 
Chemiluminescence
Bioluminescence
Luciferase
enzyme
light
oxyluciferin
luciferin 
AMP-luciferin
adenosine mono-
phosphate (AMP)
oxygen
1
2
 
Figure  1.16 The luciferin-luciferase reaction. (Steghens et al., 1998) 
 
1.5 Signalling transduction mechanisms of Ca
2+ 
release at 
fertilization in mammals 
 
Along with the development of the ability for measuring cytosolic free Ca2+, a few 
questions have come up concerning the source and the causative factor for this release 
at fertilization. Throughout the literature there have been three hypotheses concerning 
this issue. In the following paragraphs I will concentrate on these theories and discuss 
aspects that confirm or contradict each idea separately, and draw comparisons between 
different species where ever possible. 
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1.5.1 The Ca
2+
 influx theory 
 
This theory is based on the principle of Calcium induced calcium release (CICR) 
whereby injecting a relatively small amount of Ca2+ into egg can trigger greater Ca2+ 
release. This theory describes a mechanism by which sperm plays a role as  a conduit  
allowing an influx of extracellular Ca2+ into the egg through sperm membrane pores at 
sperm-egg fusion (Jaffe, 1991; Runft et al., 2002), see (Fig. 1.17A). This idea is 
supported by the finding that taking fertilized oscillating eggs and incubating them in 
Ca2+ free media stops the oscillations. They can then be restarted by regular sustained 
Ca2+ injections (Igusa et al., 1981). Further support comes from the finding that sperm 
egg fusion occurs  before the Ca2+-oscillations start (Lawrence et al., 1997). According 
to Jaffe, in mammals and in other species, sperm pick up Ca2+ in the pre-fertilization 
period then introduced it after sperm egg fusion and this Ca2+ act as a trigger stimulus 
for internal Ca2+ store release (Jaffe, 1983). However, in mammals injection of Ca2+ only 
cause a single transient and never induces oscillations (Swann and Ozil, 1994). 
Furthermore, by injecting eggs with Ca2+ repeatedly it was shown that the oscillations 
pattern that looks different from normal fertilization (Igusa et al., 1981; Swann et al., 
1994). In addition this idea was ruled out by the evidence that showed no localized 
increase of Ca2+ near the site of sperm-egg fusion in the mouse (Jones et al., 1998; 
Runft et al., 2002). Therefore, any Ca2+ increases after sperm-egg fusion do not seem 
to be a result of increased plasma membrane permeability to Ca2+. 
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1.5.2 Sperm receptor model 
 
This theory followes the principle of the hormone receptor system, in which a hormone 
binds to receptors on the plasma membrane, In this model, the sperm acts as a ligand 
that during fertilization firstly adheres to the plasma membrane via an egg membrane  
receptor (Foltz and Shilling, 1993; Schultz and Kopf, 1995). Following this model the 
sperm acts in the way of somatic cells that lead to the generation of IP3. Since sperm-
egg binding is mediated by surface proteins, the presence of some coupling protein 
such as guanosine tri-phosphate (GTP) binding proteins (G protein) in the egg 
cytoplasm, could be the link between the sperm-egg receptor structure and intracellular 
signalling, see (Fig. 1.17B).  
 Subsequently the receptors stimulate an egg specific phosphotidylinositol 
phospholipase C (PI-PLC) that, in turn, cleaves the lipid PIP2 and generates IP3 (Swann 
et al., 1994; Rhee, 2001; Miyazaki et al., 2006) and diacylglycerol (DAG) (Rhee, 2001) 
which activates protein kinase C (Miyazaki, 1991). There are two isoforms of PI-PLC 
have been postulated to play a role or involved in this process, one is PI-PLCγ which 
couples via tyrosine kinases (Swann et al., 2002) and the other is PI-PLCβ which 
attaches  to membrane receptors via G proteins.,  
  This model was supported by the finding that the injection of nonhydrolyzable GTP 
analogs to trigger G proteins has been shown to cause transient Ca2+ release in 
hamster eggs (Miyazaki et al., 1993; Swann et al., 2002). This idea also appears to 
have support from experiments in which a constant injection of IP3 gives rise to Ca
2+-
oscillations (Swann et al. 1990; Swann 1994; Miyazaki et al., 2006). Inhibiting G 
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proteins by non-hydrolyzable GDP analogue also blocks Ca2+ release during normal 
fertilization in hamster eggs (Miyazaki, 1988; Swann et al., 2002).  However, 
subsequent injection of IP3 showed no effect of GDP analogue on Ca
2+ release 
(Miyazaki, 1988). Further, blocking IP3 receptor using monoclonal antibody injection 
show an inhibitory effect on sperm induced Ca2+-oscillations (Miyazaki et al., 1992). This 
finding confirms that IP3 receptor is certainly plays an important role in Ca
2+ release 
during fertilization process in mammals (Swann et al., 1994). In addition, Fissore and 
his colleagues have studied the importance on IP3 in Ca
2+ release using different kind of 
mammalian eggs. In rabbit and cow eggs they used heparin as a competitive inhibitor of 
IP3 and have reported the inhibition of Ca
2+-oscillation at fertilization (Fissore et al., 95; 
Leguia et al., 2007).  
Although this idea of a G protein receptor seems plausible, it has been reported that 
there are some anomalies. For instance, Ca2+-oscillations during normal fertilization of 
hamster eggs show variable frequencies, with no damping of oscillation amplitude over 
a period of more than 2hrs (Miyazaki, 1991). In contrast, the pattern after injecting GTP 
analogs, or IP3, are always of   high frequency and are always critically damped 
oscillations (Swann et al., 1994; Swann et al., 1999).  In addition, the production of DAG 
together with IP3 production as a result of phospholipase C activation by G protein leads 
to protein kinase C activation (Leguia et al., 2007). And activating protein kinase C by 
phorbol ester was found to cause complete inhibition of Ca2+-oscillations that mediated 
by G protein and vice versa with the inhibition of protein kinase C using sphingosine. In 
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contrast treating eggs with phorbol ester at fertilization show no effect on Ca2+-
oscillations.  
The most convincing proof against the receptor theory is represented by the invention of 
intra-cytoplasmic sperm injection (ICSI), in which injecting a single sperm into the egg’s 
cytoplasm lead to Ca2+-oscillations and successful egg activation and live birth (Kimura 
and Yanagimachi, 1995; Stricker, 1999). From this point of view it can be claimed that 
Ca2+ release during normal fertilization in mammals is not consistent with sperm 
receptor models.  
1.5.2.1 Sperm factor hypothesis 
 
This is the most recent theory, and now seems most likely explanation for Ca2+ release 
in mammalian eggs. It proposes that following sperm-egg fusion the sperm introduces a 
Ca2+ releasing substance(s) (or soluble cytosolic factor) into the egg (Swann, 1990; 
Fissore et al., 1998), see (Fig. 1.17C). In mammalian eggs, this idea has been studied 
considerably in the last two decades (Runft et al., 2002). This model is consistent with 
data showing that sperm-egg plasma membranes and cytoplasm continuity is the 
prerequistic step for Ca2+ release in normal fertilisation (Miyazaki et al., 2006; Lawrence 
et al. 1997). Furthermore, using dye transfer studies that enable to determine the time 
of sperm-egg fusion together with simultaneous Ca2+ monitoring in in vitro fertilization, 
show that sperm-egg fusion proceeds initial rise in Ca2+ by 1–5 min (Lawrence et al., 
1997; Jones et al., 1998).  
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Figure  1.17 Schematic illustrations of different theories of Ca
2+ 
release. 
 
This suggesting that sperm factor hypothesis describes a mechanism by which a sperm 
could introduce a factor into ooplasm that responsible for Ca2+ release and induce 
activation during fertilisation (Swann, 1990; Swann and Ozil, 1994). 
The first clear evidence for this hypothesis came after the injection of sperm extracts 
from hamster or boar into hamster eggs was shown to induce Ca2+-oscillations similar to 
the fertilization pattern (Swann, 1990). Since then, other research groups have 
confirmed this finding with other mammalian species (Swann, 1994; Homa and Swann, 
1994; Sousa et al., 1996; Palermo et al., 1997; Sakurai et al., 1999).  
With the invention of intracytoplasmic sperm injection (ICSI) in early 1990s there was 
further strong evidence to the soluble factor hypothesis. It was shown that injection of 
one sperm into oocyte can cause Ca2+-oscillations mimicking to those shown in normal 
fertilization (Stricker, 1999; Swann et al., 1999). It was concluded that the soluble factor 
content of a single sperm is enough to maintain Ca2+-oscillation for the period of the 
physiological range. Further evidence which firmly stands with this hypothesis has been 
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noticed by (Lawrence et al., 1997) after carrying out IVF in mouse and they used 
confocal microscopy to show the egg and sperm cytoplasmic continuity with two 
independent fluorescence methods to monitor Ca2+ and found that the fusion precedes 
the onset of the first Ca2+ spike in mouse eggs. Moreover, they estimated the time 
elapsed after sperm-egg fusion to detect the first Ca2+ spike by several minutes (1-3) 
(Lawrence et al., 1997; Miyazaki et al., 2006). This information further suggested that 
sperm egg-fusion is necessary for normal fertilization and did not require the stimulation 
of egg plasma membrane receptors (Lawrence et al., 1997; Leguia and Wessel, 2007).   
In mammals, the sperm factor tends to be non-species specific (Swann, 1990; Wu et al., 
1997). Sperm extracts from different species including human have shown the ability to 
trigger Ca2+-oscillations and egg activation in other species such as mouse eggs 
(Swann et al., 1994; Fissore et al., 1998; Swann et al., 1999; Parrington et al., 1999; 
Coward et al., 2003). Pig sperm extracts have also been reported to trigger Ca2+ 
transients in mouse and cow eggs (Wu et al., 1997). Fish sperm extracts are also able 
to trigger Ca2+-oscillations in mouse eggs (Coward et al., 2003). Further evidence 
includes the ability of sperm extracts from non-mammalian such as chicken and frogs 
can cause Ca2+-oscillations in mouse and cow eggs (Dong et al., 2000). It can also 
been shown that sperm extracts cause Ca2+-oscillations in cells such as hepatocytes 
(Swann et al., 2002). Furthermore, the injection of the sperm factor from flowering 
plants into mammalian eggs showed Ca2+-oscillations (Li et al., 2001). Sperm extracts, 
besides causing Ca2+ release, also cause full egg activation as indicated by cortical 
granule exocytosis, protrusion of the second polar body, pronuclear formation, and cell 
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cleavage (Meng and Wolf, 1997; Wu et al., 1998; Sakurai et al., 1999; Gordo et al., 
2000), and they trigger embryo development to up to the blastocyst stage (Fissore et 
al., 1998). Importantly adding sperm extracts onto the surface of eggs has no effect 
what so ever (Swann, 1990). This further suggested that sperm factor needs to cross 
the membrane, and clearly this would not happens unless either one of these took 
place; gametes’ membrane fusion or direct injection of sperm extracts.  
1.5.2.2 Search for the sperm factor 
 
In the past decade, progress has been made in identifying sperm factor related 
molecules. The current evidence suggests that Ca2+ release in mammalian eggs is by a 
mechanism in which an activating factor introduced from the sperm cytoplasm into the 
egg cytoplasm after sperm-egg fusion (Lawrence et al., 1997). Several sperm proteins 
have been proposed as sperm factor molecules (Yoon et al., 2008). Two major issues 
need to be resolved. First, the identification of a potential factor; and second, whether it 
is the physiological egg activator or not? 
This factor was first shown to be protein in nature (Swann, 1990; Fissore et al., 1998). 
This is because its activity is abolished after protease treatment or heating (Swann, 
1990; Wu et al., 1997; Swann et al., 2002). According to Perry et al., (1999) the sperm 
factor is a sperm oocyte activating factor (SOAF) and found to be located in spermatic 
perinuclear area. With detection of c-kit in mouse sperm, SOAF was proposed to be a 
truncated version of c-kit named tr-kit (Setti et al., 1998). Additionally, mouse eggs 
undergo activation events when injected with extracts from cells expressing 
recombinant tr-kit. This activation ability of tr-kit has been reported to be blocked using 
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antibody against PLC and/or injection of SH3 domain of PLC, suggesting the role of 
PLC in activation process (Setti et al., 1998). However, injecting these SH3 domain 
constructs into normally oscillating eggs show they have no effect on Ca2+-oscillations. 
This finding was used to rule out the proposed identity of tr-kit as a physiological sperm 
factor. It is also noted that the injection of tr-kit has never been shown to cause any 
Ca2+-oscillations.  
It has been claimed that IP3 is the sperm factor, or least a primary initiator of intracellular 
Ca2+ release at fertilization (Jaffe et al., 2001). However, this is not consistent with 
findings in mammals where the sperm factor is clearly a protein of some form. However, 
injecting eggs with sperm extracts has been shown to cause a rise in the IP3 levels, 
which suggests that sperm factor perform its action through IP3 pathway (Wu et al., 
2001; Leguia and Wessel, 2007).  
Within mammals, the sperm factor theory appears to be consistent across species. It 
has been reported that sperm extracts has phospholipase C (PLC) activity, suggesting 
that sperm factor is a form or subtype of PLC (Swann et al., 1999).  Hence, the 
differences between this theory and the sperm receptor model may be mainly regarding 
the source of PLC, and the way of sperm-egg interaction. This theory argues that PLC 
comes from directly from the sperm; meanwhile, sperm model claims that it is an egg 
source of PLC. The other difference is that in the former theory, is that the sperm 
attaches to the egg plasma membrane receptor to activates the egg’s PLC, whereas in 
the sperm factor model the sperm plasma membrane fuses with the egg via a receptor 
and then delivers its PLC into the egg cytoplasm to trigger Ca2+ release.    
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The sperm factor hypothesis was hypothesized depending on three observations. First, 
the Ca2+-oscillations in mouse start several minutes after sperm-egg fusion (Lawrence 
et al., 1997). This suggests that fusion is a prelude to Ca2+ release. Second, with the 
novel discovery of ICSI, the normal Ca2+-oscillations and egg activation are possible 
using ICSI techniques which bypass sperm-egg interactions at the plasma membrane 
(Kimura and Yanagimachi, 1995; Palermo et al., 1996; Nakano et al., 1997; Lawrence 
et al., 1997). Finally, injecting the sperm extracts into eggs caused Ca2+-oscillations and 
egg activation. 
It has been suggested that the sperm extract activates eggs by the same pathway used 
at fertilization, since blocking of IP3 receptor by antibody withholds Ca
2+ release that 
was triggered by sperm extract in mouse eggs (Miyazaki et al., 1992).  
 
1.5.2.3 Discovering of PLCζ as a sperm factor 
 
The sperm factor theory has now been adopted by many groups over the last few years 
as a result of the identification of PLCζ which was identified as a new isoform of PLC 
with a size range of (~70 kDa) (Saunders et al., 2002).  
PLCζ was first discovered by the analysis of a mouse expressed sequence tags (EST) 
database from mouse testis. A gene for a PLC-related sequence was found and an 
antibody made against a peptide antigen (from the putative PLC sequence C terminus). 
Using Western blots this band was only found in testicular tissue, which suggests that 
the ~70 kDa protein that enriched in sperm is the new PLC (Saunders et al., 2002). This 
new PLC was termed PLCζ. After the identification of the novel sperm-specific PLCζ in 
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mouse, a genomic search for sperm- and testis specific PLCs has been carried out and 
has characterized a PLCζ in human (Cox et al., 2004), and other species (Saunders et 
al., 2007). 
Interestingly, during the fluorescent based assays using sea urchin egg homogenates, 
the same (~70 kDa) protein was found to co-migrate with Ca2+ releasing activity. This 
was in contrast to the results from previous studies on PLC,  and δ isoforms that 
found no co-migration with Ca2+ releasing activity (Wu et al., 2001; Parrington et al., 
2002). Additionally, the ~70 kDa PLC protein seems unrelated to the more recently 
discovered PLC which has a molecular mass ~250 kDa (Song et al., 2001; Parrington 
et al., 2002). Further supporting evidence for this novel discovery comes from three 
lines. Firstly, the removal of PLCζ from sperm extracts caused a total loss of Ca2+ 
releasing activity in eggs. Secondly, injecting eggs with cRNA encoding for PLCζ 
caused Ca2+-oscillations undistinguishable from those seen in normal fertilization. 
Finally, PLCζ has been reported to possess the ability to support embryonic 
development (Saunders et al 2002; Rogers et al., 2004; Swann and Yu, 2008). Much 
more recently, a research study reported that human sperm that lacks PLCζ neither 
trigger Ca2+ release nor induce the first step of embryo development in mouse eggs 
(Yoon et al., 2008).  
 
1.6 Phospholipase C zeta (PLCζ) 
 
 It has been widely accepted nowadays, at least in mammals, that PLCζ is the main 
candidate for the endogenous agent or the physiological egg activator at fertilization 
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(Cox et al., 2002; Swann et al., 2006). It has been shown that cRNA encoding human 
PLCζ (hPLCζ) can causes a long lasting series of Ca2+-oscillations in mouse (Cox et al., 
2002) and ‘failed to fertilize’ human eggs (Fig. 1.18) (Rogers et al., 2004). Moreover, it 
can also trigger oocyte activation which leads to enhanced embryo development to the 
blastocyst stage (Rogers et al., 2004). But before I go in the details of PLCζ, I will give a 
general overview on the PLCs family and subfamilies.    
 
Figure  1.18 Ca
2+
-oscillations in human oocytes triggered by different concentration of cRNA encoding 
PLCζ.  (Rogers et al., (2004) Reproduction.128 , 697-702). 
 
1.6.1 Structure and function of PLCs in general. 
 
At least thirteen PLC isoforms that have been discovered that are expressed in 
mammals. Based on their structure and regulatory activation mechanisms they have 
been classified into six different subfamilies, the δ (1, 3, 4),  (1, 2, 3, 4),  (1, 2),  (1, 
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2),  and more recently also ζ (Rhee, 2001; Hicks et al., 2008). Since PLC is a soluble 
protein during the resting state it is usually distributed in the cytoplasm. However, upon 
cell activation it targets to the plasma membrane to hydrolyze PIP2 which is a critical 
event for signal transduction (Fukami et al., 2010). Each PLC isoform contains subtype-
specific domains as well as conserved PLC domains (Leguia and Wessel, 2007; Fukami 
et al., 2010), see (Fig. 1.19).  
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Figure  1.19 Schematic illustration of the domain structure of different PLCs. Catalytic and regulatory 
domains and their interacting molecules are shown. PH (pleckstrin homology domain), EF (EF-hand 
domain), X & Y (PLC catalytic domains), C2 (C2 domain), PDZ (PDZ-binding motif), SH (src homology 
domain), RasGEF (Ras-GTPase exchange factor-like domain) and RA (Ras-associating domains). 
 
Although there is no high structural sequence homology between these isozymes, the 
amino acid sequence between similar domains of all isozymes is up to 50% 
homologous (Fukami et al., 2010). All isozymes are composed of catalytic X and Y 
domains that come together to form the PIP2 cleavage active site (X-Y domain), as well 
  76 
as an EF-hand motif, and a C2 domain (constant region 2 of PKC) (Rhee, 2001). The 
C2 domain was first identified in protein kinase C. Most C2 domains bind Ca2+. C2 
domains have been also characterized as membrane-associating domains referring to 
their involvement in Ca2+-dependent phospholipid interactions (Nalefski and Falke, 
1996).  
With the exception of PLCζ, all other PLCs proteins subfamilies have various 
combinations of regulatory domains including a pleckstrin homology (PH) domain and 
SH2 domains (Src homology 2) as in PLC (Rhee, 2001). PH domains in different PLCs 
are responsible for targeting to the membrane via polyphosphoinositides binding to PIP2 
or PIP3 (Harlan et al., 1994). SH2 domains bind to receptor protein tyrosine kinases and 
non-receptor tyrosine kinases like Src (Leguia and Wessel, 2007).  
1.6.1.1 Regulation and activation of PLC isozymes 
 
All PLCs are activated by specific stimulants and they generally have their own 
regulatory mechanisms (Rhee, 2001; Nomikos et al., 2007). However, Ca2+ is needed in 
the activation of all PLC isoforms. Various regulatory mechanisms can be found within 
particular PLC subfamily. For example, Ras-related GTPases such as Rac activate 
PLC2, 3, and 2, whereas PLCε is activated by Ras, Rap, and Rho (Hicks et al., 
2008). PLCβ subtypes are regulated differently by G and Gq, the components of the 
heterotrimeric G-proteins family (Offermanns et al., 1997). Similarly, PLC2 might be 
regulated also by G which is part of the G-protein coupled receptors since higher PLC 
activity has been reported with the co-expression of PLC2 and G (Zhou et al. 2005). 
However, PLC2 is very sensitive to Ca2+; it is probably the only PLC that is equal to the 
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PLCζ Ca2+ sensitivity (Fukami et al., 2010). PLC isozymes are activated by various 
receptor and non-receptor tyrosine kinases (Leguia and Wessel, 2007; Fukami et al., 
2010). In addition, The SH2 domains of PLC1 are necessary for the tyrosine auto-
phosphorylation and activation (Fukami et al., 2010). The detailed study on structural 
analysis of PLC has revealed that the RA2 domain of PLC binds to the Ras complex 
prior to the translocation and activation of PLC on the membrane (Bunney et al., 2006).  
 Interestingly, both PLCδ and ζ are very sensitive to physiological Ca2+ levels, which 
might be part of their regulation and function. PLCδ in particular might be regulated by 
Ca2+ alone (Kim et al., 1999). Its activation occurs in two steps, firstly PLCδ1 binds to 
the membrane via PH domain-PIP2 interaction, followed by another interaction mediated 
by the C2 and catalytic domains of the PLCδ1 that expose the active site leading to 
PLCδ1 activation and eventually PIP2 hydrolyzes (Lemmon et al., 1997; Fukami et al., 
2010). In general PLC,  and  bind specifically to plasma membrane proteins in a 
protein-protein interaction, whereas PLCδ1 has PH domain that binds specificity with 
high affinity to the PIP2 in a protein-lipid interaction (Nomikos et al., 2007). On the other 
hand, a specific PLCζ activator is as yet unknown. The extreme sensitivity of PLCζ to 
Ca2+ even at the resting Ca2+ concentration might be sufficient for PLCζ activity in the 
absence of a stimulus (Saunders et al., 2002). 
1.6.1.2 PLC isozymes expression in mammalian tissues 
 
The physiological function of many PLC isozymes is predicted by their tissue 
distributions. The expression of PLC isozymes is widely expressed in different 
mammalian tissue but mainly in the brain. On the other hand, PLC has been found 
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mainly in the brain and lungs (Suh et al., 2008). While PLCδ isozymes are distributed 
more widely and abundantly in the brain, heart, lungs, skeletal muscle, and testes (Suh 
et al., 2008), PLC is highly expressed in the heart, lungs and kidneys (Song et al., 
2001). PLC seems to be neuron-specific as it has been only observed in the brain 
tissue (Fukami et al., 2010). Similarly, PLCζ seems to be sperm-specific as it has been 
found mainly in sperm, suggesting its specific role in sperm (Saunders et al., 2002). 
However, it has been found with evidence of PLCζ in ovary of puffer fish (Coward et al., 
2011).   
To understand the role of different PLCs in fertilization, several studies were carried out 
to identify these PLCs in the gametes and these studies have shown that in eggs both 
PLC and γ are expressed, while in sperm more isoforms have been identified such as 
PLC, , δ, and most recently ζ (Mehlmann et al., 1998; Wang et al., 1998; Wu et al., 
2001; Parrington et al., 2002; Saunders et al., 2002). 
 
1.6.2 Structure and function of PLCζ 
 
PLCζ is a very unstable protein in vitro, which is one reason why we inject cRNA 
encoding PLCζ to study its structure and function. PLCζ has the smallest size sequence 
among all other PLC isoforms that have been identified so far (Rhee, 2001) (Fig. 1.19). 
Mouse PLCζ composes of a sequence of 647 amino acids, with a molecular mass of 74 
kDa that also includes the C-terminal peptide sequence (Saunders et al., 2002). On the 
other hand, human PLCζ is even shorter with a sequence of 608 amino acids (Cox et 
al., 2002). Interestingly, despite the fact that human PLCζ is the shortest PLCζ among 
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all other PLCζs of all species studied so far (Saunders et al., 2007) it appears to be the 
most potent isoform in eggs. This enzyme protein is composing of four main domains 
(Fig. 1.20).  
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Figure  1.20 mPLCζ domains and amino acid compositions. 
 
1.6.2.1 EF hands 
 
There are four EF hand motifs at N terminus (Saunders et al., 2002; Miyazaki and Ito, 
2006). Many known proteins contain EF-hand motifs in their structure that are able to 
modify their conformation upon Ca2+ binding. Their structures are arranged in a helix-
turn-helix motif. Structural analysis study of these motifs in PLCδ1 showed that they 
seem to be responsible for conformation changes rather than Ca2+ binding (Essen et al., 
1996; Saunders et al., 2007). Previous report suggested that EF hand domains might 
act to target the membrane PIP2 (Nomikos et al., 2005). But a newer report suggested 
that PLCζ targets the intracelullar vesicular membrane (Yu et al., 2012). 
1.6.2.2 Catalytic domains 
 
The catalytic X and Y domains of PLC is a barrel-like components consisting of α-
helices and β-sheets in alternative patterns (Saunders et al., 2007). The X and Y 
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catalytic domain are separated by a region named X-Y linker region. Significant 
sequence conservation is found in PLCζ -X and Y catalytic domains that make it distinct 
from other PLC isoforms (Saunders et al., 2007).  
1.6.2.3 X-Y linker region (XYl) 
 
This linker region in PLCζ varies in length among species, where the longest is in the 
rhesus monkey, and the shortest in humans (Saunders et al., 2007).  The XYl region of 
PLCζ consists of 77aa residues extends from 308-385 of PLCζ sequence (Fig. 1.20). 
These regions are free of any predicted secondary structure. The XYl also shows the 
greatest variation between all PLC isoforms for a region connecting the catalytic 
domains. The most interesting sequence in this region is the nuclear localisation signal 
(NLS). The latter appears to be responsible for PLCζ localization into pronuclei during 
fertilization in mice (Swann et al., 2006). To follow in this Theses I and my colleagues 
investigated the XYl region in further aspects toward PLCζ targeting and regulation. 
1.6.2.4 C2 domain 
 
C2 domains have been identified in a wide range of proteins including all isoforms of 
protein kinase C, phospholipase A and phospholipase C (Nomikos et al., 2011b), and 
structurally they all are about 120 residues in length (Fig. 1.20), and are composed of a 
sandwich of two, four-stranded β-sheets. They are quite diverse in sequence which may 
explain the wide range of lipid specificity. However, these domains bind lipid in two 
ways, either Ca2+-dependent or independent (Saunders et al., 2007). The C2 domain in 
PLCζ seems to have a pivotal role in cell physiology since truncated PLCζ with a C2 
domain deletion is unable to cause Ca2+-oscillations in mouse eggs, despite preserving 
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its PLC activity in vitro (Nomikos et al., 2005; Kouchi et al., 2005). The screening of 
phosphoinositides for interaction with the PLCζ-C2 domain, through protein-lipid overlay 
assays, revealed that PLCζ-C2 can bind both phosphatidylinositol 3-phosphate 
(PtdIns3P) and phosphatidylinositol 5-phosphate (PtdIns5P) (Kouchi et al., 2005; 
Nomikos et al., 2005), but not to phosphatidylserine (Saunders et al., 2007) . However, 
there is no proof for the PLCζ C2 domain binding to membrane phospholipids through a 
Ca2+-dependent manner (Kouchi et al., 2005).  
 
1.6.3 PLCζ Ca2+-releasing activity versus other PLCs 
 
PLCs sequence alignment analysis suggests that PLCζ has the closest sequence 
homology with PLCδ1 (47% similarity, 33% identity) (Saunders et al., 2002).  However, 
there are two distinct features noticed between the two isoforms.  First is the existence 
of the N terminal PH domain in PLCδ1 that mediates its interactions with the plasma 
membrane, The second apparent difference is in the linker region between the 
conserved X and Y catalytic domains in both PLCs. In particular a cluster of basic 
residues is found in the PLCζ linker region proximal to the Y domain that PLCδ1 lacks 
(Saunders et al., 2007). This explains why X-Y linker region in PLCδ1 is shorter than of 
its correspondent in PLCζ (Saunders et al., 2002) (Fig. 1.21).   
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Figure  1.21 Difference between PLCζ and PLCδ1. Shorter XYl and the presence of PH domain in PLCδ1. 
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Based on the close homology between PLCζ and PLCδ1 through sequence 
comparisons between PLCζ and rat PLCδ1 catalytic domains, it is predcited that both 
enzymes share a similarly structured catalytic domain (Saunders et al., 2007). 
Additionally, structural studies of the catalytic domain of PLCδ1 have been identified 
active-site residues that are essential for enzyme activity (Ellis et al., 1998). The active-
site residue analogous to one of these PLCδ1 residues, at Asp343, was mutated in 
mouse PLCζ to produce PLCζD210R (Saunders et al., 2002) (Fig. 1. 22). Injecting 
PLCζD210R into mouse eggs showed a complete absence of Ca2+-oscillations inducing 
activity. 
In terms of Ca2+-oscillations triggering ability, PLCζ has highest potency compared to 
any other PLC isoforms. PLCζ is the only PLC that able to be significantly activated 
even at a physiological Ca2+ levels (100 nM) (Saunders et al., 2007). Injecting even tiny 
amounts of cRNA encoding PLCζ (0.02 mg/ml pipette concentration) can cause clear 
Ca2+-oscillations in mouse eggs (Saunders et al., 2002). In contrast, Ca2+-oscillations 
triggering by PLCδ1 requires the injection of 20 - 50 times as much protein compare to 
PLCζ (Kouchi et al., 2004). Another study showed that injecting PLC1 in amounts ~ 
500 - 900 times higher than the PLC activity of single sperm content can cause Ca2+-
oscillations (Mehlmann et al., 2001).  
 
1.6.4 PLCζ Mutations 
 
Given the fact that PLCζ is probably the endogenous egg activating agent, it is possible 
that some cases of male infertility could be related to some defects in PLCζ in sperm. A 
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recent study reported that some infertile patients had sperm lacking PLCζ, and that 
these sperm fail to activate eggs (Yoon et al., 2008). Whilst there have been many 
reports on PLCζ structure and function, only a few studies have reported the effects of 
PLCζ mutations, whether they are made intentionally (e.g PLCζD210R (Saunders et al., 
2002) or discovered in a real patient (Heytens et al., 2009). The latter case was an 
interesting study because it was based on one patient with repeated failed IVF/ICSI, 
and this patient was found to have non-globozoospermia. By conducting a study of the 
PLCζ gene in genomic DNA of this patient, a base change affecting the open reading 
frame of the DNA sequence was identified (Heytens et al., 2009). This leads to a 
replacing of an adenine (A) by cytosine (C) at position 1193 in the DNA ORF sequence 
(Heytens et al., 2009).Protein structure modelling predicted that this mutation is in the 
Y-catalytic domain (residues 348 - 465) of PLCζ at position 398 and involves 
substituting a proline for a histidine (PLCζH398P). This seems to be responsible for his 
infertility (Heytens et al., 2009) (Fig. 1. 22).  
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Figure  1.22 Positions of different mutations in hPLCζ. 
 
In order to verify this experimentally, the researchers generated cRNA encoding hPLCζ 
in wild (hPLCζWT) and mutant (hPLCζH398P) forms and injected into two separate groups 
of mouse eggs for comparison. Interestingly, the wild type hPLCζ injected group 
exhibited Ca2+-oscillations similar to those at fertilization, whereas, the mutant hPLCζ 
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injected group showed a marked decline in the hPLCζ activity, and in some eggs not a 
single Ca2+ response was recorded (Heytens et al., 2009). These results clearly showed 
the negative effect of this mutation on hPLCζ activity. It is the first ever natural mutation 
that has been found in the hPLCζ sequence. This study also claimed that PLCζH398P 
might have a dominant negative inhibitory effect on PLCζWT (Heytens et al., 2009). This 
was based on the finding that this mutation appears to be heterozygous. Since a 
spermatozoon is a haploid cell that only possesses one allele of a particular gene, it 
might be possibly that only half of the male germ cells are affected by this heterozygous 
mutation. However, there is an interchange of mRNA transcripts in developing 
spermatids that share cytoplasmic bridges; hence it is possible that this mutation from 
one allele might have a negative inhibitory effect on the other allele expressing the wild 
type PLCζ (Heytens et al., 2009). However, recently a new PLCζ point mutation was 
discovered from the same patient that was maternaly inherited on a different allele and 
involved a substitution of a histidine by leucine at position 233 PLCζH233L (Kashir et 
al., 2012). This avoids the need for a dominant negative theory assumed in previous 
study (Heytens et al., 2009). More recently, a clinical study on fertile and non-fertile 
patients regarding PLCζ immunofluorescence showed a wide variability in PLCζ levels 
that were significantly higher in fertile group compared to non-fertile men. This result 
indicates that sperm from control men exhibited significant variance in total levels of 
PLCζ protein (Kashir et al., 2013). Such variance may prevent the diagnostic application 
of quantitative PLCζ immunofluorescent analysis. 
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In the PLCζ result’s chapter in this thesis, I examine this mutation as well as other 
mutations using analogous mutation in mouse PLCζ. In addition, I looked at some of the 
interesting structural and functional aspects of PLCζ in comparison with other somatic 
PLC isoforms such as PLCδ1.  
 
1.6.5 PLCζ and potential infertility treatment 
 
The discovery of PLCζ has given a promise of a new therapy for some cases of male 
factor infertility associated with failed activation of human eggs. Injecting cRNA 
encoding human PLCζ into aged human eggs that have failed to fertilize via IVF or ICSI 
has been shown to cause a prolonged series of Ca2+-oscillations and parthenogenetic 
activation up to the blastocyst stage (Rogers et al., 2002). In fact, it is the only available 
way to triggers Ca2+-oscillations in human eggs artificially since other activators, such as 
Ca2+ ionophores, can triggers only a single Ca2+ rise. However, there are some 
obstacles that prevent the potential clinical application of PLCζ cRNA in IVF. Firstly, 
there is a possible ethical objection to the use of a genetic based substance in human 
eggs. Secondly, it is difficult to determine the exact amount of protein that is expressed 
after injection of hPLCζ cRNA in the human egg. 
 
1.7 Aims 
 
In this Thesis I have two main objectives. Both of these involve investigating in detail the 
mechanisms of Ca2+-oscillations in mouse and human eggs. The first aim is to find a 
way to activate human eggs artificially by using Sr2+ to cause cytosolic free Ca2+-
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oscillations. To do this I carried out an extensive study of exactly how Sr2+ ions can 
trigger release from internal stores and causes Ca2+-oscillations in mouse eggs. The 
results of these investigations were then applied to studies of human eggs. The second 
main objective is to further investigate how PLCζ causes Ca2+-oscillations in mouse and 
human eggs. This is with a view to understanding the nature of cases of male factor 
infertility that involve PLCζ, as well as to providing practical steps to using PLCζ as a 
potential therapy by virtue of its ability to activate eggs. This second project involves the 
structural and functional analysis of PLCζ via investigating the effects of the identified 
hPLCζ mutations on Ca2+ releasing activity using mPLCζ. I also looked at how PLCζ 
targets the PIP2 substrate, and how it is regulated compared with other somatic PLC 
isoforms. I further investigated the effect of some PLCζ domains swaps with PLCδ1 ‘the 
closest isoform’, as well as between PLCζs from different species. Lastly, I started 
examining the use of recombinant human PLCζ protein in eggs.  
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Chapter 2 
 
MATERIAL AND METHODS 
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2.1 Health and safety & Legal procedures 
 
All chemical were handled and stored as per manufacturer’s safety recommendations 
and PLCζ RNA samples were handled as per Genetic Manipulation Advisory Group 
(GMAG) guidelines. All experiments were carried out in accordance to the regulations of 
the Control of Substances Hazardous to Health (COSHH) and Cardiff university 
laboratory regulations. All animal (mice) were killed in Joint Biological Services (JBIOS) 
facility at Heath park, Cardiff University and in accordance to HM Home Office schedule 
one procedures and licence.  Human oocytes work was started after obtaining a licence 
from Human Fertilization and Embryology Authority (HFEA), with licence number 
R0161. All collected human oocytes were treated in accordance with the HFEA Licence 
guidelines.  
 
2.2 Materials 
 
All chemicals and reagents were of the best grade available such as 'embryo tested' or 
'cell culture tested'.  They were obtained from Sigma (Sigma-Aldrich, Poole, Dorset, 
UK), unless stated otherwise. All Sr2+ experiments were carried out in Ca2+ free H-
KSOM. However some constituents were varied depending upon the target experiment. 
All PLCζ experiments were carried out in normal H-KSOM. H-KSOM was prepared on 
daily bases in laminar air flow safety cabinet.   
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2.2.1 Super-ovulation and egg collection 
Under this section there are two egg collection ways based on species types 
2.2.1.1 Mouse eggs 
 
MF1 female mice aged 6-8 weeks were injected for ovarian stimulation using 7.5 IU of 
pregnant mare’s serum gonadotropin (PMSG; Intervet) via intra-peritoneal (IP) route, 48 
hours later followed by IP injection of 7.5 IU of human chorionic gonadotrophin (HCG; 
Intervet) (Marangos et al., 2003). About 15 hours after HCG injection mice were killed 
via cervical dislocation, and subsequently their oviducts were dissected and collected. 
Under the dissecting microscope (Fig. 2.1) the egg-cumulus complex were released 
from an oviduct ampulae at the site of the cumulus bulge by tearing with a 25-gauge 
needle (Summers et al., 2000) into M2 medium  containing hyaluronidase 0.3 mg/ml or 
150 U/ml; where they were left for a few minutes to denude the cumulus cells from 
around the eggs (Lawrence et al., 1997; Marangos et al., 2003). The eggs then were 
collected and kept in 100µl droplets of M2 medium under embryo tested mineral oil at 
37°C in a 5% CO2  incubator (Binder CB150-Germany) (Summers et al., 2000)  awaiting 
injection or further treatment (Saunders et al., 2002; Campbell and Swann, 2006). 
2.2.1.2 Human eggs 
 
Human eggs were collected from the IVF Wales clinic from patients whose eggs had 
failed to fertilise after IVF or ICSI. However, in addition some fresh eggs were also 
obtained from follicle reductions following over response to hormone treatment for 
intrauterine insemination. Couples who engaged in this project were all given a consent 
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form describing the project in detail, and only those who gave written consent for use of 
their all unfertilised eggs were involved in this research. 
Using the dissecting microscope C-DSD230 (Fig. 2.1) fresh or IVF failed eggs were 
transferred into M2 medium (Sigma-Aldrich, Poole, Dorset, UK) containing 
hyaluronidase (0.3 mg/ml or 150 U/ml; embryo tested grade, Sigma) to denude the 
cumulus cells from around the eggs for 5-10 minutes. Then the eggs, including those 
from failed ICSI, were kept in a drop of M2 media under mineral oil at 37°C in a 5% CO2 
incubator ready for use in a specified project. Unless stated otherwise all the actual 
imaging experiments on human and mouse eggs in our laboratory were carried out in 
HKSOM media. 
 
 
Figure  2.1 Nikon C-DSD230 dissecting microscope used to release and collect eggs. 
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2.3 Methods 
 
Throughout my studies I carried out different experiments. In Sr2+ experiment the 
difference between experiments was mainly in the composition of H-KSOM and the 
experimental protocols. However, in PLCζ experiments the media protocols were 
essentially the same in all PLCζ experiment. 
2.3.1 Microinjection 
 
 All injection procedures on mouse and human eggs were carried out in M2 media. MII 
eggs were manipulated for microinjection in a shallow drop of M2 covered by oil in the 
lid of the petri dish using manipulators fitted on an inverted microscope (TE2000-S 
ECLIPSE, Nikon UK Ltd) (Fig. 2.2).  An electrical circuit is formed between a fine silver 
wire (placed in the injection drop and connected to the ground of an electrical amplifier) 
and the tip of the injection pipette once it touches the media (Swann et al., 2009).  
  
Figure  2.2 The injection system used routinely in our laboratory. A) The inverted microscope [Nikon 
ECLIPSE TE2000-S, Japan] fitted with pipette holders. B) The pressure injection system [Pneumatic 
PicoPump PV820 -WPI -USA], injector [intracellular Electrometer IE 251A] from WARNER Instrument 
Corporation, amplifier and the screens. 
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The holding pipette was pulled using a Narishige PN-30 puller (Intracel, UK)  (Fig. 2.3A) 
and then prepared with an angle at the tip to suite the holding process using a Narishige 
MF-900 beveller (Fig. 2.3B) (Intracel, UK). Micropipettes containing an internal filament 
were pulled using a Sutter Instrument Corporation P-30 puller (Fig. 2.3C) and filled with 
1-2 μl of the appropriate reagent. 
A
B
C
 
Figure  2.3 The different pullers we use in our laboratory. A) An image of the holding pipette (capillary) 
puller [Intracel PN-30 Narishige - Japan]. B) Photo of the holding pipette beveller [Intracel, Microforge, 
MF-900 –Narishige - Japan]. C) Photo of the injection pipette puller [SUTTER Instrument Corp P-30] 
 
This micropipette was then held by special holder with a silver wire and this was placed 
onto an electrical preamplifier [Intracellular Electrometer IE-251A, Warner Instruments 
Corporation] which is clamped into the micromanipulator (Swann et al., 2009). The MII 
arrested eggs were immobilized using suction with a holding pipette. Then the injection 
pipette pushed through the ZP and indented into plasma membrane. Insertion through 
the plasma membrane was achieved by electrical oscillations in the electric amplifier. 
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Then eggs were injected using a PicoPump pressure injection system (WPI) that 
applies pressure pulse (~ 20 psi) for 100ms - 1 sec (Swann et al., 2009) to inject 0.5-5% 
of the egg volume (depending on the injected reagent) (Halet et al., 2002). For mouse 
eggs all injections were carried out within 1 hour from the egg collection time, whereas 
in human oocytes the injections process where carried out roughly after 24 or 36 hrs 
from the collection time from the donated women. However the injection procedures are 
similar in both cases. 
2.3.1.1 The injection procedure for PLCζ experiments  
 
The luciferase tagged cRNA (PLCζ-Luc) was diluted with an RNase-free injection buffer 
(0.5´ PBS; Ambion) (Larman et al., 2004) and just before injection mixed with 1 mM 
(1:1) Oregan green BAPTA dextran (OGBD) (Molecular probes, www.probes.com) 
(Invitrogen Ltd, Paisley, UK) (Yu et al., 2008). Then the micropipette containing an 
internal filament was filled with ~1 μl of the PLCζ-Luc, OGBD mixture. The injection was 
carried out as mention in previous page and the injection volume was estimated from 
the diameter of cytoplasmic displacement caused by the bolus injection (Larman et al., 
2004).  This was consider appropraite because a bolus injection of 3-5% of egg volume 
with cRNA pipette concentration of 0.02 mg/ml appears to show similar Ca2+ oscillations 
triggering ability of a single sperm (Saunders et al., 2002). In cases where more than 
one reagent needed to be injected and to reduce the potential harming effect of multiple 
injections, a co-injection protocol was carried out (Marangos et al., 2003). Different 
experiments have different injected reagents, so for more details see the specific 
experimental procedures in results chapters.  
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2.3.1.2 The injection procedure for Sr2+ experiments 
 
It is the same process as in PLCζ experiments except in that, eggs were only injected 
with Ca2+ indicator mainly OGBD (1 mM) since we only needed to monitor the 
intracellular Ca2+. However in some Sr2+ experiments such as in case of intracellular 
Na+ monitoring, Na+ indicator sodium green (SG) was co-injected with Ca2+ dye Rhod 
dextran (RhD) in a 50:50 mixture. 
2.3.1.3 The procedure for Sr2+ injection into mouse/human eggs 
 
One of protocols we tried in order to stimulate mouse or human eggs was carried out by 
injecting Sr2+ directly into egg’s cytoplasm. The injection procedures were similar to the 
standard procedure with slight differences. However, in this case the necessary parts of 
an injection system were fitted onto the Nikon inverted fluorescent imaging microscope 
(TE2000 -S, Nikon UK Ltd) (Fig. 2.4). An injection drop of 50-100μl of Ca2+ free HKSOM 
covered by mineral oil was placed in a suitable wide dish fitted with glass floor on the 
heating stage of the inverted microscope. An electrical circuit is formed between a fine 
silver wire (placed in the injection drop and connected to the ground for amplifier) and 
the tip of the injection pipette once it touches the media.  Holding pipettes were pulled 
using a puller (Fig. 2.3A).  
MII eggs were injected with fluorescent dye (OGBD) using the standard injection system 
(Fig. 2.2), then the pre-injected MII eggs were placed in the injection drop and 
immobilized by suction with the holding pipette. A very sharp micropipette containing an 
internal filament were pulled using a puller (Fig. 2.3C) and filled with few micro-litres of 
the SrCl2 (100mM). This micropipette was then held by a holder provided with silver wire 
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and placed onto preamplifier which is clamped into the micromanipulator (Swann et al., 
2009). 
BA
 
Figure  2.4 The fluorescence system in the laboratory. A) The complete system; the inverted 
microscope [Nikon ECLIPSE Ti – Japan], camera, light source, stage heater stabilizer [WARNER 
Instrument CL-100] and PC. This system is the one I used to inject Sr
2+
 into mouse and human eggs. B) 
Closer picture of the heating stage containing the dish with the cover lid in hand. 
 
After holding the egg, the injection pipette pushed through the ZP and plasma 
membrane and the injection pipette was put into place in the egg for up to 30min before 
it was drawn back. During this time a series of positive current pulses were applied via 
the electrical amplifier to start injecting Sr2+ every second for 0.5 second continuously 
for 2000 pulses. This process causes continuous amounts of Sr2+ to enter the cytoplasm 
by ionotophoresis. Intracellular Ca2+ changes were monitored by changes in the 
fluorescence intensity throughout this time. 
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2.3.2 Media preparation 
 
M2 media was aliquot into test tubes, ~10 ml each and kept in fridge. Each day one 
tube was taken out onto heated block for that day use. On a daily bases H-KSOM was 
prepared from the concentrated H-KSOM stocks. However, different types of this media 
were made depending on the intended experiment. 
 
2.3.2.1 H-KSOM (Hepes-buffered Potassium Simplex Optimised 
Media).  
 
HKSOM is the media I used in almost all of my experiments during my study. Hence I 
made large quantity of a concentrated H-KSOM stock. I added sterile water of up to 
500ml to the following amounts (Table 2.1, see next page) of all the components to 
make concentrated stocks of H-KSOM (Lawitts et al., 1993; Erbach et al., 1994). 
However, different preparations of the final HKSOM were optimised according to the 
intended experiment.  
2.3.2.2 Sr2+ H-KSOM Preparation 
 
In case of Ca2+ monitoring during Sr2+ stimulation experiments I prepared Ca2+ free H-
KSOM in the same way of preparing normal H-KSOM but without adding 10µl of a 1.71 
M of CaCl2. I replaced that Ca
2+ by adding Sr2+ to the media in different concentrations 
(0.5, 5.0 and 10.0mM) depending on the experiment protocol. However, based on 
pronuclear development, blastocyst formation and the cell number in parthenotes, it has 
been reported that the best optimum Sr2+ activation protocols in mouse eggs is 10mM 
with 2.5 hrs exposure in Ca2+ free media (Ma et al., 2005). 
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 In some experiments I modify the composition of H-KSOM to make H-KSOM with low 
Na+ (~30mM) by opting out NaCl or else totally Na+ free H-KSOM, details to follow. 
However, in order to keep the osmolarity within the normal range, I replaced Na+ with 
choline or KCl. The osmolarity was monitored using calibrated freezing point osmometer 
(Gonotec Osmometers - Osmomat 030, GERMANY). Then the medium was kept on the 
heated block. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table  2.1 Exact concentrations of the different components of the concentrated stock of H-KSOM. 
 
2.3.2.2.1 Low sodium H-KSOM   
Further in Sr2+ experiments and in some special circumstances, I prepared H-KSOM 
with low Na+ content (~30mM) by not adding NaCl in the concentrated stock. The rest of 
Chemical Working media 
(1X) pH 7.4 
10X stock (stored at -
20C, filter sterilised) 
Sigma 
code 
M W 
 mM g/l g/500ml ml/500ml   
NaCl 95 5.55 27.75   58.44 
KCl 2.5 0.185 0.925   74.56 
KH2PO4 0.35 0.0476 0.238   228.2 
Na Pyruvate 0.2 0.022 0.11   110.04 
Streptomycin sulphate  0.05 0.25    
Penicillin G  0.063 0.315    
EDTA 0.01 0.0038 0.019   416.2 
MgSO4. 7H2O 0.2 0.0493 0.246   246.48 
Na Lactate (liquid) 10.0   7.37  112.1 
NaHCO3 4.0 0.336 1.68   84.01 
HEPES 20.0 4.76 23.8  H6147 238.31 
Phenol red   0.055 5.0  354.38 
L-glutamine 1.0 0.146 0.73   146.15 
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the constituents were the same as in Table 2.1. It is known that missing out NaCl from 
the media leads to hypoosmotic media (~ 200mOsm/kg).  
In order to try and stimulate human eggs with Sr2+ a different protocol was used in which 
a special H-KOSM was prepared by modifying the H-KSOM to be totally Na+ free so as 
to enable the reversal of the Na+/Ca2+ exchanger in Sr2+  media that could enhance Sr2+ 
influx (details in first result’s chapter). The other benefit of this media is that the egg 
membrane potential should depolarize due to high K+ content and this could facilitate 
the exchanger causing Na+ efflux with Sr2+ influx. In order to maintain the osmolarity I 
replaced all Na+ salts with their K+ correspondents and finally made 10 times stock 
solutions of the modified H-KSOM by adding all the followings and sterile water of up to 
500ml (Table 2.2). 
Chemical Working media 
(1X) pH 7.4 
 Sigma  
 code  
10X stock (stored at -
20C) 
 M.W 
 mM   g/500ml ml/500ml  
 KCl 2.5  0.932    74.56 
 KH2PO4 0.35  0.399   228.2 
 Pyruvic acid (liquid) 0.2  0.088  0.088/1.276= 
0.07ml (70ul) 
 88.06 
 MgSO4 0.2  0.12   120.37 
 Lactic acid (powder) 10.0  4.5   90.08 
 KHCO3 4.0  2.0   100.12 
 HEPES K-buffered 20.0  H0527 27.64   276.4 
 Phenol red   0.055   354.38 
 L-glutamine 1.0  0.73   146.15 
Table  2.2 Exact concentrations of the different components of zero Na
+
 modified H-KSOM. 
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2.3.2.3 H-KSOM for PLCζ experiments  
 
On the day of an experiment I prepared H-KSOM from the concentrated stock by adding 
all the following: 1ml of H-KSOM (10X stock) (Table 2.1), 20µl of Na+ Hydroxide 1.0N 
solution to buffer the media (pH 7.2 – 7.4), 10µl of a 1.71M of CaCl2, 10µl of a 0.2M 
glucose, and finally adding sterile water to achieve the required osmolarity. This was 
then mixed well and kept in the heated block for use during the whole day. On the day 
of use I took 1ml and mix it with 1μl of (100M) luciferin to get a final concentration of 
(100µM) luciferin (Dumollard et al., 2004). I then placed a small drop under oil on the 
heated stage of the inverted microscope for recording. 
 
2.3.3 Measurements of intracellular Ca
2+ 
and luciferase 
expression 
 
In all experiments H-KSOM was used as a medium during experimental recording. The 
injected oocytes were placed in a chamber with 500ml H-KSOM medium (Summers et 
al., 2000) containing 100μM luciferin under mineral oil (Dumollard et al., 2004) on a 
temperature-controlled stage [Intracel] of an inverted microscope. On the same sets of 
eggs both luciferase expression (luminescence) and Ca2+ oscillations (OGBD 
fluorescence) were simultaneously measured using a Zeiss Axiovert S100 (Fig. 2.5) or 
Nikon TE2000 microscope (Fig. 2.6) equipped with a light source (halogen lamp) with 
emitted light directed towards a cooled intensified CCD camera (ICCD) with a bialkali-
type or S20 photocathode-based intensifier cooled to 10°C or 0oC respectively (Yu et 
al., 2008 and Swann et al., 2009). Ca2+ measurements were considered valid only if the 
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egg was also luminescent. The luminescence was measured as the light emission 
recorded in the absence of excitation light. Fluorescence signals were 10–100 times 
that for luminescence.  
A B
 
Figure  2.5 The Zeiss luminescence system in the laboratory. A) The inverted microscope [Zeiss - 
Germany] fitted within the dark box {Photek]. B) The complete system; the inverted microscope, ICCD 
camera, cooler system, light source, stage temperature controller [Intracel - Japan] and PC. 
A B
 
Figure  2.6 The Nikon luminescence system in the laboratory. A) Inverted microscope [Nikon 
ECLIPSE TE2000-S Japan] fitted within the dark box [Photek]. B) The complete system; the inverted 
microscope, ICCD camera, cooler system, light source, stage temperature controller [Intracel -UK] and 
PC. 
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Figure 2.7, is representative diagram of ICCD camera imaging process. Since the goal 
is to study the expression at low levels, a highly sensitive camera was needed.  The 
combination of a high-gain amplifier with a good low-light image sensor is found with 
ICCD camera. The typical intensifier has three key components; a photocathode, a 
series of two-dimensional micro-channel plates and the phosphorescent output screen. 
The photocathode converts the received photon energy to electrons, which is then 
emitted from the photocathode and travels across an electric field through the two-
dimensional micro-channel plate that has a high-voltage across its ends. A dramatic 
amplification of the electrons numbers can be obtained.  
photons
 
Figure  2.7 The Intensified CCD camera imaging process. A single photon hits the input window and is 
amplified to a million photons by the time it reaches the CCD sensor.  
 
The amplified electrons impact with a phosphorescent output screen which is connected 
to a fibre optic faceplate to give an ‘amplified image’.  Since the ICCD cameras are 
highly sensitive to light, to obtain the image from eggs a completely dark environment is 
necessary. Hence, the microscope and ICCD camera were placed inside a custom-
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made dark box which including all parts of the system. The dark box and associated 
software [Photek IFS-32] was supplied by Photek Ltd (www.photek.co.uk) (St Leonards 
on Sea, East Sussex, UK) (Campbell and Swann, 2006). The software controls the 
switching mechanism between fluorescence and luminescence recording (Fig. 2.8).  
The fluorescence was displayed in arbitrary units of intensity and was setup to record in 
most experiments by exposing eggs to excitation light (450–490 nm) with 10% ICCD 
camera sensitivity for 10 seconds. The luminescence which represents the absolute 
number of measured photon counts per second (cps) was recorded also for 10 second 
by blocking the excitation light and switching the ICCD camera to 100% sensitivity (Yu 
et al., 2008).  
Fluorescence 
Luminescence
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Figure  2.8 Switching between the fluorescence and the luminescence during PLCζ expression 
experiments. 
 
  To estimate the levels of luciferase protein that corresponds to a given luminescence 
level, a standard luminescence calibration curve was used. This standard was prepared 
by injecting a known amounts of recombinant luciferase protein (Sigma–Aldrich, Poole, 
Dorset, UK) into another group of mouse eggs and then the luminescence of these eggs 
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was measured under the same conditions as those injected with cRNA of mouse PLCζ-
luc (Yu et al., 2008). The standard luminescence calibration curve has yield this formula 
(Protein [fg]‎=‎[luminescence‎“cps”‎x‎0.169] + 0.288) which I used for my estimation 
of the expressed proteins. In some of the Sr2+ experiments, the same system was used 
but only in fluorescence photon counting mode to continuously monitor the Ca2+ 
changes in eggs. 
2.3.3.1 Fluorescence system and data analysis  
 
The oocytes or zygotes were imaged continuously for 2hrs after microinjection using a 
Nikon ECLIPSE TiU epifluroescence microscope (Fig. 2.4) with a 20x 0.75 NA objective 
(Swann et al., 2012). The dish was covered by a black plastic lid to minimise the stray 
light exposure. Fluorescence excitation from a halogen lamp was passed through a 
490nm bandpass filter, reflected via a 505nm dichroic mirror, and collected with a 
530nm bandpass filter.  
Light source
(Halogen lamp)
CCD
camera 
Band-pass 
Filters
Band-pass
Filters
Dichroic
mirrors
Reflector 
mirrors
 
Figure  2.9  Pathway of the light through the fluorescence system.  
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A Coolsnap HQ2 CCD camera (Photometrics) was taking a series of images from the 
fluorescent eggs every 10 seconds with 100-200 msec exposures. Both image 
collection and initial analysis were carried out using InVivo software (Media 
Cybernetics) and images were stored as tiff stacks (Fig. 2.9). 
The fluorescence images were analysed using a free software package called ImageJ 
(http://rsbweb.nih.gov/ij/). In brief, in order to measure the fluorescence intensity 
changes in each egg separately, a circle the same size as the egg was drawn around 
each image of an egg and in a background region near the eggs. Then the ‘multi-
measure’ plugin was used to give a series of outputs for each egg as numerical values. 
These row data then were transferred into a SigmaPlot file where the background value 
was subtracted from each egg intensity value. The fluorescence intensity of the dye 
from the whole each egg was then plotted against time. 
 
2.3.4 Complementary RNA (cRNA) synthesis  
 
All PLCζ cRNA samples were prepared by Micheal Nomikos or Maria Theodoridou in 
Tony Lai’s laboratory. Complementary RNA (cRNA) was synthesised from the open 
reading frame (ORF) of mouse PLCζ and c-myc tagged-PLCζ (Saunders et al., 2002; 
Swann et al., 2009). Each batch of cRNA produced was quantified by measuring its 
absorbance at 260nm in a 500µl quartz cuvette and calculated using this equation (RNA 
conc [ug/ml] = 40 x A260 x 500) (Nomikos et al., 2005; Swann et al., 2009). Then the 
cRNA was checked for in vitro protein expression in a rabbit reticulocyte lysate system 
(Promega). A full detail of this has been described in previous publications (Saunders et 
  105 
al., 2002; Nomikos et al., 2005; Swann et al., 2009). The cRNA encoding the 608-
residue human PLCζ or 647-residue mouse PLCζ tagged via the C-terminus with firefly 
luciferase (PLCζ-Luc) was prepared as previously described (Nomikos et al., 2005), 
diluted with an RNase-free injection buffer (0.5´ PBS; Ambion) (Larman et al., 2004). 
PLCζWT and mutants were amplified by PCR from the corresponding pCR3 plasmid 
using Phusion polymerase (Finnzymes) to incorporate a 5′ EcoRI site and a 3′ SalI site. 
PCR products were cloned into pGEX-6P1 (GE Healthcare). The primers used for 
amplification of WT and mutant PLCζ were: 5′-
ACATGAATTCATGGAAAGCCAACTTCATGA-3′ (forward) and 5′-
TAACGTCGACTCACTCTCTGAAGTACCAAAC-3′ (reverse). Following linearization of 
WT and mutant PLCζs, cRNA was synthesized using the mMessage Machine T7 kit 
(Ambion) and a poly (A) tailing kit (Ambion), as per the manufacturer's instructions. 
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Chapter 3 
 
Sr
2+
 & Ca
2+
-OSCILLATIONS IN MOUSE EGGS  
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3.1 Introduction 
 
In mammals, sperm is the natural egg activator and works by triggering long-lasting 
oscillations in free ooplasmic Ca2+ (Kline and Kline, 1992; Miyazaki et al., 1993; Swann 
and Lai, 1997). However, mammalian eggs can also be activated via different artificial 
stimuli (Swann and Ozil, 1994). For many years Sr2+ has been known as the most 
successful and efficient activating agent, or substance, and it can parthenogenetically 
activate mouse, hamster and rat eggs’ (Whittingham and Siracusa, 1978; Kline and 
Kline, 1992; Rogers et al., 2004). It does this by inducing Ca2+ oscillations (Zhang et al., 
2005). Treating mouse eggs with Sr2+ triggers Ca2+ oscillations that look close to the 
normal pattern at fertilization (Kono et al., 1996; Kyono et al., 2008). Nowadays, Sr2+ is 
widely used in research labs as an egg activator in rodent eggs. Normal mice offspring 
have been reported after combinations of 10mM Sr2+ and ICSI of misshaped epididymal 
spermatozoa collected from alkylated imino sugar [N-butyl-deoxynojirimycin (NB-DNJ) 
and N-butyl-deoxygalactonojirimycin (NB-DGJ)] treated males (Suganuma et al., 2005). 
These compounds are reversible male infertility-inducing agents. They work after short-
term administration at the minimal dose and have been used as non-hormonal 
contraceptives (Suganuma et al., 2005). There is no other report showing that Sr2+ 
causing Ca2+ oscillations in eggs from either human or domestic animals (Rogers et al., 
2004). However, some reports claim that Sr2+ can be used to activate bovine (Méo et 
al., 2005), pig (Okada et al., 2003) and human eggs with different means of Sr2+ 
applications. In the literature, different concentrations of Sr2+ have been reported as 
being required to activate mammalian eggs from 50mM (Méo et al., 2005) down to 
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1.7mM (Bos-Mikich et al., 1995). So it is unclear why Sr2+ only works in rodent eggs and 
what factors determine the concentration of Sr2+ used to activate eggs. 
 
3.1.1 Critical levels of extracellular Sr
2+
 are required to trigger 
intracellular Ca
2+
 oscillations.   
 
H-KSOM without Ca2+ is the media used in all Sr2+ experiments. I started by testing 
three different concentrations of Sr2+ (0.5mM, 5.0mM and 10mM) on mouse eggs in 
Ca2+ free H-KSOM. The detailed steps of eggs manipulation and the injection procedure 
were mentioned in the previous chapter. Mature MII mouse eggs were injected with the 
Ca2+ sensitive dye, OGBD. The injected eggs were then placed into a drop of media on 
the inverted microscope stage that contained the Sr2+ concentration for the intended 
experiment. The fluorescence recordings started as soon as possible (~1min).  
After two hours of recording the experiment was stopped and the eggs were taken out 
from the Sr2+ media, and then the data were analysed. Not surprisingly my initial results 
were not very different from the previous studies. I found that at 0.5mM Sr2+ causes no 
oscillations in any eggs for as long as the 2 hrs recording period, 20/20 (100%). 
However, in 5mM Sr2+ and 10mM Sr2+, Ca2+ oscillations were seen, but they were more 
frequent in 10mM Sr2+ (71.4%,10/14) and (84.6%, 22/26) respectively. The remaining 
eggs either died or not responded. These data suggests that Sr2+-induced oscillations in 
mouse eggs in normal media requires a critical level of external Sr2+ of around 5-10 mM 
see (Fig. 3.1). The question that is still unsolved is why this critical Sr2+ levels is needed.    
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Figure  3.1 Sr
2+
 induced Ca
2+
-oscillations in mouse eggs in Ca
2+
 free media (HKSOM) requires a 
critical level of external Sr
2+
. A) Prompt frequent oscillations in 10mM Sr
2+
, B) Prompt but less frequent 
in 5mM Sr
2+
 and C) no oscillations in 0.5mM Sr
2+
. 
 
3.1.2 How does extracellular Sr
2+
 trigger Ca
2+
 release? 
 
Sr2+ is divalent cation similar to Ca2+. It dissolves easily in the various culture media 
used for eggs. Treating mouse eggs with Sr2+ in optimized Ca2+ free media triggers 
Ca2+-oscillations. Interestingly, it has been shown that Sr2+ acts via stimulating the IP3R 
in cells (Marshall and Taylor., 1994) and this is consistent with findings in mouse eggs 
(Zhang et al., 2005). So, in this case one can ask how Sr2+ could reach intracellular 
IP3R and trigger Ca
2+ release.  One simple proposal is that Sr2+ influx is prerequisite 
step to release Ca2+ from the internal store (Fig. 3.2). Since eggs activate by adding 
Sr2+ in the culture media, it can be expected that in order to triggers Ca2+-oscillations, 
Sr2+ needs to cross the plasma membrane. Another possible mechanism is that Sr2+ 
works via cell membrane receptor mechanism.  
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Figure  3.2  Suggested mechanism of Sr
2+
-induced Ca
2+
-oscillations in mammalian eggs.  The question 
mark indicates the elusive potential mechanism of Sr
2+
 influx. 
 
3.1.3 Objectives 
 
 Most of my work in this chapter is designed to establish that continuous Sr2+ influx is 
required for long lasting Ca2+-oscillations in mouse eggs.  In addition, I also aim to 
identify the possible pathway/s of Sr2+ entry into the mouse egg. In order trying to clarify 
this, I have applied different protocols. These included trying to bypass the membrane 
barrier by injecting Sr2+ directly into mouse eggs to rule out the potential membrane 
receptor theory. Other protocols include either blocking or facilitating the Sr2+ influx 
across the egg membrane. In addition, this chapter includes some other experiments 
related to nature of the Sr2+ triggered oscillations in mouse eggs. Finally, some of these 
protocols were also adopted for experiments on human eggs in a later results chapter. 
 
3.2 Sr
2+
 injection into mouse eggs and Ca
2+
 release  
 
Based on the idea that Sr2+ influx needs to occur across the egg membrane to trigger 
Ca2+-transients, I have undertaken a more rigorous, challenging experiment. The idea 
was to inject Sr2+ directly into the cytoplasm bypassing the plasma membrane, and see 
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if this can trigger Ca2+-oscillations. The injection of divalent cations including Sr2+ into 
mammalian eggs has been reported in hamster eggs (Georgiou et al., 1987) and in pig 
eggs (Okada et al., 2003). Georgiou and his colleagues studied the effect of Sr2+ upon 
the hamster egg’s membrane potential and described a single transient 
hyperpolarization and fall in resistance similar to the effect of a single Ca2+ injection 
(Georgiou et al., 1987). Okada and his colleagues were aiming to activate pig eggs, and 
they conclude that Sr2+ can activate pig eggs similar to Ca2+ via means of one Ca2+ 
transient (Okada et al., 2003). This transient is different from the physiological pattern of 
Ca2+ changes during fertilizations.   
My study was intended to activate mouse eggs with Sr2+, not in the media, but through 
Sr2+ injection directly into the egg cytoplasm. The protocol has been described in the 
material and methods chapter. The challenging point in this protocol is the egg survival; 
some eggs lysed as a result of keeping the injection pipette inside the egg for long 
periods. In these experiments some injected eggs also died after their first response to 
Sr2+ injection. However, I did not include them in my data and I only counted those that 
survived after removal of the Sr2+ injection pipette.  
Figure 3.3A results show that soon after starting the Sr2+ injection (2000 pulse every 
second for 0.5 sec) all  injected eggs (15/15) had a rapid rise of in their Ca2+ signal, with 
a slow decline that resulted in a long duration first spike. This was then repeated with 
shorter spike durations between 5 and 8 times before oscillations stopped. It was of 
interest that some eggs could be re-injected with same concentration of Sr2+ using a 
new pipette and they all responded with a few extra Ca2+ spikes. This is the first 
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reported Ca2+-oscillations in mouse eggs using Sr2+ injection. These results are 
consistent with the idea that the influx of Sr2+ is able to cause Ca2+-oscillations and that 
Sr2+ works directly on the internal store rather than a plasma membrane receptor. 
 
3.2.1 KCl injection into mouse eggs and Ca
2+
 release 
 
To confirm that Ca2+-oscillations shown in the above Sr2+ injection experiments were 
triggered by Sr2+ and not membrane potential changes driven by the current injection 
(Georgiou et al., 1987), I used the same technique for Sr2+ injection but replaced 
100mM Sr2+ with 100mM KCl. My results showed that all KCl injected eggs [5 eggs] 
gave no Ca2+ response. However, those eggs that were subsequently re-injected with 
Sr2+ 100mM (2/5) start to oscillate as soon as current pulses were started, see (Fig. 
3.3B). These results confirm that these oscillations were Sr2+ triggered Ca2+-oscillations 
and not caused changes in membrane potential or by current injection.  
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Figure  3.3 Ca
2+
-oscillations in mouse eggs triggered by direct Sr
2+
 injection. A) Ca
2+
-oscillations in 
eggs start straight away after the onset of the injection and stopped after a couple of spikes. It also shows 
that oscillation can be recover by re-injection Sr
2+
. B) Shows that mouse eggs do not respond to KCl 
injection, however, oscillations start after subsequent Sr
2+ 
injection. 
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3.3 Sr
2+
-triggered oscillations; are they Ca
2+
 or Sr
2+
 
transients? 
 
It can be argued that since Sr2+ is similar to Ca2+ it could substitute for Ca2+ to refill the 
internal store during Sr2+ triggered oscillations in eggs. If this is the case then the 
oscillations seen in mouse eggs treated with Sr2+, particularly those followed the first 
few spikes, could be Sr2+ transients rather than Ca2+ transients. From a survey of the 
literature, there is no apparent dye that can easily distinguish Ca2+ from Sr2+. The only 
suggested way to clarify this is to use a Ca2+ ionophore that has much lower Sr2+ affinity 
compared to Ca2+. The only suitable ionophore is the ionomycin with an affinity ratio of 
Sr2+ to Ca2+ of 1: 48 (Liu and Hermann, 1978). 
 
3.3.1 Sr
2+
-triggered fluorescence and ionomycin 
 
Ionomycin is a monocarboxylic polyether antibiotic that has shown, using ion 
competition experiments,  to have a high affinity binding to Ca2+ with insignificant affinity 
for  Sr2+ (Liu and Hermann, 1978). It has been used as an ionophore to complex with 
Ca2+ and and carry it across lipophilic membranes (Liu and Hermann., 1978). However, 
some reports show that ionomycin works by a store-regulated Ca2+-influx mechanism 
and not through plasma membrane cation translocation (Morgan and Jacob, 1994). The 
reason for examining the effect of ionomycin on Sr2+ experiment is that some 
researchers have suggests that in Ca2+ free Sr2+ media the Sr2+ could replaces Ca2+ in 
the internal store and result in Sr2+-oscillations replacing Ca2+-oscillations. In order to 
investigate whether these oscillations are Ca2+ transients I have carried out a series of 
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experiments using ionomycin to test the if the Ca2+ store is loaded with Ca2+ or not after 
a series of Ca2+-oscillations has been induced by Sr2+. 
The first set of experiments were started by triggering Ca2+ oscillations with Sr2+ until 
oscillations stopped after about 2 hrs. I then added 5µM ionomycin. The fluorescence 
signal then went up for a while before restoration to the previous fluorescence intensity. 
After a detailed analysis of each egg signal’s, the results showed a prompt rise in Ca2+ 
signal in almost all exposed eggs (90.9%, 10/11)  which then recovered to the base line 
in few minutes time (Fig. 3.4A). This shows that the previous oscillations and this spike 
is Ca2+ spike. It also suggests Sr2+ does not substitute Ca2+ in the internal store which 
still has Ca2+ in it even after Ca2+-oscillations triggered by Sr2+ have already stopped.  
The second set of experiments was carried out by adding 5µM ionomycin to mouse 
eggs before exposing them to Sr2+. The results showed that there was a big jump in 
Ca2+ signal in all eggs (which is normal response) before their Ca2+ levels recovered to 
lower cytoplasmic level. When 5mM Sr2+ was subsequently, added the majority of eggs 
start to respond to Sr2+ with the 1st Ca2+ rise but they failed to restore Ca2+ back to the 
base line levels and eventually all eggs died (8/8) (Fig. 3.4B).  
These two set of experiments were repeated twice and always gave similar results. 
These results could be interpreted as follows. In Fig. 3.4A, even though the Ca2+-
oscillations stopped, the internal stores (ER) are still filled with Ca2+ because if they 
contained Sr2+ ionomycin would not be effective in causing an increase in fluorescence 
of OGBD. 
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Figure  3.4 The effect of ionomycin on Ca
2+
-oscillations in mouse eggs triggered by 5.0mM Sr
2+
. A) 
5µM ionomycin added after Sr
2+
 5.0mM in Ca
2+
 free eggs show a clear transient with similar amplitude to 
preceding oscillations. B) 5µM ionomycin was added to eggs before Sr
2+
 5.0mM in Ca
2+
 free media.  
 
In Fig. 3.4B, the emptying and permeabilization of Ca2+ stores by ionomycin shows that 
there are no fluorescence oscillations when there is no Ca2+. This then suggests that 
Sr2+ cannot replace the Ca2+ in the ER to enable oscillations. These data support the 
idea that the oscillations triggered by Sr2+ in mouse eggs are truly Ca2+-oscillations, and 
not oscillations of Sr2+ in and out of the ER. 
 
3.4 The relationship between Sr
2+
-triggered Ca
2+
- 
oscillations and medium osmolarity 
 
It is a normal reaction or phenomenon that eggs will swell up or shrink if placed in low or 
high osmolarity media respectively. A previous study suggested that reduced osmolarity 
can potentiate Sr2+ induced oscillations (Bos-Mikich et al., 1995). It’s known that the 
normal osmolarity of the experimental or culturing media is in the range from 280 to 
300mOsm/kg, which is also the normal osmolarity in mammalian serum. To investigate 
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the effect of osmolarity upon Sr2+ induced oscillations, I have deliberately changed the 
osmolarity of the recording media by adding or subtracting NaCl from the media, whilst 
making measurements of the osmolarity values using a calibrated freezing point 
osmometer.  
To be able to study appropriately the effect of osmolarity on Sr2+-induced Ca2+-
oscillations, I prepared three new concentrated (10x) stocks of H-KSOM. Firstly, H-
KSOM with normal Na+, secondly, H-KSOM with a low Na+ concentration (~30mM) and 
finally, H-KSOM with no Na+ in which all Na+ salts were replaced with K+ salts to get 
zero Na+ and high K+ H-KOSM, see material and methods chapter (Table 2.1 & 2.2). 
Different H-KSOM recording media were then prepared with different osmolarities from 
200 up to 400mOsm/kg. Here I used either KCl or choline to adjust the osmolarity 
values. i.e I add KCl or choline based on the target osmolarity level.   
My initial results were consistent with the potential facilitating effect of lowering media 
osmolarity on Sr2+ stimulation that has been reported (Bos-Mikich et al., 1995). Not only 
that but they also show that Ca2+-oscillations can be triggers even with very low 
extracellular Sr2+ concentrations (0.5mM), by lowering media osmolarity. 
  For these studies Ca2+ was monitored in eggs in response to different concentrations 
of Sr2+, at a variety of osmolarities. Figure 3.5, shows that 0.5mM Sr2+ cannot  trigger 
Ca2+-oscillations in mouse eggs placed in 280mOsm/kg HKSOM since there was no 
response in almost all eggs (16/17) 94.1% (Fig. 3.5A next page). However, 0.5mM Sr2+ 
media  does trigger oscillations in the majority of eggs (20/25) 80% with delayed onset 
when the osmolarity was taken down to 250 mOsm/kg (Fig. 3.5B next page), and a 
  117 
further decrease down to 200mOsm/kg lead to a prompt series of oscillations in the 
majority of eggs (19/21) 90.5% (Fig. 3.5C). The threshold Sr2+ concentration to trigger 
Ca2+-oscillations seems to be between 0.5mM and 1.0mM Sr2+. Since, in similar 
experiments in normal osmolarity (≥ 300mOsm/l) shows that Sr2+ cannot cause Ca2+-
oscillations at 1mM concentration (15/15) (Fig. 3.6A next page), however by decreasing 
the osmolarity to 280 mOsm/kg a clear Ca2+-oscillations response was seen in the 
majority of treated eggs (32/38) 84% (Fig. 3.6B next page). 
* The time bar is 30 min
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Figure  3.5 Mouse eggs response to 0.5mM Sr
2+
 in different osmolarity values. A) In normal 
osmolarity media (280mOsm/kg) eggs showed no response, B) in 250 mOsm/kg eggs showed a delayed 
onset with clear Ca
2+
-oscillations and C) in 200mOsm/kg eggs showed prompt onset Ca
2+
-oscillations. 
• The time bar is 30 min
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Figure ‎3.6 Mouse eggs response to 1.0mM Sr
2+
 in different osmolarity media. A) In 300 mOsm/kg 
eggs showed no response, whereas in B) in 280 mOsm/kg 1mM Sr
2+
 is able to trigger clear Ca
2+
-
oscillations in the majority of eggs. 
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On the other hand, increasing the osmolarity of media required increasing Sr2+ 
concentrations to triggers Ca2+-oscillations in mouse eggs. Figure 3.7, shows that 
5.0mM Sr2+ is able to cause Ca2+-oscillations in most mouse eggs kept in HKSOM with 
osmolarity of 325mOsm/kg (85.7%, 12/14) (Fig. 3.7A), and in some eggs in 
350mOsm/kg (5/16) 31.25% (Fig. 3.7B), but it did not causes oscillations in eggs placed 
in the range of 380mOsm/kg (9/9) (Fig. 3.7C).  
* The time bar is 30 min
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Figure  3.7 Mouse eggs response to 5.0mM Sr
2+
 in different osmolrity media. A) In 375mOsm/kg 
eggs showed no response, B) in 350mOsm/kg some eggs showed clear Ca
2+
-oscillations but less 
frequent compared to C) those placed in 325mOsm/kg 
 
In the same way 10mM Sr2+ was unable to triggers Ca2+-oscillations in a very high 
osmolarity media ~ 400mOsm/kg (17/19) (Fig. 3.8A), but it does in the lower osmolarity 
media of 375mOsm/kg (11/21) and 350mOsm/kg (8/11) (52.38% and 72.72%) 
respectively (Fig. 3.8B&C).  
To summarize the above results of the effect of osmolarity on Sr2+ triggering Ca2+ 
release, Fig. 3.9 (see page 120) shows a line graph that illustrates the relation between 
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osmolarity and the concentrations of Sr2+ required to trigger Ca2+-oscillations in mouse 
eggs. The bars and points are the standard deviation of the mean respectively. 
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Figure  3.8 Mouse eggs response to 10.0mM Sr
2+ 
in different osmolarity values.  A) In 400mOsm/kg 
showed no response. B) in 375 mOsm/kg there is a late response and C) in 350mOsm/kg there is a 
prompt response with clear Ca
2+
-oscillations 
 
The spike number in 2hrs (frequency) is used as a standard measure of response in 
these Sr2+ concentration experiments. The simple interpretation of this graph is that the 
Sr2+ concentration that is able to trigger Ca2+-oscillations in mouse eggs is directly 
related to the osmolarity of the medium used. For example, the media osmolarity 
threshold of Sr2+ triggering Ca2+ release at 1mM is around 280mOsm/kg. The addition 
or subtraction of NaCl to change the media osmolarity to generate these results 
suggests that some of the effect of media osmolarity on Sr2+ influx is related to the Na+ 
concentration. In this case Na+ ions could be an important factor in the effectiveness of 
Sr2+ as mouse egg artificial activator. This suggests that it is also worth investigating the 
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replacement of Na+ with other ions that are capable to stabilizing the media osmolarity, 
such as choline or K+. 
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Figure  3.9 The relationship between Sr
2+
 concentrations and medium osmolarities on the Ca
2+
-
oscillations frequency triggered by Sr
2+
 in mouse eggs. 
 
3.4.1 The effect of choline in low Na
+
 media on Sr
2+
-triggered 
Ca
2+
-oscillations  
 
To confirm the effect of Na+ on Sr2+ influx, it was required to make changes to the Na+ 
concentration whilst keeping osmolarity levels constant. An available substitute for Na+ 
is a choline. The choline ion is unlike the Na+ ion in that it does not cross the cell 
membrane via channels, and it also works as cell membrane protector (Stachecki et al., 
1998). This idea was investigated with a simple experiment, by reducing Na+ 
concentration from 130mM to ~30mM. Choline was added to the media to replace the 
Na+ to maintain osmolarity. As before eggs were placed in this media and after 2 hrs of 
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recording Ca2+ levels the data were collected and analyzed. The interesting result of this 
manipulation was that 0.5mM Sr2+ (in normal osmolarity media) was found to trigger 
Ca2+-oscillations in mouse eggs in which the majority of Na+ is substituted with chloine 
(11/16) (Fig. 3.10), the remaining eggs either died or not responded. It is worth recalling 
here that in Sr2+ media with normal osmolarity, Sr2+ 0.5mM is completely unable to 
triggers any Ca2+-oscillations. This experiment was repeated twice with similar results. 
*The time bar is 30 minutes
0.5mM Sr2+ in 300mOsm/kg with 
choline ~100mM & Na+ ~ 30mM
n = 11/16F
 o
f 
C
a
2
+
 d
y
e
 (
a
.u
)
0.5mM Sr2+ in 300mOsm/kg 
with Na+ ~ 130mM 
n = 20/20
A
B
 
Figure  3.10 The effect of choline (osmolarity stabilized) on the ability of Sr
2+
 to induce Ca
2+
-
oscillations. A) Sr
2+
 0.5mM cannot trigger Ca
2+
 increases in eggs in Ca
2+
 free HKSOM media (with 
normal Na
+ 
and osmolarity values). In  B) by substituting Na
+
 with choline 0.5mM Sr
2+
 triggering Ca
2+
-
oscillations in most eggs. 
 
3.4.2 The effect of high K
+
 in low Na
+
 media on Sr
2+
-triggered 
Ca
2+
-oscillations  
 
Similar to choline experiments I also used KCl to adjust and normalize the Sr2+ media 
osmolarity with a low Na+ (~30mM) content. The same protocol was used as in the 
above experiments. The initial experiments (Fig. 3.11A) showed no Ca2+-oscillations in 
normal osmolarity with normal Na+ contents and 0.5mM Sr2+ media (11/12) 91.66%.  
However, (Fig. 3.11B) illustrates that 0.5mM Sr2+ triggered Ca2+ oscillations in the 
majority of eggs in normal osmolarity maintained with K+ (>100mM) and ~ 30mM Na+ 
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(35/38) 92.1%. These data support the idea that a reduction in Na+ concentration alone 
significantly promotes the action of Sr2+ ions in mouse eggs.  
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Figure  3.11 The effect of KCl as an osmolarity stabiliser on 0.5mM Sr
2+
. A) Sr
2+
 (0.5mM) cannot elicit 
Ca
2+
-oscillations in eggs in normal Na
+ 
normal osmolarity media. B) a representative trace of Ca
2+
-
oscillations in eggs triggered by 0.5mM Sr
2+
 in low Na
+
 (~30mM) and normal osmolarity media containing 
high K
+
 (>100mM). 
 
3.4.3 Na
+
 (0mM) media facilitates Sr
2+
-triggered Ca
2+
-oscillations 
in mouse eggs  
 
The facilitating effect of Sr2+ triggered Ca2+-oscillations in low Na+ media experiments 
with either choline or high K+ could be due to the promotion of Sr2+ influx via the 
activation of the reverse mode of the NCX. This was tested by the preparation of a 
completely Na+ free (0mM) H-KSOM media that should maximize the exit of Na+ and 
promote Sr2+ influx. Here I just used KCl in zero Na+ media since it was impossible to 
use choline to replace all the Na+ salts. In this media all Na+ salts were replaced by K+ 
salts for two reasons. Firstly it was important to normalise the osmolarity. Secondly it 
was helpful to depolarise the membrane potential of eggs and it is known that high K+ 
can cause membrane potential depolarisation. With this media we can promote the 
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NCX in a chemical way, by promoting Na+ exit, and in an electrical way, by reducing the 
membrane gradient that drives the normal mode of NCX operation.  
Figure 3.12A&B shows that 0.5mM Sr2+ media can trigger Ca2+-oscillations in 
310mOsm/kg media if the buffer is totally Na+ free and contains high K+ (16/19) 84.21%. 
Although the majority of eggs responded after a varying time, a few eggs (3/19) did not 
respond. Similar results were obtained by repeating the experiments twice. These data 
suggests that Na+ is the key element for Sr2+ action on mouse eggs and this could be 
because zero Na+ media can activate the reverse NCX and facilitates Sr2+ influx in Ca2+ 
free media. 
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Figure  3.12 The effect of zero Na
+
 media on the ability of Sr
2+
 to trigger Ca
2+
-oscillations. Both A&B 
traces are from the same experiment which shows that 0.5mM Sr
2+
 can trigger Ca
2+
-oscillations even in 
high osmolarity media (310m0sm), that if it is Na
+
 free and in which Na
+
 is replaced with K
+
. A) 
Represents example of eggs that started to oscillate early and with high frequency. B) Exemplify the eggs 
that oscillated late and with a lower frequency. 
 
3.4.4 The relationship between Sr
2+
-triggered Ca
2+
-oscillations 
and mouse egg swelling  
 
In the above experiments it was clearly noticed that after two hours of incubation many 
mouse eggs in Sr2+ media became swollen. Additionally, if they were kept for long 
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periods of time in Ca2+ free Sr2+ media, most if not all eggs become swollen see (Fig. 
3.13, before and after). I decided to study the possible connection between this 
phenomenon and Ca2+ oscillations in mouse eggs and establish if there is a causal 
relationship.  
Before Af ter  
Figure  3.13 Images are of mouse eggs in normal osmolarity H-KSOM (not Sr
2+
 media) and then 
after lowering the osmolarity. Eggs swell up in low osmolarity H-KSOM media. Similar phenomenon 
where also notice in Sr
2+
 0.5mM experiments and typically seen if eggs kept in for a long time (>2hrs). 
 
The simplest way to study the relationship between Ca2+ and swelling was to co-inject 
eggs with two fluorescent dyes (one Ca2+ sensitive and the other non-Ca2+ sensitive). I 
could then use one to measure Ca2+ and the other to provide a clear outline of the egg 
in order to measure its cross sectional area. The two dyes need to have different 
emission spectra i.e. the non-Ca2+ binding dye spectrum should not overlap with the 
Ca2+ dye emission spectrum. The most suitable non-Ca2+ binding dye to use alongside 
OGBD is Alexa594. Mouse eggs were co-injected with OGBD and Alexa594 together 
(1:1) and transferred into a drop of Ca2+ free H-KSOM with a borderline osmolarity 
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~270mOsm/kg containing 0.5mM Sr2+. I used this osmolarity to have a delayed effect of 
Sr2+ in trigger Ca2+-oscillations and yet facilitate egg swelling. Any changes in the egg 
size should not change the fluorescence intensity of Alexa594 dextran, but egg swelling 
should result in an increase in the size of the fluorescent cross surface area of the 
target egg. By monitoring the outline of eggs against time we can plot a line graph using 
image-J soffware and shows the volume changes in each egg separately.  
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Figure  3.14 The relation between 0.5mM Sr
2+
 triggered Ca
2+
-oscillations and egg swelling in 
~270mOsm/kg media. In A) the Alexa594 dextran signal (thick line) increased gradually just after the 
time of Ca
2+
-oscillations onset. B) Shows that some eggs start to swell up before oscillations onset. C) 
Represents part of (A) eggs and shows that in 39% of eggs swelling starts just after the onset of the first 
Ca
2+
-oscillations. 
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After 2 hrs of recording the data were collected and analysed as usual. The results 
shows that most eggs started their first Ca2+ spike before the swelling started (71.87%, 
23/32) (see Fig. 3.14A). However some eggs started to swell up just before they started 
to oscillate (9/32) 28.12% (see Fig. 3.14B). However in some eggs the swelling started 
towards the end of the first Ca2+ increase’ (Fig. 3.14C). The other interesting point of 
note is that the longer the 1st Ca2+ spike the prompt in the rise of the curve for the Alexa 
594 fluorescence (9/32) 39.1% see within the circle in (Fig. 3.14C). 
These finding suggests that although the majority of eggs undergo swelling during Sr2+ 
induced Ca2+-oscillations, and whilst egg swelling may facilitate ongoing Sr2+ influx in 
mouse eggs, there is no indication that oscillations are triggered by an increase in cell 
volume.  
 
3.5 The nature of Strontium influx pathways  
 
Sr2+ is a divalent cation similar to Ca2+ and it can potentially cross cell membranes using 
different types of Ca2+ channels. However, the specificity and affinity of these channels 
to Sr2+ are often different from Ca2+. Based on previous reports the mouse egg 
membrane may contain a variety of ion channels and exchangers, however, the full 
spectrum of Ca2+ influx channel types in the plasma membrane of the mouse egg is 
unknown. The confirmed Ca2+ channels or exchangers in mouse eggs include the 
stretch activated channels and the NCX (Pepperell et al., 1999; Carroll, 2000; Machaty 
et al., 2002). TRP channel expression has also been described in mammalian eggs 
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(Zhu et al., 1996). Before returning to a more detailed to study of the NCX, I decided to 
investigate the role of stretch activated channels in Sr2+ influx.  
 
3.5.1 Stretch activated channels and Sr
2+
 influx  
 
The stretch activated channels are known to be present in cell membranes in many cell 
types and they can be osmotically activated (Kondoh et al., 2003). As mentioned 
previously our protocol in Sr2+ experiments was to keep mouse eggs in Sr2+ media for 2 
hrs, and I had noticed that at the end of this time most eggs increased in size, even in 
the normal osmolarity media. This occurs particularly when I used borderline osmolarity 
with particular Sr2+ levels, for example a combination of 260mOsm/kg and 0.5mM Sr2+, 
where some eggs oscillated and other did not. To look into this further I analysed these 
experiments by correlating the each eggs appearance with their Ca2+ responses. 
Interestingly, the results show that those eggs who swollen that the ones who showed 
Ca2+-oscillations and vice versa i.e. those who didn’t oscillate they didn’t swollen either. 
I then decided to carry out a key experiment which was to suddenly change the 
osmolarity of the Sr2+ media whilst recording Ca2+ levels. I did this by transferring OGBD 
injected mouse eggs into a 300µl drop of Sr2+ (0.5mM) media (HKSOM) with a normal 
osmolarity (300mOsm/kg). Then the experiment was started for and after 1 hr I added 
150µl of the same media but with low Na+ (30mM) to decrease the osmolarity to 
~220mOsm/kg. After over 1 hr of further recording the experiment was stopped.  
Figure 3.15, shows that all eggs failed to oscillate for the first ~30 min, but after 
deliberately reducing the osmolarity the majority of eggs began to oscillate (38/45), and 
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at the same time all become larger in size (swollen). This result suggests that a lower 
osmolarity media potentiates Sr2+ influx that elicits Ca2+ release. The data also suggests 
that the stimulation of Ca2+-oscillations requires an appropriate combination of Sr2+ and 
media osmolarity (Fig. 3.9).  
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Figure  3.15 The effect of osmolarity on Ca
2+
-oscillations driven by Sr
2+
 influx augmentation. The 
switch to a lower osmolarity media triggered Ca
2+
-oscillations with low extracellular Sr
2+
 concentrations 
(0.5mM). 
 
The possible explanation of this type of effect could be that, by decreasing the media 
osmolarity the eggs size increases and   this then stretches the egg membranes.  This 
stretch could l then open ion channels which could facilitate Sr2+ influx across the 
plasma membrane and triggers Ca2+ release. This idea prompted further investigation of 
the channels involved in influx in eggs. 
 
3.5.2 The effects of non-selective Ca
2+
 channel blocker on Sr
2+
-
triggered Ca
2+
-oscillations 
 
There are several substances are known to be a non selective Ca2+ channel blockers 
such as gadolinium (Ga3+) (Biagi and Enyeart,1990) and lanthanum (La3+) (Machaty et 
al., 2002). These can be used to investigate the role of TRPC in Sr2+ influx.   The most 
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common inhibitor used is the Ga3+ ion, which is a positively charged and also a known 
blocker of stretch activated Ca2+ channels (Yang and Sachs, 1989). Its effects were 
investigated upon Ca2+ responses of mouse eggs kept in Sr2+ media. To start I used 
final concentrations of Ga3+ of 50µM and La3+ of  1mM to look at the effects on Ca2+ 
oscillations. These concentrations were chosen based on available literature on other 
cells. The protocol I used was to transfer OGBD injected mouse eggs into Sr2+ media on 
the recording stage. Then ~30 min after Ca2+-oscillations had started I added either 
Ga3+ or La3+ and then kept the recording going for another hour. Unfortunately these 
initial experiments were not successful. This was because of the formation of crystals or 
either Ga3+ or La3+ in the Sr2+ media (Ca2+ free HKSOM). Ga3+ and La3+ are ions with 
three positive charges. This makes it easy for them to precipitate with the negatively 
charged ions, such as phosphate, that are present in HKSOM.  So, to overcome this 
obstacle we used a modified media that is phosphates and sulphates free (Okada et al., 
2003). The  Ca2+ free version of this buffer  is NaCl 137mM, KCl 5.5mM, MgCL2 1.2mM, 
and HEPES NaOH 7.5mM, (Kondoh et al., 2003) with 0.2 mM pyurvate as the main 
nutrient and the osmolarity was adjusted to 297mOsm/kg. Before repeating the previous 
protocols with the new buffer, I confirmed that both Ga3+ and La3+ can dissolve in this 
modified media. By carrying out the same protocol with the new buffer, the results 
showed that there are clear effects of both ions upon Sr2+-induced Ca2+-oscillations in 
mouse eggs. In detail, after a few Ca2+ oscillations, the addition of Gd3+ (50µM) or La3+ 
(1mM) clearly stopped the oscillations, generally after one or more Ca2+ spikes either 
with Gd3+ (24/30) 80% of eggs)  or with La3+ (14/19 73.7% of eggs) (Fig. 3.16A&B).  
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Figure ‎3.16 The effect of non-selective TRPC blockers on Ca
2+
-oscillations caused by 10mM Sr
2+ 
in 
mouse egg places in Ca
2+
 and phosphate free buffer. A) After oscillations were established, adding 
50uM Gd
3+
 stopped oscillations after one or more Ca
2+
 spikes. B) Similar results were obtained by adding 
1mM La
3+
 after oscillations Ca
2+
 had been established.   
 
However, it was noted that for the remaining eggs (6/30) and (5/19) there was a some 
response to Gd3+ and La3+, but this consisted of an increase in Ca2+ level that never 
recovered and eventually lead to egg death. These results suggest a pivotal role of a 
continuous Sr2+ influx for the continuation of Ca2+-oscillations. Although these Ca2+ 
channel blockers are a non specific, these results do suggest that some Ca2+ influx 
channels are present in mouse eggs and that they are required to support Sr2+ influx 
and Ca2+-oscillations. 
 
3.5.3 The effect of selective TRP Ca
2+
 channel blockers upon 
Sr
2+
-induced Ca
2+
-oscillations  
 
To be more precise about which type of Ca2+ channel is involved in Sr2+ influx I tried to 
block different kinds of channels selectively using known selective Ca2+ channel 
blockers. The presence or the selectivity of these channels towards Sr2+ influx was 
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judged by the effect of the particular blocker on Sr2+-induced Ca2+-oscillations in treated 
mouse eggs.  
 
3.5.3.1 The responses of Sr2+-induced Ca2+-oscillations in mouse eggs 
to GsMTx-4 application  
      
GsMTx-4 is a peptide toxin from Grammostola spatulata spider venom that blocks 
stretch activated ion channels (Suchyna et al., 2000). TRPC1 it is widely expressed in 
different mammalian tissues, this makes it as one of best example of a stretch activated 
ion channels (Maroto et al., 2005), making it as a potential candidate for inhibition by 
GsMTx-4. Some reports show that GsMTx4 blocks TRPC1 as well as TRPC5 (Gomis et 
al., 2008). TRPC5 has been shown to allow Sr2+ influx into mast cells in conjunction with 
STIM1and Ori1 (Ma et al., 2008). TRPC6 is also a GsMTx-4 sensitive stretch activated 
ion channel (Alessandri-Haber et al., 2009).  
To investigate GsMTx4 I followed the previous protocol using OGBD injected eggs and 
placing them into Sr2+ media at a concentration of 5.0mM. After oscillations had started I 
added 5µM GsMTx4 (final concentration) which was mixed well in the dish before 
continuing recording. However, the result of adding this peptide was that there was no 
inhibitory effect of GsMTx-4 on Sr2+-induced Ca2+-oscillations. The majority of eggs 
(77.7%, 7/9) continued oscillating after adding the peptide (see Fig. 3.17). This 
experiment was repeated with 20µM of GsMTx-4 and the outcomes were the same. 
Then I modified the protocol by adding 20µM of GsMTx-4M from the beginning to the 
Sr2+ media before even transferring the eggs. The results showed that all eggs in this 
experiment displayed a continued increase in Ca2+ signal and eventually all died. In 
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general these data provide not support for the idea that TRPC play a role in Sr2+ influx in 
mouse eggs. 
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Figure  3.17 Representative trace showing the response of Ca
2+
-oscillations induced by 5mM Sr
2+
 in 
mouse egg to which 5uM of GsMTx-4 peptide was added. 
 
3.5.3.2 The effect of other specific Ca2+ channel blockers on Sr2+-
triggered Ca2+-oscillations  
 
Carvacrol is a novel inhibitor of mammalian TRPM7 (Melastatin) channels (Parnas et 
al., 2009). TRPM7 is a divalent cation-selective ion channel that is permeable to 
essential ions such as Ca2+ and Mg2+, physiologic metals such as Zn2+ and Mn2+, as 
well as non-physiological ones such as Ni2+, Cd2+, Ba2+, and Sr2+ (Penner and Fleig, 
2007). Furthermore, TRPM7 has been shown to be expressed in mouse eggs (Evsikov 
et al., 2006).  
I investigated the possibility of stopping Sr2+-triggered Ca2+-oscillations by blocking 
TRPM7 in mouse eggs using carvacrol. The experiment protocol was the same as 
previous experiments, and after Ca2+ oscillations triggered I added carvacrol to the dish 
with a final concentration of 500μM. The results were inconclusive since some eggs 
showed declined in the oscillations frequencies whilst some did not, (5/19) 26.3% and 
(14/19) 73.68% respectively. Similar results were obtained twice, however, the eggs’ 
responses were variable each time, i.e. (10/23) 43.47% responded and (13/23) 56.52% 
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did not respond. It could be that Sr2+ influx occurs through various membranous pores 
and TRPM7 is just one of many influx pathways. 
I also tried to block store-operated Ca2+ entry (SOCE) channel using their specific 
inhibitor SKF96365 This drug has been found to block voltage-gated Ca2+ entry, TRP 
channels and K+ channels (Singh et al., 2010). I used this drug in a concentration range 
from 10 to 20µM. Unfortunately, the drug kept precipitating in any media including M2 
media, HKSOM, and Ca2+ free HKSOM and even in the modified phosphate and Ca2+ 
free buffer that was used with Ga3+ experiments.  
 
3.5.4 Attempts at TRPC channel activation. 
 
It was difficult to know the exact channel/s that Sr2+ used to influx across the membrane 
of mouse eggs. Since using inhibitors end with limited success, an alternative approach 
is to try to stimulate specific channels. TRPC5 and TRPC1 have been shown to respond 
positively to application of reduced thioredoxin (rTRX) or dithiothreitol (DTT) (Xu et al., 
2008). TRPC5, TRPC4 and TRPC1 proteins contain a pairs of cysteine residues near 
glutamic acid 543. These cysteine residues may be covalently linked by a disulphide 
bridge that can be broken by reduction by a reducing agent that then enables enhanced 
channel activity such as described for TRPC5 (Xu et al., 2008).  I tried to induce Sr2+ 
influx by activating some of the TRPC with these agents in situations where Sr2+ is 
otherwise unable to trigger Ca2+ oscillations, such as in normal osmolarity Ca2+ free 
media with 0.5mM Sr2+.  
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3.5.4.1 The effect of DTT on Sr2+-stimulated Ca2+-oscillations 
 
To investigate the possible role of TRPC5 on Sr2+ influx in mouse eggs, eggs were 
injected with OGBD as a Ca2+ indicator and transferred to Ca2+ free media with an 
osmolarity of 250mOsm/kg and containing 0.5mM Sr2+. Then after over 1.5 hour from 
the experiment starting time, DTT was added to the dish at a final concentration of 
1mM. The data showed that after establishing Sr2+-induced Ca2+-oscillations the 
addition of 1mM DTT clearly accelerates the frequency of oscillations (11/13) 84.6% 
(Fig. 3.18A). The mean spikes number in pre and post DTT is 2.6/1hr (s.e = 0.24) and 
6.3/1hr (s.e = 0.65) respectively, with an overall increase by 2.4 folds. However, some 
responding eggs (4/11) 36.36% showed a persistent Ca2+ signal increase that 
eventually lead to cell death (Fig. 3.18B).  
This experiment was then repeated with Sr2+ 1mM, and so I added DTT (1mM) after 1 
hour from starting time, and then continued recording for another hour. The data show 
that 87.5% (14/16) of treated eggs responded to DTT by accelerating the frequency of 
their Ca2+ oscillations from (5.4/1hr) to (9.5/1hr) before and after DTT respectively (Fig. 
3.18C). The overall increase was 1.7 times. Similarly, (6/14) 42.85% of eggs showed a 
sustained Ca2+ increase that lead to cell death.   
Overall, these data with DTT show a clear augmentation effect on Sr2+-induced Ca2+-
oscillations rises. These results also suggest that DTT potentially possess some toxic 
effect on mouse eggs if the later is kept in for a longer time. This suggests that the 
TRPC5 could be involved in Sr2+ influx, but they cannot be used to conclude or exclude 
the presence of TRPC5 in the mouse egg plasma membrane.   
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Figure  3.18 Representative data showing the responses of mouse eggs to DDT whilst undergoing 
Sr
2+
 induced Ca
2+
-oscillations. A) Shows representative mouse egg responding to 1mM DTT in 0.5mM 
Sr
2+ 
by increased frequency. B) Shows and example of an egg the (A) that died after responding to DTT. 
C) Shows an example of mouse egg responding to DTT (1mM) in 1mM Sr
2+ 
which showed and increased 
frequency of Ca
2+
-oscillations. 
 
3.5.4.2 Thioredoxin (TRX) and Sr2+ influx  
 
Thioredoxin is an important intracellular redox protein with established biological roles in 
physiological processes and it is also a secreted protein. It is reduced by the NADPH-
dependent flavoprotein thioredoxin reductase which produces the reduced (r) form of 
thioredoxin (TRX). The rTRX has a capability to cleave disulphide bridges and hence 
work like DTT as a TRPC5 activator. It is regarded as a novel endogenous extracellular 
regulator of TRPC5 (Xu et al., 2008).  
Bearing in mind the possible toxic effect of the DTT, I used rTRX at a concentration of 
1µg/ml. The protocol was similar to DTT experiments in which OGBD injected mouse 
eggs were transferred into the recording drop containing Sr2+ (0.5mM in Ca2+ free 
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media) with an osmolarity of 275mOsm/kg. After the experiment had recorded for 
~30min I then added 1µg/ml (final concentration) of rTRX and then recorded for another 
30min. The results showed that all eggs survived after adding rTRX, and a clear effect 
of rTRX on Sr2+ influx was noticed. After recording for ~1hr, over half of the tested eggs 
(13/25, 52%) started oscillating after rTRX addition. However, 20% (5/25) of eggs that 
were already oscillating even before adding rTRX, continued to oscillate with no clear 
changes in the frequency. Only 28% (7/25) do not respond after adding rTRX (Fig. 
3.19A, B and C).  
*The time bar is 30minutes
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Figure  3.19 The effect of rTRX on Sr
2+
 influx and Ca
2+
-oscillations. A, B and C shows the combination 
effects of Sr
2+
 (0.5mM) and rTRX (1µg/ml) on Ca
2+
-oscillations. More than 50% of eggs responded by 
triggering oscillations and less than 30% did not respond. D and E were similar protocols to previous 
experiments but with (0.25mM) Sr
2+
 to prevent eggs from undergoing prior oscillations. Similar findings 
were seen. Only 35% of eggs do not respond to rTRX in such lower Sr
2+
 concentration.  
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To stop eggs oscillating before adding rTRX, I repeated this experiment with much 
lower Sr2+ concentration (0.25 mM) whilst keeping the other conditions the same. The 
results were promising in that the majority of eggs (9/14, 64.3%) started oscillating after 
adding 1µg/ml, and only 35.7% (5/14) did not respond (Figure 3.19D and E) 
respectively.  
However, the time of response was variable between eggs. This variability could be 
related to intrinsic factors of eggs. These results suggest that TRPC5 could be present 
in mouse eggs and Sr2+ could conduct through TRPC5. However, it does not mean that 
TRPC5 is the only channel that allows Sr2+ to influx through into mouse eggs. To 
summarize the blocking and facilitating or promoting Sr2+ influx results, it can be 
proposed that Sr2+ may flow through TRPC5 but that this is not likely to be the only 
channel.  Different kinds of Ca2+ channels might be involved.  
3.5.5 The role of the NCX in Sr
2+
-induced Ca
2+
-oscillations  
 
Previous work I presents suggested that the stimulation of Ca2+ oscillations by low Na+ 
media, containing choline ‘Fig.3.10’ could be due to the reversal of the NCX. As 
mentioned earlier in the first chapter, NCX is a plasma membrane transporter that 
moves Ca2+ in or out of the cell, depending on membrane potential and trans-membrane 
ion gradients. In mouse eggs the intracellular Na+ ion concentration plays a key role in 
determining the direction of NCX as well (Carroll, 2000). In other words, a minimal 
increase in the intracellular Na+ concentration could reverse the NCX. Similarly, the 
membrane potential can reverse the NCX, and this is likely to happen when the 
  138 
exchanger reversal potential is similar to the resting membrane potential as suggested 
for mouse eggs (Carroll, 2000).  
The hypothesis illustrated in (Fig. 3.20A&B) and suggests that in the various Sr2+ 
experiments, Sr2+ can substitute for Ca2+ and be taken into the cell on the reverse mode 
of the NCX. This would allow Sr2+ to enter the egg in exchange with intracellular Na+. 
Based on this idea I studied the effect of applying a specific blocker of the reverse mode 
of the NCX on Ca2+ triggered by Sr2+ influx. 
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Figure  3.20 Schematic diagram of the hypothesis for Sr
2+
 entry. A) Normal (forward) mode of NCX. 
B) Reverse mode NCX by which Sr
2+
 could enter the egg and trigger Ca
2+
 release. 
  
3.5.5.1 The effects of KB-R7943 on Sr2+-induced Ca2+-oscillations in 
mouse eggs 
 
     KB-R7943 is a selective blocker of a reverse mode of NCX (Barrientos et al., 2009). 
The effect of KB-R7943, on Sr2+ triggered Ca2+ release in mouse eggs was investigated 
using different protocols and timings of applying of KB-R7943. I used this blocker after 
and before oscillations had started, and also washed it out after blocking Ca2+ 
oscillations. The results showed a clear effect of KB-R7943. Figure 3.21A, shows the 
effects of KB-R7943 (20µM) on Ca2+-oscillations triggered by Sr2+ (0.5mM). It clearly 
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shows the inhibition of Ca2+-oscillations in that after addition there was just one extra 
spike in 16 out of 20 eggs (80%). This protocol was repeated with Sr2+ concentrations of 
5.0mM and 10.0 mM, and both gave similar results. Figure 3.21B, also shows the effect 
of KB-R7943 (20µM) upon eggs from the start of the incubation in Sr2+ media. The 
results show that KB-R7943 blocked (0.5mM) Sr2+-induced Ca2+-oscillations in all used 
eggs (15/15). Similar results were obtained with various Sr2+ concentrations (5.0 and 
10.0mM). Finally, Fig. 3.21C shows that oscillations could be recovered by washing 
eggs with KB-R7943-free Sr2+ media to remove the drug. Furthermore, the recovered 
oscillations can be re-blocked by the re-addition of KB-R7943 (20µM). This experiment 
was repeated twice and gave similar results. 
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Figure  3.21 The effect of KB-R7943 on Ca
2+
-oscillations triggered by 0.5mM Sr
2+
. All experiments 
were started in 0.5mM Sr
2+
 media. A) adding KB-R7943 ~ 1hr after oscillations, B) Adding KB-R7943 in 
Sr
2+
 media from the beginning, C) Is in 3 stages, the 1
st
 stage is  similar to A, in the 2
nd
 stage KB-R7943 
was washed out which recovers the oscillations,  and finally in the 3
rd
 stage the re-addition of KB-R7943  
re-blocked Ca
2+
-oscillations.  
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In my study of KB-R7943's effect on Ca2+-oscillations triggered by Sr2+, I found that the 
optimal concentration of this blocker was 20µM for mouse eggs. Concentrations of 
15µM or less did not blocks oscillations, whereas 25µM or more, not only blocked the 
oscillations but lead to the death of the some of the eggs.  These data suggest that 
reverse mode of the NCX plays a key role in mediating Sr2+ influx that leads to Ca2+-
oscillations in mouse eggs. 
3.5.5.2 The effects of SN-6 on Sr2+-induced Ca2+-oscillations in mouse 
eggs  
    
 The drug SN6 is also a NCX inhibitor which is structurally related, and has similar 
properties to, KB-R7943. It also has been shown to block the reverse mode of NCX 
(Barrientos et al., 2009). I tested SN-6 (20µM) on Sr2+-triggered Ca2+-oscillations in 
mouse eggs using the same protocol as used in KB-R7943 experiment. I did one 
experiment and the results showed that SN-6 can also stop Ca2+-oscillations. This result 
suggests again that Sr2+ enters egg cytoplasom via the reverse NCX, since blocking 
Sr2+ influx stops Ca2+-oscillations. Although, most exposed eggs survived after this 
experiment, I stopped using SN-6 for further experiments because at the end of the 
experiment I noticed that SN-6 began to precipitate in the media.  
 
3.5.6 Does intracellular Na
+
 oscillate during Sr
2+
-triggered Ca
2+
-
oscillations?  
    
Given the above data a further investigation into the involvement of Na+ and the reverse 
mode of the NCX and its exchange with Sr2+ was required. If there is significant 
movement of Na+ out of the cell via the NCX then it is possible that Ca2+-oscillations 
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triggered by Sr2+ could be accompanied by intracellular Na+ changes. In order to 
monitor intracellular Na+ concentrations, sodium green (SG) a specific fluorescent 
sensitive Na+ indicator (Despa et al., 2000) was used to measure intracellular Na+ 
together with a different emission spectrum  intracellular Ca2+ indicator  ‘Rhod dextran’ 
(RhD). However, monitoring intracellular Na+ is not an easy target, since we know that 
the normal intracellular value ranges within a narrow window. 
In this set of experiments I mixed both dyes together (1:1) with final concentration of 
1mM, and then injected them into mouse eggs as part of the routine protocol. The eggs 
were then transferred into a recording dish containing 10mM Sr2+. The SG signal was 
measured at a wavelength 530nm and RhD at 600nm. After recording for 2 hours 
continuously, the experimental data were collected and analysed. Our obtained results 
showed clear Ca2+-oscillations for RhD and shallow fluctuations in SG signals were 
seen in almost all tested eggs (15/16) 93.75%. However, these Na+ changes were 
clearly following the baseline signals of RhD in each egg (Fig. 3.22A).  
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Figure  3.22 The affect of 10mM Sr
2+
 on mouse eggs injected with Na
+ 
indicator (SG) and Ca
2+
 dye 
(RhD) (1:1).  Shown figure is a representative mouse egg displaying clear Ca
2+
-oscillations (RhD) with 
shallow oscillations in the SG signal.   
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This protocol has been repeated twice and gave similar results. These results suggest 
that Na+ fluctuations accompany Sr2+ influx via NCX in mouse eggs. However, it is not 
clear how significant these intracellular Na+ fluctuations are during Sr2+-induced Ca2+-
oscillations.   
 
3.5.7 The effect of Na
+
 ionophore (monensin) on Sr
2+
-triggered 
Ca
2+
-oscillations 
 
Monensin is a monovalent ion-selective ionophore that facilitates the translocation of 
Na+ ions across the cell membrane. Based on this I hypothesized that monensin would 
facilitate Na+ influx, increase cytosolic Na+, and this should promote the reverse mode 
of the NCX. In an exchange of Na+ with Sr2+ this could facilitate Sr2+ influx and triggers 
Ca2+-oscillations in mouse eggs.   
To investigate this hypothesis I carried out series of experiments. Ca2+ dye injected 
mouse eggs were placed in Sr2+ optimized H-KSOM media with osmolarity 
(~270mOsm/kg) containing 0.5mM Sr2+ with normal extracellular Na+. The experiment 
started and was kept running for ~ 1 hr before I added monensin in the media at a final 
concentration of 10mM. After another hour of recording, the experiment was stopped 
and the results were analysed. The results showed that some eggs (8/17) 47% start 
oscillating even before monensin (Fig. 3.23A). The rest (53%) of the eggs (9/17) then 
started oscillating just after monensis addition (Fig. 3.23B).  Regarding the former eggs 
that oscillated before the addition of monensin could be because of the osmolarity level 
(270mOsm/kg). The interesting point in this experiment is that compared with pre-
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monensin addition, the oscillating eggs showed an increase in the oscillation frequency 
after monensin by (75.5%). All eggs were then incubated in HKSOM over night in the 
incubator (5% CO2, 37C°) and on the next day 12 eggs (70.85%)  had progressed to the 
two cell stage, 4 eggs (23.53%) stayed in MII stage and 1died. Similar results were 
obtained after the experiment was repeated once. 
*The time bar is 30 minutes
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Figure ‎3.23 The effect of Monensin (10µM) on Sr
2+
 (0.5mM) induced Ca
2+
-oscillations in low Na
+
 
HKSOM Sr
2+
 media. A) Shows an egg that has an increase in oscillation frequency after monensin 
addition. B) Show Ca
2+ 
oscillations triggered after monensin addition in an egg that has not responded to 
Sr
2+
 alone. 
 
The second set of experiments was performed with higher osmolarity (300mOsm/kg) to 
prevent eggs from oscillating before monensin addition. A similar protocol was followed 
and the results showed that (9/14) 64.28% of eggs started oscillating after monensin 
addition, and that (5/14) 35.71% of eggs did not respond even after monensin addition. 
These results could be explained by the reversal of the NCX due to an increase in 
intracellular Na+. This data is consistent with the idea that the NCX is a significant 
mechanism by which Sr2+ can cross the oolemma in mouse eggs. 
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3.6 Discussion  
 
It has previously been suggested that Sr2+ is the most effective parthenogenetic mouse 
egg activator (Whittingham and Siracusa, 1978; Kline and Kline 1992; Swann and Ozil, 
1994; Rogers et al., 2004). I carried out most of the above work based on the theory 
that Sr2+ influx is required to initiate Ca2+-oscillations. I also suggest that a continuous 
Sr2+ influx is necessary for the continuation of the long lasting Ca2+-oscillations in the 
established Sr2+ activation protocols in mammalian eggs. I have also provided some 
ideas on the mechanism of Sr2+ influx in mouse eggs.  
  
3.6.1 Sr
2+
 Influx can cause Ca
2+
-oscillations 
 
The most challenging experiment I did was the direct intra-cytoplasmic injection of Sr2+ 
(100mM pipette concentration). Prompt Ca2+-oscillations were seen in all survived 
injected eggs, however, the continuous leaking of Sr2+ is required for the continuation of 
Ca2+-oscillations to cause full activation, since the 2000 pulses were only able to elicited 
5 to 9 spikes in injected eggs. However, a couple of more spikes were triggered by re-
injecting Sr2+. The restarting Sr2+ injection from the same pipette was not always 
successful, but this is not the case with a new injection pipette. These results clearly 
suggest that once a sufficient amount of Sr2+ is in the cytoplasm it can trigger Ca2+-
oscillations. It implies that the factors that affect the ability of Sr2+ to trigger oscillations 
could be related to factors effecting Sr2+ influx.  
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3.6.2 Ca
2+
-Oscillations are affected by medium osmolarity and 
Na
+
 contents  
 
It was noticed that keeping mouse eggs in Sr2+ optimized media for longer periods of 
time leads to egg swelling. This was especially true for those eggs that underwent Ca2+-
oscillations. It is know that the egg plasma membrane contains different kind of Ca2+ 
channels including stretch activated channels (SAC). I investigated this by deliberately 
altering the osmolarity of the media via either addition or subtraction of Na+ contents (i.e. 
changing media Na+ concentration). The data showed a clear correlation between Sr2+ 
triggered Ca2+-oscillations and the osmolarity levels. Specifically, in a low osmolarity 
media, even a low Sr2+ (0.5mM) concentration can easily trigger Ca2+-oscillations. The 
possible explanation for this result is that the mechanical effects of egg swelling could 
stretch these channels resulting in them opening their pores. This in turn could allow 
Sr2+ influx. 
 
3.6.3 The involvement of SAC and TRPC 
 
A clear impact of Sr2+’s action on Ca2+-oscillations in mouse eggs was noticed after the 
exposure of eggs to plasma membrane Ca2+ channel blockers. Blocking Ca2+ channels 
with nonspecific blocker Gd3+, which is known to block different categories of Ca2+ 
channels, was shown to be effective at completely stopping of Sr2+ triggered Ca2+ 
oscillations. This suggests that Gd3+ is blocking of Sr2+ influx.  However, various more 
specific blockers were unable to block Sr2+ influx and stop Ca2+ transients. One 
explanation of this is that Sr2+ might cross the plasma membrane by different channels.  
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On the other hand, demonstrating that Sr2+-induced Ca2+-oscillations can be enhanced 
by facilitating Sr2+ influx was successful in some experiments with agents like DTT and 
rTRX. The activation of TRPC5 channel by DTT or rTRX shows either an increase in 
frequency in pre-oscillating eggs, or else the triggering of Ca2+-oscillations in non-
oscillating eggs in normal osmolarity (290-300mOsm/kg) media.  Hence, any means to 
enhance Sr2+ influx may be useful as a way of promoting Ca2+-oscillations.  
 
3.6.4 The oscillations are Ca
2+
, not Sr
2+
 fluorescent signals 
 
Since there is no specific indicator for Sr2+ that is selective over Ca2+, I tried to 
distinguish between Ca2+ and Sr2+ using Ca2+ ionophore (ionomycin), which has Ca2+ 
affinity of 48 times higher  compared to Sr2+ (Liu and Hermann., 1978). I tried different 
protocols using ionomycin with Sr2+ on mouse eggs. The addition of ionomycin to eggs 
after Sr2+ triggered oscillations already stopped resulted in a large Ca2+ dye 
fluorescence spike before the signal. This suggests Ca2+ is still present within the Ca2+ 
store. This then implies that the Ca2+ store has not been replaced by Sr2+.  
 
3.6.5 The key influx mechanism of Sr
2+
 is the NCX reverse mode  
 
Finally, Sr2+ triggered Ca2+-oscillations were also seen after the activation of the reverse 
mode of NCX in 0.5mM Sr2+ with normal osmolarity media. This was demonstrated in an 
experiment with either a low, or zero Na+ media. The oscillations in these experiments 
were completely and reversibly abolished by using a specific reverse mode inhibitor of 
NCX (20µM of KB-R7943) (Fig. 3.21).  
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In addition, by applying the Na+ ionophore (monensin) to eggs, Sr2+-triggered Ca2+-
oscillations that were increased in frequency, or else caused new transients in non-
oscillating ones (Fig. 3.23). This suggest that Sr2+ substitutes for  Ca2+ in the reverse 
mode of NCX, which could mean that Sr2+ influx can occur via SAC and TRPC 
channels, as well as the reverse mode of the NCX. However, the reverse NCX seems to 
be that a major route for Sr2+ influx, since Ca2+ oscillations were completely abolished 
after addition of 20µM of KB-R7943. The effects of this drug represent the only 
successful inhibition of oscillations with a specific drug.  
 
3.6.6 The role of intracellular Na
+
 in Sr
2+
-induced Ca
2+
-oscillations 
 
Some extra experiments were done based on the role of Na+ in Sr2+ triggered Ca2+-
oscillations. These were suggested by the effects of osmolarity and the by the reverse 
NCX experiments. The idea was to see if intracellular Na+ would oscillate during Sr2+-
induced Ca2+-oscillations. To investigate this possibility a specific Na+ indicator was 
required. SG was the best Na+ indicator I could use since it has fluorescence with a 
different wavelength from the Ca2+ dye RhD. The interpretation of these results suggest 
that intracellular Na+ fluctuates within a narrow range, since the SG signal shows 
shallow fluctuations, and these seems to follow the Ca2+ base line levels (see Fig. 3.22).   
The other study which was carried out to try and confirm the role of intracellular Na+ in 
Sr2+-induced Ca2+-oscillations was to raise cytosolic Na+ levels artificially. The principle 
of this study was based on using the Na+ ionophore, Monensin. Adding monensin 
(10µM) into in low Na+ H-KSOM Sr2+ (0.5mM) media shows a clear augmentation effect 
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upon Sr2+-induced Ca2+-oscillation activity. This effect was noticed by the way monensin 
either triggered Ca2+-oscillations or increased the frequency of the current oscillating 
eggs (Fig. 3.23).   
To sum up, putting  all these experimental  results together, I can conclude that in order 
for Sr2+ to  trigger Ca2+ releases it has to cross the plasma membrane to reach the IP3R. 
The influx mechanism is mediated through different Ca2+ membrane channels and 
exchangers. Amongst all of these the NCX, in the reverse mode is the major contributor 
in mouse eggs. 
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Chapter 4 
 
PLCζ‎AND‎Ca2+-OSCILLATIONS  
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4.1 Overview of Phospholipase Cs  
 
As mention in the main introductory section that there are 13 PLCs isozymes, grouped 
into 6 isoforms. All PLCs are cytosolic enzymes that require membrane association to 
access their phospholipid substrate. PLCζ has the smallest molecular mass and most 
primary domain organization among mammalian PLC isozymes. PLCζ consists of a 
tandem pair of EF hand domains at the N-terminus, followed by catalytic X and Y 
domains connected by specific amino acid sequence and called XY linker region, and a 
C-terminal C2 domain. All of which are common to the other PLC isozymes (Saunders 
et al., 2002; Swann et al., 2006; Suh et al., 2008). 
Although, PLCζ possess a similar domain organization to PLCδ1, there are two notable 
exceptions in that PLCζ lacks an N-terminal pleckstrin homology (PH) domain and has a 
longer XY linker region compared to PLCδ1. The PH domain of PLCδ1 has been shown 
to plays a major role in membrane binding to PLCδ1 whenever PIP2 is available 
(Pawelczyk and Lowenstein, 1993; Lomasney et al., 1996). However, PLC2 binds 
strongly but non-specifically to lipid membranes via interaction with a G protein (Singh 
and Murray, 2003), whereas PLC binds to membranes specifically with high-affinity to 
PIP3 (Bae et al., 1998; Falasca et al., 1998). PH domains are a significant mediator of 
membrane binding. They are well-defined structural modules comprising of over 120 
amino acid residues and have been identified in >100 different proteins (Rebecchi and 
Pentyala, 2000). 
The somatic PLC, δ and XYl region has been shown to mediate auto-inhibition of PIP2 
hydrolytic activity specifically. It is proposed that the electrostatic repulsion of the 
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negatively charged residues of the XYl in these PLCs is stopped from making close 
contact with the negatively charged PIP2 substrate (Hicks et al., 2008). The presence of 
additional regulatory domains SH2, SH3 (Src homology)  in the PLC XY linker region  
regulates PLC via tyrosine phosphorylation (Ozdener et al., 2002) and the identification 
of PLC inhibition  via  the SH2 domains has led to a proposed general mechanism of 
PLC auto-inhibition mediated by the XYl region (Gresset et al., 2010). 
Several studies are carried out in this chapter on PLCζ, all were performed as a 
collaboration with Tony Lai’s group. All molecular constructs for the PLCζ work including 
the RNA preparation in this thesis were carried out by Michael Nomikos and Maria 
Theodoridou. All created PLC constructs including wild type, were tagged at the C-
terminus with luciferase to enable real-time monitoring of the relative protein expression 
by luminescence quantification (Swann et al., 2009). It is worth mentioning here that 
each study in this chapter was done with a newly prepared batch of cRNA for PLCζ. As 
a consequence there are some differences in the wild type luminescence /egg and Ca2+ 
spike number.  
A  key role and involvement of PLCζ in fertilization has been further supported  by  two 
recent clinical reports that have linked either a reduced protein (PLCζ) level (Yoon et al., 
2008) or mutated forms of PLCζ with cases of human male infertility (Heytens et al., 
2009).  
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4.2 Male infertility-linked point mutation that disrupts the 
calcium oscillation-inducing activity and PIP2 hydrolysis 
activity of sperm PLCζ 
 
A recent report has identified one infertility case following failed ICSI treatment that was 
associated with a point mutation in the PLCζ catalytic Y domain. The replacement of 
histidine with a proline residue at a position 398 (H398P) correlated with the absence of 
Ca2+ oscillation-inducing activity of human PLCζ as tested in mouse eggs (Heytens et 
al., 2009). His398 is conserved in PLCζ from various mammalian species as well as in 
PLCδ1 (Nomikos et al., 2011a). 
The resultant constructs were tested in vivo by injecting the cRNA encoding for 
constructs into mouse eggs along with Ca2+ sensitive dye (OGBD).  I then analysed 
their effects on Ca2+ oscillation-inducing activity and correlated this with the levels of 
protein expression. It is important to get a proper assessment of the Ca2+ oscillation-
inducing activity of each of these PLCζ constructs, including the wild type and mutants, 
and to verify that these constructs were faithfully expressed as functional proteins in 
cRNA-microinjected mouse eggs. Consequently, PLCζ-luciferase fusion constructs 
were prepared to enable accurate quantification of the relative protein expression in the 
same eggs were Ca2+ was measured. Our primary interest was to look at the Histidine 
to proline substitution at positon 435. However, for comparative analysis, we also 
introduced a new mutation on the same site by replacing His435 with a neutral non helix-
destabilizing residue, alanine, to produce PLCζH435A. Furthermore, in these studies a 
negative control experiment was carried out, and for this purpose we used an additional 
  153 
charge-reversal mutant that produces an inactive PLCζ enzyme ‘PLCζD210R’ that has 
been described previously (Saunders et al., 2002). Additionally, we also examined the 
effect of the histidine to proline type of mutation on the activity of PLCδ1 by replacing its 
equivalent conserved His542 with proline to yield PLCδ1H542P. Finally, we investigated 
potential dominant-negative inhibitory effects of PLCζH435P on the Ca2+ oscillation-
inducing activity of mouse PLCζWT cRNA and mouse sperm PLCζ during in vitro 
fertilization. 
In this study cRNA was prepared for PLCζWT, PLCζH435P, PLCζH435A, PLCζD210R and 
PLCδ1H542P. To avoid using PLCζWT at concentrations that might cause the 
overstimulation of Ca2+-oscillations, PLCζWT was diluted with RNAase free KCl  and 
microinjected at a level that could match the Ca2+-oscillations frequency that is typically 
induced by a single sperm. The final concentration of PLCζWT was co-injected into 
mouse eggs with OGBD in a 50:50% mix.   
4.2.1 Methodology 
 
In order to study the effects of the above mutation in molecular terms, Nomikos and his 
colleagues introduced the infertility-linked human PLCζH398P mutation into its equivalent 
position in mouse PLCζ. This is at His435 and gives rise to a mutation referred to as 
PLCζH435P (Figure 4.1). The full details of how this mutation was made are given in 
(Nomikos et al., 2011a). In brief, cloning of PLCζ, PLCδ1, and mutant constructs were 
amplified by PCR from the original cDNA clone (GenBank™ accession number 
AF435950) using Phusion polymerase (Finnzymes). The PCR products were cloned 
into pCR3-PLC vector after the amplification of the luciferase open reading frame. 
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Mouse PLCζ-luciferase in pCR3 was then subjected to site-directed mutagenesis 
(QuikChange II; Stratagene) to generate the PLCζH435P, PLCζH435A and PLCζD210R 
mutants. PLCζWT and mutants were amplified by PCR from the corresponding pCR3 
plasmid and were cloned into pGEX-6P1 (GE Healthcare). Similarly, rat PLCδ1 in 
pGEX-5X2 was subjected to site-directed mutagenesis to generate PLCδ1H542P. 
Following linearization of wild type and mutant PLCζs, The cRNA was synthesized 
using the mMessage Machine T7 kit (Ambion) and a poly(A) tailing kit (Ambion), as per 
the manufacturer's instructions (Nomikos et al., 2005 and Nomikos et al., 2011a). 
The resultant constructs were then handed over  to me for in vivo testing, I co-inject 
them individually into unfertilized mouse eggs with Ca2+ dye (OGBD) as usual protocol 
see material and method (chapter 2).  
4.2.2 Objectives  
 
In the present study, my objective was to investigate the newly reported human PLCζ 
mutation quantitatively using mouse PLCζ. In addition, my aim was to investigate the 
potential negative effects of the H435P mutation on the PLCζWT activity by determine 
whether an equivalent or excess level of PLCζH435P protein expressed in mouse eggs 
can interfere with the Ca2+ oscillation-inducing activity of either PLCζWT or sperm (IVF). 
Finally, as a comparative study, we looked at the possible effects on PLCζ Ca2+-
triggering activity of inserting a neutral amino acid [alanine] in the same His435 residue 
position. 
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4.2.3 Results 
 
4.2.3.1 H-to-P mutation abolishes Ca2+ triggering activity of PLCζ   
 
Figure 4.1 shows that all PLCζWT-injected mouse eggs (17/17) displayed prominent 
Ca2+ oscillations, with the first Ca2+ spike occurring at a luminescence average of (0.35 
c.p.s) around 30 min post injection time (also see Table 4.1) This level of luminescence 
is estimated to be equivalent to a protein expression level of around 35 fg/egg (see 
materials and methods for how we estimate this). This figure is similar to what 
previously reported for myc tagged PLCζ (Saunders et al., 2002). In contrast, 
microinjecting cRNA encoding either PLCζH435P or PLCζD210R failed to cause any Ca2+-
oscillations in all injected eggs (17/17) and (22/22) respectively (Fig. 4.1 & Table 4.1). 
The lack of response for these two constructs remains the case even after relatively 
high levels of protein expression such (10.7 c.p.s and 8.6 c.p.s/egg). This is in 
comparison to only (7.33 c.p.s/egg) for the wild type PLCζ (Table 4.1). However, 
microinjecting the PLCζH435A mutant caused Ca2+-oscillations in all injected eggs (22/22) 
(Fig. 4.1), exhibiting a closer potency to PLCζWT. The main exception was that the first 
Ca2+ spike was detected after a protein expression level of (0.73 c.p.s./egg) and the 
oscillations starting time was just less than an hour after the time of injection (Table 
4.1). These results show that the mouse PLCζH435P mutation is completely inactive in 
mouse eggs, whereas the PLCζH435A mutation retains most of its Ca2+ oscillation-
inducing activity. These experiments were repeated twice and similar results were 
obtained. 
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Figure  4.1 Ca
2+ 
oscillation-inducing‎activity‎of‎PLCζ-luciferase and mutants in unfertilized mouse 
eggs. (A) Schematic representations of mouse PLCζ domain structure of wild type and mutant H435P 
,H435A  and D210R (control mutation) and identifying their locations within the catalytic Y and X domains.  
(B) The left-hand panels show representative fluorescence (a.u.; arbitrary units) and luminescence (c.p.s.) 
recordings reporting the Ca
2+ 
concentration changes (black traces; Ca
2+
) and luciferase expression (red 
traces; Lum) respectively in a mouse egg following microinjection of the indicated PLCζ-luciferase cRNA 
(encoding either PLCζ
WT
, PLCζ
D210R
, PLCζ
H435P
 or PLCζ
H435A
). Right-hand panels show integrated images 
of luciferase luminescence from eggs microinjected with the corresponding PLCζ-luciferase cRNA. The 
peak luminescence (Lum) recorded is shown in c.p.s. 
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Luciferas
e-tagged 
PLCz
no of Ca2+ 
spikes in 
1st 2 hrs
Lum
peak 
(c.p.s.)
Protein 
peak expre-
ssion (fg)   
Time of 
1st spike 
(min)
Lum at 
1st spike 
(c.p.s.)
Protein 
expression = 
1st spike (fg)
Total 
no of 
eggs
PLCz wt
19.0 ±
0.14
7.33  
0.38
152.6 ~30
0.35  
0.037
34.8 17
PLCz H435P -
10.7  
0.62
229.9 - – - 17
PLCzH435A
9.8 ±
0.65
1.74  
0.14
58.2 ~55
0.73  
0.038
41.1 22
PLCzD210R -
8.6  
0.55
174.1 - – - 22
 
Table  4.1 Properties of PLCζ-luciferase and mutants expressed in mouse eggs. Ca
2+
 oscillation-
inducing activity (Ca
2+
 spike number in 2 h; time to first Ca
2+
 spike) and luciferase luminescence levels 
(peak luminescence; luminescence at first spike) are summarized for mouse eggs microinjected with each 
PLC-luciferase construct (see Fig. 4.1).  
 
4.2.3.2 H435P has no potential dominant negative effects on the 
PLCζWT and sperm Ca2+-oscillatory activity 
To investigate whether PLCζH435P can alter the Ca2+ oscillation-inducing activity of 
PLCζWT, we co-microinjected into mouse eggs an equal mixture of cRNA encoding 
luciferase-tagged PLCζH435P and PLCζWT (Fig. 4.2, top panel). The co-injected cRNA 
produced Ca2+-oscillations with comparable properties with those observed with PLCζWT 
alone (Fig. 4.1, top panel and Table 4.1), showing a time to the first peak of ~30 min 
(Table 4.2). This suggests that the expression of PLCζH435P at similar levels to PLCζWT 
does not interfere with Ca2+-oscillations. To determine whether an excess of PLCζH435P 
was required to block PLCζWT-induced Ca2+-oscillations, we performed sequential cRNA 
microinjections. PLCζH435P was injected into eggs first, followed after a period of 1 or 2 
hrs by a second injection of PLCζWT (Fig. 4.2, middle and lower panels). I performed this 
protocol in order to get prior expression of PLCζH435P for 1 or 2 hrs before there could be 
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any expression of the PLCζWT. Carrying out this protocol did not interfere with the 
induction activity of PLCζWT cRNA which triggered normal Ca2+-oscillations that started 
in average of ~30 min after injection. Table 4, shows that, in these double cRNA 
injection experiments, the cumulative luminescence for both PLCζH435P and PLCζWT at 
the time of first spike (7.06 and 18.68 c.p.s./egg)  for 1 and 2 h respectively) was much 
higher than for control PLCζWT alone (0.35 c.p.s.; Table 4.1). This suggests that an 
excess of PLCζH435P protein does not interfere with PLCζWT-induced Ca2+-oscillations. 
The estimated PLCζH435P protein level of 344 fg in the egg after 2.5 h (2hrs before 
+30minutes after recording) (Fig. 4.2 and Table 4.2), when the first spike is observed 
~30 min after injection of PLCζWT, is well above the (~35 fg/egg) estimated to be 
required for Ca2+-oscillations with PLCζWT alone (see Fig. 4.1 and Table 4.1). This result 
therefore suggests that the PLCζH435P protein even when expressed at a 10-fold excess 
remains unable to block Ca2+ oscillation-inducing activity of PLCζWT.  
Luciferase-
tagged 
PLCz
no of Ca2+
spikes in  
1st 2 hrs
Lum. 
peak
(c.p.s.)
Protein 
peak expr-
ession (fg)   
Time of 
1st spike 
(min)
Lum at 
1st spike 
(c.p.s.)
Protein 
expression = 
1st spike (fg)
Total 
no of 
eggs
PLCzH435P & 
PLCzWT mix
21 ±
1.7
3.4 ±
0.14
86.26 ~30
0.68 ±
0.045
40.4 19
PLCzH435P
after 1hr 
PLCzWT
17.2 ±
1.0
15.8 ±
0.47
295.8 ~30
7.06 ±
0.72
148.2 21
PLCzH435P
after 2hrs 
PLCzWT
15.5 ±
1.09
28.1 ±
1.6
453 ~30
18.68 ±
1.2
344.6 13
 
Table  4.2 Properties‎of‎PLCζ
WT
 and‎PLCζ
H435P
 co-expressed in mouse eggs. Ca
2+
 oscillation-inducing 
activity (Ca
2+
 spike number in 2 h; time to first Ca
2+
 spike) and luciferase luminescence levels (peak 
luminescence; luminescence at first spike) are summarized for mouse eggs microinjected with each PLC-
luciferase construct (see Figure 4.2). Values are means±S.E.M.  
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Figure  4.2 Co-expression‎of‎PLCζ
H435P
 and‎PLCζ
WT
 in mouse eggs  
Left-hand panels show representative fluorescence and luminescence recordings reporting Ca
2+
 
concentration changes (black traces; Ca
2+
) and luciferase expression (red traces; Lum) respectively in a 
mouse egg. The egg was co-microinjected with equal amounts of PLCζ-luciferase cRNA encoding 
PLCζ
WT
 and PLCζ
H435P
 (top panel), or was initially microinjected with cRNA for PLCζ
H435P
 followed, after a 
period of 1 h (middle panel) or 2 h (bottom panel), by the microinjection of cRNA for PLCζ
WT
. Right-hand 
panels show the integrated image of luciferase luminescence from eggs microinjected with PLCζ
H435P
 and 
PLCζ
WT
 cRNA. The peak luminescence (Lum) recorded is shown in c.p.s.  
 
To examine whether normal sperm-induced Ca2+-oscillations are affected by the 
presence of PLCζH435P, IVF experiments with mouse sperm were also performed. As 
with the above experiments the cRNA (PLCζH435P) was injected together with OGBD two 
hour prior to adding sperm into the dish in order to get prior expression of PLCζH435P. In 
this experiment we used a fluorescence imaging system (TE2000 -S, Nikon UK Ltd). 
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The injected eggs were then transferred into the dish containing control mouse eggs 
(only injected with OGBD) fitted in the fluorescent system. The two groups of eggs were 
securely separated and adhered onto the bottom of the dish floor after zona removal 
with Acid tyrodes solution. This was then followed by sperm addition. After two hours of 
recording, successful IVF was obvious by the presence of Ca2+-oscillations.  
IVF control IVF+ PLCζH435P
2 hours 
 
Figure  4.3 Effect‎of‎PLCζ
H435P
 on sperm-induced Ca
2+
 oscillations. Mouse eggs were either untreated 
(IVF control) or injected with PLCζ
H435P
 cRNA (IVF+PLCζ
H435P
) 3hrs prior to the start of recording. 
PLCζ
H435P
 expression produced luminescence of 41.7±1.8 c.p.s. (value is mean±S.E.M., n=11). 
Fluorescence recordings [arbitrary units (a.u.)] reporting Ca
2+
 concentration changes were monitored after 
the addition of capacitated mouse sperm. Following IVF, both control and PLCζ
H435P
 cRNA-injected eggs 
exhibited robust Ca
2+
-oscillations and formed pronuclei 
 
The results were analysed and showed that even after high protein expression levels of 
PLCζH435P were achieved in the mouse eggs  (41.7 c.p.s./egg), as tested on the 
luminescence system, there was no discernible effect on sperm-induced Ca2+ 
oscillations. The Ca2+ spike number in the first  3 hours are closely similar, with  33.4 
spikes in the IVF control group and 32.9 spikes in the IVF + PLCζH435P group (Fig. 4.3 
and Table 4.3). 
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Constructs
Injected
no of Ca2+
spikes in  1st 3 
hrs
Lum. Before
(c.p.s.)
Time of 1st
spike (min)
Total no 
of eggs
sperm
33.4 ±
3.8
~30 7
PLCzH435P & 
sperm
32.9 ±
4.5 
41.7 ±
1.8
~30 11
 
Table  4.3 Properties‎of‎sperm‎PLCζ
WT
 with cRNA PLCζ
H435P
 in mouse eggs. Ca
2+
 oscillation-inducing 
activity by sperm alone and sperm + PLCζ
H435P
 are summarised in this table. The number of Ca
2+
 spikes 
in control eggs (sperm only) was 33.4±3.8 (mean±S.E.M., n=7), and the number of Ca
2+
 spikes in sperm 
+ PLCζ
H435P
 cRNA-injected eggs was 32.9±4.5 (mean±S.E.M., n=11) 
 
4.3 The role of the X-Y linker region of PLCζ in causing 
Ca
2+
- oscillations in eggs  
 
Each isoform of PLCs has a different way to access the target phospholipid substrate. 
For example, PLCδ1, the closest relative to PLCζ, binds strongly to membranes via its 
PH domain. Interestingly, PLCζ lacks a PH domain, making the exact mechanism of 
how PLCζ targets its membrane substrate unresolved. Previous study used Venus 
GFP–PLCζ claimed that PLCζ dispersed all over the cytoplasm and only a small fraction 
of PLCζ binds to PIP2 in plasma membrane (Yoda et al., 2004). This apparently 
suggests that PLCζ does not specifically targeting the plasma membrane and might 
interact with membranes of the cytoplasmic vesicles. Given that we already have 
presumed roles of the N-terminal EF hand and the catalytic X and Y domains, there are 
only two putative candidate domains that might be involved in targeting of PLCζ to PIP2: 
the C-terminal C2 domain and the XYl region, which is the intervening region separating 
the catalytic X and Y domains. 
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The first putative candidate for targeting PLCζ to PIP2 is the C2 domain which is similar 
to PH domain that comprising of over 120 amino acid residues and has been identified 
in numerous proteins, including all isoforms of protein kinase C, synaptotagmin, 
phospholipase A and PLC. First identified in protein kinase C, the C2 domain was 
functionally implicated in Ca2+-dependent phospholipid interactions (Nalefski and Falke, 
1996). The C2 domain has since been characterized as an intermolecular interaction 
and membrane-associating domain in a variety of proteins (Medkova and Cho, 1999). 
Most C2 domains bind to Ca2+, a crucial determinant for the associated enzyme activity 
(Zheng et al., 2000). The PLCζ C2 domain appears to have an essential role in cellular 
function because deletion of this domain leads to inability of the truncated PLCζ to 
cause Ca2+-oscillations in intact mouse eggs, although enzyme activity is retained 
(Nomikos et al., 2005; Kouchi et al., 2005). There is currently no evidence for PLCζ C2 
domain binding to membrane phospholipids through Ca2+-dependent or -independent 
way, although screening phosphoinositides for interaction with the C2 domain of PLCζ 
revealed that it can bind to both phosphatidylinositol 3-phosphate (PtdIns3P) and 
phosphatidylinositol 5-phosphate (PtdIns5P)  (Kouchi et al., 2005). 
The alternative putative candidate that might be involved in targeting of PLCζ to 
biological membranes PIP2 is the PLCζ-XYl region. Notably, the sperm-specific PLCζ is 
unique in displaying extended XYl region compared to PLCδ1 (the closest isoform to 
PLCζ). Furthermore, this XYl region in PLCζ is abundant with  positively charged basic 
amino acid residues (lysine) (Saunders et al., 2002; Cox et al., 2002), which is not the 
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case in the somatic cell PLCβ, δ and γ isoforms, where this region is negatively 
charged.  
In this Chapter, I investigate the potential importance of the XYl region on 
PLCζassociation with Ca2+ releasing activity in mouse eggs.  This study was carried 
out by preparing a full-length PLCζWT cRNA and series of site-directed mutagenesis to 
produce three cumulative mutations within the positively charged region (lysine amino 
acid) that clustered within the XYl of mouse PLCζ. The resultant mutants PLCζ 
produced by sequentially inserting an alanine neutral amino acid in positions 374, 
374&5, 374,5&7 instead of the positively charged lysines, to create the single 
(PLCζK374A), double (PLCζK374,5AA) and triple (PLCζK374,5,7AAA) X-Y domain mutants (Fig. 
4.4). I carried out the in vivo study, by comparing the Ca2+ oscillation-inducing properties 
of these lysine mutants with that of PLCζWT by microinjecting them into unfertilized 
mouse eggs. In addition and in order to establish the degree of inhibition effected by the 
generated (K-to-A) mutations, a negative control was also injected into eggs, 
(PLCζD210R) the catalytically inactive PLCζ mutant (Saunders et al., 2002; Nomikos et 
al., 2011b). Other studies within our research team have also investigated the in vitro 
interaction of the PLCζ-XYl and C2 domain with PIP2 by employing the protein-lipid 
overlay and a liposome-binding assay (Nomikos et al., 2011b).  
 
4.3.1 Methodology 
 
In order to study the effects of the above mutation on Ca2+-inducing activity of PLCζ, 
Nomikos and his colleagues introduced sequential mutations within the XYl region by 
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substituting lysine (positively charged) by alanine (neutral) to yield single  (PLCζK374A), 
double (PLCζK374,5AA) and triple (PLCζK374,5,7AAA) PLCζH398P mutants (Fig. 4.4).  
YXFF EE C21 647
308 --- 385
XY linker
PLCzWT 374  KKRKRK  379
PLCzK374A 374  AKRKRK  379
PLCzK374,5,7AAA 374  AARARK  379
PLCzK374,5AA 374  AARKRK  379
 
Figure  4.4  Schematic of mouse PLCζ domain structure and identifying the successive K-to-A mutations 
between residues 374 and 379 in the XY-linker region  
 
The full details of how this mutation was made are given in (Nomikos et al., 2011b). In 
brief, after the cloning of PLCζ-XYl, C2ζ and PLCδ1PH constructs from the original 
cDNA clone (GenBank™ accession number AF435950) (Saunders et al., 2002), using 
Phusion polymerase (Finnzymes) and the appropriate primers, the pCR3 mouse PLCζ-
luciferase construct (Nomikos et al., 2005) was subjected to site-directed mutagenesis 
(QuikChange II, Stratagene) to sequentially generate the three substitutions of alanine 
for lysine at K374, K375 and K377, thus producing the PLCζK374A, PLCζK374,5AA 
and PLCζK374,5,7AAA mutants. Following linearization of wild-type and mutated PLCζ 
constructs, cRNA was synthesized using the mMessage Machine T7 kit (Ambion) and 
then polyadenylated using the poly(A) tailing kit (Ambion), as per the manufacturer's 
instructions (Nomikos et al., 2005 and Nomikos et al., 2011b). Then I took the resultant 
constructs and test them individually in vivo by co-injecting them into unfertilized mouse 
eggs with Ca2+ dye (OGBD) as per usual protocol.  
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4.3.2 Results 
 
To investigate the potential importance of the cluster of basic residues within the 
PLCζXY linker region (Fig. 4.4), the three mutated PLCζ constructs; the single 
(PLCζK374A), double (PLCζK374,5AA) and triple (PLCζK374,5,7AAA) were tested by 
microinjection of the corresponding cRNA into eggs mouse eggs. This was to assess 
their ability to trigger Ca2+-oscillations and in order to verify their expression.  
Figure 4.5, 4.6 and Table 4.4 summarize the results of the wild-type and mutant PLCζ–
luciferase cRNA microinjection experiments. In the PLCζWT cRNA-injected eggs 
prominent Ca2+-oscillations (19 spikes in the first 2 hours) were observed, with the first 
Ca2+ spike occurring ~30 minutes after microinjection at a luminescence level of (0.35 
c.p.s./egg) (Fig. 4.5). Microinjection of cRNA encoding the PLCζK374A single mutant 
also caused prominent Ca2+-oscillations in injected mouse eggs, exhibiting a similar 
potency to wild-type PLCζ (17 spikes in 2hrs) with the first Ca2+ spike detected at a 
expression level of (0.33 c.p.s./egg) (Fig. 4.6). On the other hand, microinjection of 
cRNA of either PLCζK374,5AA or PLCζK374,5,7AAA into mouse egg clearly resulted in 
a significant reduction in the frequency of Ca2+ oscillations and causing only (8.0 and 
2.6 spikes in 2 hours) respectively (Fig. 4.6) compared with 19 spikes in case of 
PLCζWT. Notably, there was also a dramatic increase (more than twice) in the time 
required for initiation of Ca2+-oscillations in both the double and triple PLCζ mutants, 
with the first Ca2+ spike appearing at ~65 minutes (Fig. 4.6 and Table 4.4). Moreover, 
the luminescence level required to produce the first Ca2+ spike has also significantly 
increased compared to the PLCζWT (0.93 and 1.43 c.p.s./egg) for the double and triple 
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mutant, respectively. Finally, as reported previously (Saunders et al., 2002) the 
microinjection of cRNA encoding the PLCζD210R mutant failed to cause any Ca2+-
oscillations even though it was expressed at much higher levels (14.5cps/egg) than 
wild-type PLCζ (7.3 c.p.s/egg) (Fig. 4.5 and Table 4.4) and PLCζ K-to-A mutants (3.1, 
3.0 and 5.8 c.p.s/egg) for single, double and triple mutation respectively (Table 4.4).  
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Figure ‎4.5  The‎ effect‎ of‎ PLCζ
WT
 and‎PLCζ
D210R
 mutation on Ca
2+
 oscillation-inducing activity in 
mouse eggs. Fluorescence and luminescence recordings reporting the Ca
2+
 changes (black traces; Ca
2+
) 
and luciferase expression (red traces; Lum, in counts per second; cps) in unfertilized mouse eggs 
following microinjection of cRNA encoding luciferase-tagged, wild-type PLCζ or D210R mutant of PLCζ 
(left panels). The average luminescence level (cps) achieved in mouse eggs is indicated for each 
microinjected cRNA, e.g. PLCζ
WT
 Lum=7.33 (top trace) and 14.5 cps for D210R. Panels on the right are 
the integrated luminescence images of individual mouse eggs following cRNA microinjection of either 
wild-type or mutant PLCζ (Table 4.4). 
  
These data indicate that the substitution of two or more alanines for lysines within the 
positively charged cluster of the PLCζ XYl dramatically alters their Ca2+ oscillation-
inducing activity in mouse eggs by reducing the Ca2+ spike frequency and increasing 
both the time and amount of mutant PLCζ expression required to initiate the first spike. 
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Figure ‎4.6 Effect‎of‎PLCζ‎XY-linker mutations on Ca
2+
 oscillation-inducing activity in  
mouse eggs. Fluorescence and luminescence recordings reporting the Ca
2+
 changes (black traces; Ca
2+
) 
and luciferase expression (red traces; Lum, in counts per second; cps) in unfertilized mouse eggs 
following microinjection of cRNA encoding luciferase-tagged, wild-type PLCζ or the indicated single, 
double, triple K-to-A and D210R mutants of PLCζ (left panels). The average luminescence level (cps) 
achieved in mouse eggs is indicated for each microinjected cRNA, e.g. PLCζ
WT
 Lum=7.33 (top trace). 
Panels on the right are the integrated luminescence images of individual mouse eggs following cRNA 
microinjection of either wild-type or mutant PLCζ (Table 4.4) 
 
To sum up, the results from the in vivo experiments are consistent with the suggestion 
that the PLCζ XYl possesses significant affinity for PIP2. This in vivo study showed the 
generated mutations (K-to-A) of sequential reduction of the XYl net positive charge 
significantly affects in vivo Ca2+ oscillation-inducing activity. From these results it 
appears that the PLCζ XYl region plays a major role in the binding of PLCζ to PIP2-
enriched membranes. 
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Luciferase-
tagged PLCz
1st 2 hrs 
Ca2+ spike 
no 
Lum. 
peak
(c.p.s.)
TimWTe of 
1st spike 
(min)
Lum at 1st
spike 
(c.p.s.)
Protein 
expression = 
1st spike (fg)
Total 
no of 
eggs
PLCz
19 ±
0.14
7.3 ±
0.38
~30
0.35 ±
0.037
347.15 17
PLCzD210R 0
14.5±
0.87
0 0 0 17
PLCzK374A
17 ±
1.0
3.1 ±
0.23
~30
0.33 ±
0.03
343.77 12
PLCzK374,5AA
8.0 ±
0.30
3.0 ±
0.1
~65
0.93 ±
0.07
45.26 16
PLCzK374,5,&AAA 2.6 ±
0.50
5.8 ± 1.5 ~65
1.43 ±
0.30
537.32 29
 
Table  4.4 Summary of the properties of Ca
2+
-oscillations observed in mouse eggs following cRNA 
microinjection of the luciferase-tagged PLCζ
WT
 and various PLCζ
XYl K-to-A 
mutants. See Fig. 4.5 and 4.6.  
 
4.4 Novel regulation of PLCζ activity via the XY-linker 
 
Since the discovery of PLCζ it has been recognised as the most likely physiological 
mammalian sperm factor by its recognized role in the fertilization process, however the 
exact mechanism/s that regulate/s PLCζ activity are still unknown. Sperm specific PLCζ 
is a unique PLC in different aspects compared to somatic PLCs. Notably it lacks a PH 
domain that present in most somatic PLCs. Also it possess unique positively charged 
XYl region compared to the negatively charged XYl region in all somatic PLCs. It has 
been shown that in the somatic PLC, δ and γ the XYl region mediates auto-inhibition of 
PIP2 hydrolytic activity specifically. This has led to a proposed general mechanism of 
PLC auto-inhibition mediated by the XYl region (Gresset et al., 2010). However, there is 
no report that has examined this proposed regulatory mechanism in PLCζ.  
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4.4.1 Objectives 
 
The main objective in this section is to investigate the idea that the XYl region of PLCζ 
plays a role in inhibiting the catalytic activity of the enzyme, and hence to establish in 
this respect its similarity to other mammalian PLC isoforms.  
4.4.2 Methodology 
 
In order to establish whether the XYl-mediated auto-inhibition applies to PLCζ activity, 
we specifically removed the entire PLCζ XYl region. To create the XYl deletion 
constructs PLCζΔXYl and PLCδ1ΔXYl respectively, we excised XYl (amino acids 308–385) 
and (amino acids 441-490) from PLCζ and PLCδ1 respectively (Fig. 4.7). The 
generated constructs were examined and monitored for their consequent affects on the 
in vivo Ca2+ oscillation-inducing activity. There is a unique cluster of basic residues in 
the XYl region of PLCζ that may be involved in enzyme function (Swann et al., 2006 and 
Saunders et al., 2007). For further investigation about the potential role of this short 
positively charged XYl segment in the regulation of PLCζ activity, we generated  
chimaeric constructs between PLCζ and PLCδ1, in which the last 12 amino acids from 
the XYl region (residues 374-385, KKRKRKMKIAMA; +7 charged residues) were 
replaced with their correspondents stretch from PLCδ1 (residues 480–491, 
KPKEDKLKLVPE; +4/−3 charged residues) creating PLCζ-XYlδ1480–491 (Fig. 4.7).  All 
created constructs including wild-type PLCs, were each tagged at the C-terminus with 
luciferase to enable real-time monitoring of relative protein expression by luminescence 
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quantification (Swann et al., 2009). Each constructs was injected separately into mouse 
eggs and monitor its in vivo Ca2+ oscillation-inducing activity. 
YXFF EE C21 647
XY linker (308-385aa)
YXFF EE C21 647
mPLCz (647aa)
PLCz ∆XYl (570aa)
XY linker (441-490aa)
1 YXFF EE C2 756PHPLC1∆XYl (707aa)
XY linker PLC1 (480-491aa)
YXFF EE C21 647
XY linker PLCz (308-374aa)
PLCz-XYl1 (647aa)
YXFF EE C21 756PHPLC1(756aa)
 
Figure  4.7  Domain organization of wild type PLCζ, PLCδ1 and the deletion/chimaera constructs. 
Schematic representation of the domain organization of wild-type PLCζ and PLCδ1 and their 
corresponding XYl deletions PLCζ
ΔXYl
 (PLCζΔXYlinker) and PLCδ1
ΔXY
 (PLCδ1ΔXYlinker), and the 
PLCζ/XYlδ1
480-491
 (PLCζ/XYlinkerδ1) chimaera. Note the similar presence in PLCζ and PLCδ1 of the EF, 
X, XYl, Y and C2 domains, but the absence of the PH domain in PLCζ. The various amino acid (aa) 
lengths and respective XYl co-ordinates are also indicated for each construct.  
 
4.4.3 Results 
 
Consistent with the previous studies microinjection of PLCζ cRNA always gives 
prominent Ca2+ oscillations in unfertilized mouse eggs (25 spikes/2hrs) (Fig. 4.8), with 
the first Ca2+ spike starting within 30 minutes of recording and at a luminescence of (0.5 
c.p.s./egg) for the expressed PLC-luciferase fusion protein (Table 4.5). In contrast, 
much lower frequency (3.4 spikes/2hrs) Ca2+-oscillations were observed in mouse eggs 
microinjected with cRNA encoding the XYl-deletion construct PLCζΔXYl  compared to 
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wild-type PLCζ, and with the first Ca2+ spike only appearing after around 100 minutes of 
recording and when luminescence had reached (3.6 c.p.s./egg). These results show 
that the absence of the XYl region of PLCζ dramatically attenuated the Ca2+ oscillation-
inducing activity, yielding a 7-fold reduction in spike frequency 3.4 spikes/2hrs 
compared to 25 spikes/2hrs in PLCζWT and requiring a 7-fold increased level of PLCζΔXYl 
expression (3.6 c.p.s./egg) compared with (0.52 c.p.s./egg) in PLCζWT to initiate the first 
Ca2+ spike (Table 4.5). Similarly, microinjection of cRNA corresponding to the XYl 
chimaera PLCζ-XYlδ1480–491 also triggered relatively low-frequency Ca2+ oscillations (5.3 
spikes/2hrs), with the first Ca2+ spike appearing at a luminescence of (4.0 c.p.s./egg) but 
appearing after ~50 minutes of recording (Fig. 4.8 and Table 4.5). These molecular 
changes in PLCζWT by replacing the cluster of basic residues in the XYl region (seven 
out of 12 residues are positively charged; overall +7) with the corresponding residues 
from the XYl of PLCδ1WT (four positively charged residues and three negatively charged 
residues; overall charge +1), has also dramatically reduced the Ca2+ oscillation-inducing 
activity of PLCζ by 5-folds with a requirement for an 8-fold increased level of PLCζ-
XYlδ1480–491 expression to triggers the first spike 4.0 compared with (0.52 c.p.s./egg) in 
PLCζWT (Table 4.5). Regarding the cRNA encoding PLCδ1WT microinjection into mouse 
eggs, very low-frequency Ca2+-oscillations (1.8 spikes/2hrs) were only observed after 
~100minutes that commenced only when luminescence reaches a relatively large value 
(20.4 c.p.s./egg) of the expressed PLCδ1-luciferase protein. However, the cRNA 
PLCδ1ΔXYl deletion construct caused a ~2-fold increase in Ca2+-oscillations frequency 
(3.3 spikes/2hrs) compared with (1.8 spikes/2hrs) in PLCδ1WT, with the first Ca2+ spike 
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appeared earlier at ~70 minutes with a reduced luminescence of (17.2 c.p.s./egg)  
compared with PLCδ1WT (Fig. 4.8 and Table 4.5). These results were the converse of 
the PLCζ results, but they are consistent with the proposed regulatory auto-inhibition 
mechanisms of the XYl in the other somatic PLCs isoforms.  
This suggests that XYl region presence in PLCζ is required to get higher catalytic 
activity of sperm PLCζThese results together indicating that the presence of the XYl 
region and the highly positively charged cluster are necessary for maximal PIP2 catalytic 
activity of PLCζ. In contrast, deleting the XYl from PLCδ1 (i.e. PLCδ1ΔXYl) enhanced the 
enzymatic activity by > 2.0-fold compared with PLCδ1WT. Our studies show that, in 
contrast with somatic cell PLCs, the XYl of PLCζ does not confer enzymatic auto-
inhibition. These differential results for XYl-deleted PLCs suggest that there are 
disparate regulatory roles for the XYl of PLCζ and this is a distinctive feature of the 
sperm-specific PLC isoenzyme (PLCζ) with respect to hydrolytic activity. 
Luciferase-
tagged PLCz
1st 2 hrs 
Ca2+ spike 
no 
Lum. peak
(c.p.s.)
Time of 
1st spike 
(min)
Lum at 1st
spike 
(c.p.s.)
Protein 
expression = 
1st spike (fg)
T no 
of 
eggs
PLCζWT 24.58 ±
0.88
8.7 
1.16
~30 0.5  
0.06
372.5 13
PLCζΔXYl 3.4  
0.27
7.1  
0.20
~100 3.6  
0.20
896.4 20
PLCδ1WT 1.8 ±
0.1
45.0 ±
1.7
>100 20.4  
3.00
3735.6 17
PLCδ1ΔXYl
3.30  
0.20
40.2  
1.7
~70 17.2  
0.35
3194.8 19
PLCζ-δ1XYl 5.3  
0.16
30.48 ±
2.0
~50 4.0 ±
0.39
964 9
 
Table  4.5 Properties of PLC-luciferase and deletion/chimaera constructs expressed in eggs.      
Ca
2+
 oscillation-inducing activity (Ca
2+
 spike number in 2hrs) and luciferase luminescence levels (peak 
luminescence and luminescence at first spike) are summarized for mouse eggs microinjected with each of 
the PLC–luciferase constructs, PLCζ, PLCζ
ΔXYl
, PLCδ1, PLCδ1
ΔXYl
 and PLCζ
XYlδ1
 (Fig. 4.7).  
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0
5
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15
20
PLCzWT (n = 13)
PLCzXYl (n = 20)
Ca2+
cps =
7.1
0
2
4
6
8
10
12
0
20
40
60
80
PLC1WT (n = 17)
PLC1XYl (n = 19)
50
cps = 
40.2
cps = 
30.48
cps =
45.0
cps =
8.7
0
20
40
60
80
Ca2+
Ca2+
Ca2+
Ca2+
25
 
Figure  4.8 Ca
2+
 oscillation-inducing activity of the PLCs and XYl deletion or chimaera expressed in 
mouse eggs. Fluorescence and luminescence recordings reporting the Ca
2+
 changes [fluorescence (red 
traces), in arbitrary units (a.u.), and luciferase expression (black traces; luminescence) in c.p.s. 
respectively] in unfertilized mouse eggs following microinjection of cRNA encoding luciferase-tagged 
PLCζ, PLCδ1, their corresponding XYl deletions (PLCζ
ΔXYl
  and PLCδ1
ΔXY
) and chimaera [PLCζ/XYlδ1
480–
491
; (PLCζ/XYlinkδ1)] (left-hand panels). Right-hand panels show the integrated luminescence image of a 
field of mouse eggs following cRNA microinjection of each PLC construct (see Table 4.5).  
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4.5 The PLCζ-XY linker region has the similar role in 
different species  
 
Further to our previous work on the novel regulation PLCζ by its XYl we created 
different constructs using human PLCζ as a framework and swapping its XYl region by 
those from mouse and rat PLCζs to generate hPLCζ-mXYland hPLCζ-rXYl. We then 
examined their Ca2+ releasing activities by injecting them individually into unfertilized 
mouse eggs. The same protocol was used to examine the two generated constructs by 
comparing their effects on the in vivo Ca2+ oscillation-inducing activity with that of 
hPLCζWT.  
4.5.1 Results 
 
Human PLCζ has to been shown to be the most potent PLCζ among all mammalian 
species tested. Microinjection of hPLCζWT cRNA into mouse eggs triggers  prompt high 
frequency Ca2+ oscillations (39.2 spikes/2hrs) that are observed within 20 minutes post 
injection and it does this when the luminescence reaches only (0.16 c.p.s./egg) of the 
expressed hPLCζ–luciferase protein see (Fig. 4.9 and Table 4.6). On the other hand, 
hPLCζ-mXYl injected eggs show only flat Ca2+ traces and in comparions to the case of 
hPLCζ-rXYl injected eggs, only low frequency Ca2+ oscillations (6.74 spikes/2hrs) were 
noticed. It was noted that not only the Ca2+ oscillations activity of the newly created 
constructs (hPLCζ-mXYl and hPLCζ-rXYl) were completely abolished or reduced, but their 
protein expression levels were also significantly reduced and  even when eggs were 
injected with the highest concentration of cRNA (0.95 and 1.96 c.p.s./egg). This 
contrasts with markedly with that of hPLCζWT (7.04 c.p.s./egg) (Fig. 4.9 and Table 4.6).  
  175 
hPLCz mXYl (n = 25)
Lum =
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Figure  4.9 The effects of PLCζ species‎chimeras‎between‎hPLCζ‎and‎mouse‎or‎rat‎XY‎domains‎on‎
Ca
2+
-oscillations and expression levels in mouse eggs. Left-hand panels show representative 
fluorescence and luminescence recordings reporting Ca
2+
 concentration changes (black traces; Ca
2+
) and 
luciferase expression (red traces; Lum) respectively in a mouse egg. The egg was microinjected with 
PLCζ-luciferase cRNA encoding hPLCζ
-hXYl
 (top panel), or hPLCζ
mXYl
 (mid panel) or hPLCζ
-rXYl
 (bottom 
panel). Right-hand panels show the integrated image of luciferase luminescence from eggs microinjected 
with these chimeras 
  
These data suggest that the substitutions of XYl region in hPLCζ with its analogues 
from either mouse or rat PLCζ will dramatically reduce the protein stability and PIP2 
catalytic activity of hPLCζ. 
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Luciferas
e-tagged 
PLCz
1st 2hrs 
spike  no 
Peak 
Lum
cps
Time to 
1st spike 
(min)
Lum at 1s t 
spike (cps)
Protein1st 
spike (fg)
T no 
of
eggs  
hPLCzWT 39.2 ±
3.5
7.04  
0.43
~20 0.16 ±
0.02
315 22
hPLCz rXY 6.74  
0.39
1.96  
0.15
~30 0.18  
0.01
318.4 31
hPLCzmXY - 0.95  
0.06
- - - 25
 
Table  4.6 Summary of the properties of Ca
2+
-oscillations observed in mouse eggs following cRNA 
microinjection of the luciferase-tagged hPLCζ wild type and species PLCζ chimeras between hPLCζ and 
both mouse or rat XYl domains (see Fig. 4.9)  
 
4.6 PLCζ & PLCδ1 chimeras; the effect of swapping 
PLCδ1 domain(s) with PLCζ domain(s) upon PLCδ1 
activity in mouse eggs  
 
Based on sequence alignment analysis of all PLCs, PLCζ has the closest sequence 
homology to PLCδ1 (47% similarity, 33% identity) (Saunders et al., 2002). On further 
sequence comparison between PLCζ and rat PLCδ1 catalytic domains it was notable 
that both share a similarly structured catalytic domain (Saunders et al., 2007). 
Moreover, studies on structural analysis on PLCδ1catalytic domain has identified an 
active-site residue (Essen et al., 1996) The mutation of this active-site residue 
analogous in PLCζ Asp343 created PLCζD210R, this was a completely inactive construct 
(Saunders et al., 2002). 
Based on the closer homology between PLCζ and PLCδ1 Ca2+, we decided to remove 
PH domains from PLCδ1 and generate chimeras between the two. We used PLCδ1 as 
frame-work and replaced different domain(s) with their analogous domains from PLCζ to 
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create three different constructs. These were PLCδ1∆PH-ζEF&XYl, PLCδ1∆PH-ζEF&C2 and 
PLCδ1∆PH-ζXYl (Fig. 4.10). The generated constructs were examined by monitoring their 
effects on the in vivo Ca2+-oscillation-inducing activity compared to PLCδ1WT.  
PLCδ1∆PH-zEF&C2
PLCδ1∆PH-zEF&XYl
PLCδ1∆PH-zXYl YXFF EE C21 756
PLCz-XYl
(308-385aa)
YXFF EE C21 756
PLCz-EF
(10-144aa) 
YXFF EE C21 756
PLCz-C2
(522 - 625aa)
YXFF EE C21 756PHPLCδ1
WT
(756aa)
 
 
Figure  4.10 Domain organization of PH deletion from PLCδ1 and PLCζ domain(s) chimaera 
constructs. Schematic representation of the domain organization of PLCζ1
WT
, PLCδ1
∆PH-zEF&C2, 
PLC1
∆PH-zEF&XYl, and PLCδ1
∆PH-zXYl. 
 
4.6.1 Objectives 
 
We intended to cross match the different domains between the two PLCs (PLCζ and 
PLCδ1) in order to examine their effect on the catalytic activity in vivo, and whether any 
swapping could potentially augments the catalytic activity of that construct. 
4.6.2 Results 
As shown earlier PLCδWT cRNA microinjection into mouse eggs triggers a very low-
frequency Ca2+-oscillations (3.2 spikes/2hrs) that were only observed after ~100minutes 
post injection, and  which was when luminescence reached relatively large value (22.48 
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c.p.s./egg) of the expressed PLCδ1–luciferase protein see (Fig. 4.11 and Table 4.7). On 
the other hand, none of the  chimeras between PLCδ1 and PLCζ domain(s) (PLCδ1PH-
zEF&C2, PLCδ1PH-zEF&XYl, and PLCδ1PH-zXYl) showed any sign of Ca2+ releasing activity 
despite the relatively very high expression levels (84.56, 56.79 and 65.84 c.p.s./egg) 
respectively (Fig. 4.11 and Table 4.7).   
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Figure  4.11 The effects of PLCδ1‎chimeras‎with‎selected‎domain(s)‎ from‎PLCζ‎on‎Ca
2+
-inducing 
activity. Fluorescence and luminescence recordings reporting the Ca
2+
 changes (black traces; Ca
2+
) and 
luciferase expression (red traces; Lum, in  cps) in unfertilized mouse eggs following microinjection of 
cRNA encoding luciferase-tagged, PLCδ1
WT 
 or PLCδ1&PLCζ chimeras (left panels). The average 
luminescence level (cps) achieved in mouse eggs (n is number of eggs) is indicated for each 
microinjected cRNA, e.g. PLCδ1
WT 
Lum=63.7 (top trace). Panels on the right are the integrated 
luminescence images of individual mouse eggs following cRNA microinjection of either wild-type or 
chimeras construct (see Table 4.7).  
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Luciferase-
tagged PLCz
1st 2 hr 
spike 
no
Peak 
Lum
(cps)
Time 
to 1st
spike
Lum at   
1st spike 
(cps)
1st spike 
Protein 
(fg)
T no 
of
eggs  
PLC1WT
2.3 ±
0.3
63.7 ±
4.0
>100 22.48 ±
0.9
4087.12 17
PLC1PH-z EF & C2 - 84.56  
1.8
- - - 21
PLC1PH-z EF &X-Y       - 56.79  
2.58
- - - 25
PLC1PH-z XYl - 65.84  
2.73
- - - 33
 
Table  4.7 Summary of expression levels and the properties of Ca
2+
-oscillations observed in mouse eggs 
following cRNA microinjection of the luciferase-tagged PLCδ1
WT 
and various PLCδ1 & PLCζ chimeras 
(see Fig.4.11). 
 
These data suggest that with the deletion of PH domain and replacing PLCδ1 domain(s) 
with their analogue from PLCζ will completely disrupt PIP2 catalytic activity of PLCδ1. 
 
4.7 PLCζ species domain(s) swapping and their effects 
upon PLCζ-activity in mouse eggs 
 
Human PLCζ is the most potent among all tested mammalian species is the PLCζ. To 
investigate why this may be we swapped domains between two species of PLCζ i.e. 
human and mouse. Based on closer number compositions of amino acid between 
hPLCζ
WT
 (608aa) and mPLCζ
WT
 (647aa), we made six different chimeras between the 
two. These constructs was created by swapping a selected domain from one species 
and replaced it with its analogue from the other, to end with three constructs from each 
one, i.e. for mouse (mPLCz
WT
 mPLCζ
hXYl
 mPLCζ
hEF
  mPLCζ
hC2 
) and for human 
(hPLCζWT,  hPLCζmXYl, hPLCζmEF, hPLCζmC2). All generated constructs were again 
tagged at the C-terminus with luciferase before examined in vivo by monitoring their 
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consequent effect on the Ca2+ oscillation-inducing activity in comparison with the 
correspondent wild type PLCζ.  
4.7.1 Results 
 
Microinjection PLCζ
WT
 from any tested species into unfertilized mouse eggs always 
showed strong activity by triggering prominent Ca2+ oscillations. This was evident by the 
15.7 spikes/2hrs (Table 4.8) and 46.2 spikes/2hrs (Table 4.9) for mPLCζ
WT
 and 
hPLCζ
WT
 respectively. These oscillations were initiated within the 1st 30 minutes post 
injection, i.e. ~20minutes in hPLCζ
WT
 when expression level reached (0.17c.p.s. see 
Table 4.9), and ~ 30 minutes in mPLCζ
WT
 when the level of expression reaches (0.193 
c.p.s. see Table 4.8). 
In the case of the mPLCζ chimeras, I injected different concentrations of cRNA, i.e. in 
wild type it was 0.5µg/µl and for the chimera it was from 5.0 to 5.5µg/µl in the chimeras 
constructs. With the first replacement of  the mouse PLCζ with a XYl from human PLCζ 
to yield mPLCζ
hXYl
, a dramatic decline in activity noted since it only caused Ca2+-
oscillations 5 times lower frequency (3 spikes/2hrs) compare to wild type PLCζ (15.7 
spikes/2hrs) see Table 4.8 & Fig. 4.12. Similarly the first Ca2+ spike was delayed up to 
100 minutes and only occurred when the luminescence had reached level of 60 times 
higher than the PLCζWT (11.98 c.p.s. compare to 0.193 c.p.s.) respectively, see Table 
4.8. Similar results were obtained by substituting EF hand domains mouse PLCζ by its 
analogue from hPLCζ (i.e. mPLCζ
hEF
). Again less frequent Ca2+-oscillations (6.3 
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spikes/2hrs compared to wild type 15.7 spikes/2hrs) were recorded (Table 4.8 & Fig. 
4.12).  
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Figure  4.12 The effects of PLCζ species‎ chimeras‎ between‎mPLCζ‎ and‎ selected‎ domains‎ from‎
hPLCζ‎ on‎ Ca
2+
-oscillations and expression levels in mouse eggs. Left-hand panels show 
representative fluorescence and luminescence recordings reporting Ca
2+
 concentration changes (black 
traces; Ca
2+
) and luciferase expression (red traces; Lum) respectively in a mouse egg. The egg was 
microinjected with PLCζ-luciferase cRNA encoding mPLCζ
WT
 (top panel), or mPLCζ
hEF
 or mPLCζ
hXYl 
or 
mPLCζ
hC2
 (bottom panel). Right-hand panels show the integrated image of luciferase luminescence from 
eggs microinjected with these chimeras. The peak luminescence (Lum) recorded is shown in c.p.s.  
 
These oscillations were further delayed and only first noted after around 120 minutes , 
which  is almost 4 times longer than with the wild type (30 minute), and at a significantly 
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higher luminescence level (110 times higher) than that seen with the wild type PLCζ 
(21.9 c.p.s. compare to 0.193 c.p.s. respectively), see Table 4.8. Finally, when the 
mouse C2 domain of mPLCζ was substituted by its human equivalent (mPLCζ
hC2
) there 
was also a negative effect on mPLCζ Ca2+-releasing activity.  In this case the severity of 
this decline was not as extensive as with the previous two chimeras. The time to first 
spike was delayed by 75 minutes which is 2.5 times longer than with the wild type (30 
minute) mPLCζ , and Ca2+ release was only seen with a luminescence value of around 
5.7 c.p.s., which is 28 times  higher than with the wild type mPLCζ (0.193 c.p.s.). The 
frequencies of these oscillations were the highest among all three chimeras (8.27 
spikes/2hrs) but still much lower than with the wild type mPLCζ (15.7 spikes/2hrs) 
(Table 4.8). 
Luciferas
e-tagged 
PLCz
1st 2 hrs 
spike  no 
Peak 
Lum
cps
Time to 
1st  spike 
(min)
Lum at  
1st spike 
(cps)
Protein1st
spike
(fg)
T no 
of
eggs  
mPLCzWT 15.7  
2.84
8.2  
0.65
~30 0.193  
0.05
32.0 16
mPLCzhXY 3.0   
0.15
20.9  
1.21
~100  11.98  
0.65
231.26 22
mPLCzhEF 6.30   
0.36
28.4  
2.04
~120 21.9  
1.61
398.9 16
mPLCzhC2 8.27  
0.26
27.0  
1.26
~75 5.70  
0.22
125.13 29
 
Table  4.8 Summary of the properties of Ca
2+
-oscillations observed in mouse eggs following cRNA 
microinjection of the luciferase-tagged PLCζ
WT
 and species PLCζ chimeras between mPLCζ and selected 
hPLCζ domains (see Fig. 4.12)  
 
In case of hPLCζ chimeras, all cRNA constructs including the wild type hPLCζ were 
injected into mouse eggs at the same concentrations (0.10µg/µl). With the replacement 
  183 
of the human XYl by its mouse analogue (hPLCζ
mXYl
), a complete loss of activity was 
noted in that there were no Ca2+ oscillations at all in recordings, This compared to wild 
type hPLCζ injected eggs that were injected in the same experiments where 15.7 
spikes/2hrs were triggered, see Table 4.9 & Fig. 4.13. Similarly the peak expression 
levels were also significantly reduced (0.33 c.p.s.) with this chimera compared with that 
of wild type hPLCζ (7.6 c.p.s.) see Table 4.9.  In contrast, the results obtained from 
substituting the human C2 domain with its mouse equivalent (hPLCζ
mC2
) were 
completely different. In this chimera I noted that there were slightly higher Ca2+ spikes 
frequencies (49.1 spikes/2hrs) compared to (46.2 spikes/2hrs) in hPLCζ
WT 
(Table 4.9). 
However, it was noted that the expression level at the first Ca2+ spike and the maximum 
expression levels were also slightly higher (doubled) in hPLCζ
mC2
 (0.32 c.p.s) and (14.6 
c.p.s.) compared to that of hPLCζ
WT
 (0.17 c.p.s) and (7.6 c.p.s.) respectively, (see Table 
4.9 & Fig. 4.13). Finally, the effect of inserting of EF hand domains from mPLCζ in place 
of its equivalent in hPLCζ sequence (i.e. hPLCζ
mEF
) showed lower frequency Ca2+-
oscillations (10.5 spikes/2hrs compared to wild type 46.2 spikes/2hrs) that were only 
seen at luminescence level of (0.25 c.p.s.) compared to 0.17 c.p.s in hPLCζ
WT
 (see 
Table 4.9 & Fig.4.13). These oscillations were delayed and first noted after around 45 
minutes after microinjection which is more than twice the time seen with the hPLCζ
WT
 or 
indeed with hPLCζ
mC2
 (~20 minutes).  
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Figure  4.13 The effects of PLCζ species‎ chimeras‎ between‎ hPLCζ‎ and‎ selected‎ domains‎ from‎
mPLCζ.‎Left-hand panels show representative fluorescence and luminescence recordings reporting Ca
2+
 
concentration changes (black traces; Ca
2+
) and luciferase expression (red traces; Lum) respectively in a 
mouse egg. The egg was microinjected with PLCζ-luciferase cRNA encoding hPLCζ
WT
 (top panel), or 
hPLCζ
mC2
or hPLCζ
mEF
 or hPLCζ
mXYl
 (bottom panel). Right-hand panels show the integrated image of 
luciferase luminescence from eggs microinjected with these chimeras 
 
 To sum up, all these results with various chimeras suggest that any changes or 
swapping of  the PLCζ domain(s) of human with  mouse results in  either a complete, or 
else a  very significant loss of Ca2+ oscillation-activity. 
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Luciferas
e-tagged 
PLCz
1st 2 hrs 
spike  no 
Peak Lum
cps
Time to 
1st  spike 
(min)
Lum at  
1st spike 
(cps)
Protein1st
spike
(fg)
T no of
eggs  
hPLCzWT
46.2 ±
5.4
7.6 ±
1.28
~ 20
0.17±
0.03
316.7 11
hPLCzmXY 0
0.33 ±
0.02
0 0 0 18
hPLCzmC2
49.1 ±
2.89
14.6 ±
0.89 
~ 20
0.32 ±
0.033
342 17
hPLCzmEF
10.5 ±
0.47
1.76 ±
0.15
~ 45
0.25
0.02
330.2 17
 
Table  4.9 Summary of expression levels and the properties of Ca
2+
-oscillations observed in mouse eggs 
following cRNA microinjection of the luciferase-tagged hPLCζ
WT 
and various chimeras between hPLCζ & 
selected domain from mPLCζ (Fig. 4.13) 
 
Despite the apparent positive effect of inserting the mouse PLCζ-C2 domain in the place 
of human C2 domain in hPLCζ sequence (hPLCζ
mC2
), this newly created construct was 
unable to triggers first Ca2+ spike until the luminescence has reached (0.32 c.p.s) which 
is an equivalent protein expression of around 56.96 fg compared to only 31.61 fg (or 
with 0.17 c.p.s) in hPLCζ
WT
. These figures suggest that that the wild type hPLCζ is still 
more active by nearly two-fold compared with this newly created construct (hPLCζ
mC2
). 
 
4.8 Discussion  
 
Since the discovery of PLCζ ten years ago (Saunders et al., 2002) accumulating 
evidence suggests that sperm-specific PLCζ play a pivotal role at fertilization in 
mammals by triggering Ca2+-oscillations and consequent egg activation. It appears that 
each domain of PLCζstructures has its specific role in generating Ca2+ oscillation-
inducing activity.  
  186 
4.8.1 Sperm PLCζ point mutation in the Y catalytic domain linked 
to male infertility  
 
The PLCζ role in mammalian fertilization has been recently reinforced by two clinical 
studies that linked PLCζ with cases of male infertility after ICSI (Yoon et al., 2008; 
Heytens et al., 2009). ICSI is still the most successful IVF technique that is employed to 
solve many male infertility conditions such as severe oligospermia, asthenospermia and 
teratospermia. However, a significant ICSI failure rate occurs, and in some cases of 
repeat ICSI failure this could be attributed to either reduced or absent PLCζ expression 
in sperm from those patients whose sperm was also shown to be unable to initiate Ca2+-
oscillations in mouse eggs (Yoon et al., 2008).  
Further correlation between infertility and PLCζ came with a second clinical study that 
identified a point mutation at position 398 in the catalytic Y domain that involved a 
replacement of a histidine with a proline residue in the PLCζ gene of a patient with failed 
ICSI (Heytens et al., 2009). This study also reported also that the injection of the mutant 
(H398P) human version of cRNA-PLCζ has failed to induce Ca2+-oscillations in 
unfertilized mouse eggs.  
In our collaborative study, I have taken this result further by studying this newly 
discovered mutation and its effects on Ca2+ oscillation-inducing activity using mouse 
PLCζ To create the mouse PLCζ version of this infertility-linked human PLCζH398P 
mutation, the mouse PLCζ equivalent residue was identified to be histidine 435 and 
switching this to a proline generates mPLCζH435P (Fig. 4.1A). My study was involving the 
monitoring in vivo Ca2+ release-inducing activity of PLCζH435P after injection into mouse 
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eggs. Our results indicate that the H435P mutation totally abolishes the ability of PLCζ 
to trigger Ca2+-oscillations in mouse eggs (Fig. 4.1B; Table 3). These results were 
corroborated with in vitro studies that showed complete abrogation of PLCζH435P enzyme 
activity in a PIP2 hydrolysis assay (Nomikos et al., 2011a). We also employed an 
additional PLCζ mutation at the same residue (His435) in order to see if the specificity of 
this position on the PLCζ might be related to a general helix-destabilizing effect on the 
protein structure. This was tested by replacing His435 with a neutral non-helix-
destabilizing amino acid, alanine to create PLCζH435A. The injection of cRNA encoding 
PLCζH435A into mouse eggs interestingly showed  robust Ca2+-oscillations with a similar 
potency to PLCζWT in contrast to the inactive PLCζH435P (Fig. 4.1B; Table 4.1). 
Consistent with that proposed explanation in the previous study (Heytens et al., 2009) 
this result suggests that the H435P substitution may cause major protein structural 
changes that inactivate of PLCζ. In this study and in the others by our group we have 
also examined the effect of PLCζH435P mutation on its equivalent in PLCδ1 (PLCδ1H542P) 
upon in vitro enzymatic properties on PIP2 hydrolysis assay. Interestingly similar results 
were obtained from the in vitro studies of these mutants which were carried out by 
Nomikos and his colleagues. In brief, PIP2 hydrolysis assays of H435P and D210R 
show completely inactive enzymes at both low (1 μM) and high (1 mM) Ca2+. This is in 
contrast to PLCζWT which showed a specific activity at low Ca2+ and slightly less activity 
at high Ca2+. On the other hand PLCδ1WT displayed high activity at higher Ca2+ level (1 
mM) that is almost 3.5 folds higher than PIP2 hydrolysis activity at low Ca
2+ (1 μM), in 
contrast, PLCδ1H542P retained only 16% of the PLCδ1WT activity at 1 mM Ca2+ and was 
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completely inactive at 1 μM Ca2+. Full details can be found in this study (Nomikos et al., 
2011a). Consistently, we found out that none of the in vitro results were contradicted 
with my results. These results altogether show that the above H435P mutation 
completely inactivates the PIP2 hydrolysis activity of both PLCζ and PLCδ1 in vivo and 
in vitro, whereas the H435A substitution in PLCζ retains only in vivo functionality 
(Nomikos et al., 2011a). 
In the previous study based on the heterozygosity of identified sample it was suggested 
that human PLCζH398P might have a dominant-negative effect on PLCζWT (Heytens et 
al., 2009). I performed two protocols using cRNA PLCζH435P and PLCζWT to investigate 
this. First by co-microinjection of both constructs together into mouse eggs, and the 
second by sequential injection of PLCζH435P and PLCζWT starting with PLCζH435P 1 hr 
and 2 hrs before re-injecting those eggs with the PLCζWT. However, despite nearly 8 
fold (7.06 c.p.s./egg) and 26 fold (18.68 c.p.s./egg) higher expression of PLCζH435P in 1 
hr and 2 hrs respectively compared with controls (0.68 c.p.s./egg), the co-injected 
experiment, PLCζH435P did not block the PLCζWT ability to trigger Ca2+ oscillations (Fig. 
4.2 and Table 4.2). This suggests that, in the mouse, PLCζH435P does not demonstrate 
any dominant-negative behaviour. Similar results were obtained after the exposing the 
unfertilized (post-injected with PLCζH435P) mouse eggs to in vitro fertilization by mouse 
sperm (Fig. 4.3 and Table 4.3). These results avoid the need for a dominant negative 
hypothesis of the H-to-P over the wild-type activity. In fact, an explanation of the 
infertility is gieven after a new point mutation was discovered in the same patient PLCζ 
sequence but in different allele. This new mutation involved replacing histidine 189 by 
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leucine at position 233 (H233L) (Kashir et al., 2012). This newer mutation was shown to 
cause a dramatic loss of PLCζ activity (Kashir et al., 2012). 
My study is an extension of the previous work (Heytens et al. 2009) in displaying 
several facts. Firstly it reveals that a mouse PLCζH435P mutation which is the equivalent 
of the infertile human PLCζH398P is completely inactive both in vivo and in vitro. Secondly 
my study has enabled a quantitative analysis of their level of inactivity by monitoring in 
vivo expression of the luciferase-tagged mutant PLCs. Finally, this study has 
demonstrated that PLCζH435P has no role by any means as dominant-negative inhibition 
mechanism with respect to either cRNA PLCζ injection or with the sperm at fertilization. 
4.8.2 PLCζ-PIP2 binding specifically requires PLCζ XYl region 
 
Despite the evidence for the role of PLCζ in fertilization, the exact way by which PLCζ 
targets the PIP2 in eggs is still elusive. It has been suggested that the positively charged 
PLCζ residues within the XYl region potentially targeting the negatively charged PIP2 of 
the biological membranes via electrostatic interactions (Nomikos et al., 2007). To 
investigate this in vivo we employed different approach using site-directed mutagenesis 
to generate three cumulative mutations within the positively charged region of the 
mouse PLCζ XYl region (Fig. 4.4). A sequentially replacement of three lysine residues 
cluster (K374, K375 and K377) with the neutral amino acid alanine, to generate three 
mutant constructs of PLCζ, with single (K374A), double (K374,375AA) and triple 
(K374,375,377AAA) substitutions. The reason behind choosing the alanine to replace 
lysine is that it is less likely to cause large effects on PLCζs structure compared with a 
charge-reversed amino acid. The microinjection of the luciferase-tagged cRNA 
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encoding PLCζWT, PLCζK374A, PLCζK374,5AA or PLCζK374,5,7AAA individually into unfertilized 
mouse eggs  all caused a robust recombinant protein expression followed by the 
initiation of a series of Ca2+-oscillations with variable frequencies (Fig. 4.6). A reduction 
in the Ca2+-oscillations frequency was observed significantly with the triple and to some 
extend with the double mutants, PLCζK374,5,7AAA (14% vs wild type) and PLCζK374,5AA 
(40% vs wild type) (Fig. 4.5, Fig. 4.6 and Table 4.4). In contrast, only a slight decrease 
was observed with the single PLCζK374A mutant (90% vs wild type). Compared with the 
rapid initiation of Ca2+-oscillations (~30 minutes) in wild type PLCζ and the single K-to-A 
mutant there was a significant delay (~65 minutes) with the double and triple K-to-A 
mutants (Table 4.4). All together this suggests a significant change in PLCζ in vivo 
activity was mediated by the loss of two or more positive charges in the XYl. It is 
reasonable to suggest that his reduction of the net positive charge diminishes the 
affinity of PLCζ for its negatively charged, membrane-bound substrate, PIP2.  
A previous study showed that the XYl region is the most non-conserved region of PLCζ 
despite that fact that it connects the two highly conserved halves of the catalytic barrels 
(the X and Y domains) (Saunders et al., 2007). The importance of this diversity structure 
is unclear, but it might explain the different relative potency in inducing Ca2+-oscillations 
between PLCζ isoforms of different species. However, the XYl region retains a net 
positive charge. Notably, the XYls of PLCβ, δ and ε are also highly negatively charged. 
It has been suggested that these XYls might have auto-inhibitory effect on the PLC 
activity by preventing PIP2 getting access to the active site. This could be mediated by a 
combination of steric exclusion and electrostatic repulsion of negatively charged 
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membranes (Hicks et al., 2008). However, our observations suggest that the PLCζ has 
unique regulatory mechanism and the XYl region role might be distinct from other 
mammalian somatic cell PLCs pattern.  
My collaboration group have examined the binding ability of the XYl and C2 domain of 
PLCζ to bind to PIP2. This was done by employing the protein-lipid overlay and a 
liposome-binding assay to assess distinct GST fusion proteins of either the XYl or C2 
domain of PLCζ and compare that with the PH domain of PLCδ1 as a positive control. 
The results obtained from in vitro experiments have provided congruent evidence that 
only the PLCζ XYl and not the C2 domain has the ability to bind to PIP2 (Nomikos et al., 
2011b). Furthermore, these mutations also affect the in vitro interaction of PLCζ with 
PIP2  (Nomikos et al., 2011b). 
4.8.3 XYl is the novel regulator of PLCζ activity  
 
Although its precise regulatory mechanism remains unclear, PLCζ is the smallest 
mammalian PLC isoform and only one not found in mammalian somatic cells (Saunders 
et al., 2002). PLCζ has a unique Ca2+ sensitivity that requires only the egg’s basal 
cytosolic Ca2+ concentrations of ~100 nM to display strong enzymatic activity. It exhibits 
~100-fold higher affinity for Ca2+ than the more structurally closest isoform, PLCδ1 (Fig. 
4.7). The molecular determinants that confer the high Ca2+ sensitivity of PLCζ and how 
PLCζ activity is intrinsically regulated still need investigation. Previous studies on the 
negatively charged XYl regions in somatic PLCs suggest that are part of an auto-
inhibition mechanism (Hicks et al., 2008).  It was therefore important to investigate 
whether this putative auto-inhibition also applies to the sperm-derived PLCζ. 
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In the present study, five different constructs were created, PLCζWT, PLCδ1WT, PLCζXYl, 
PLCδXYl and PLCζδ1-XYl (Fig. 4.7). The microinjection of the these constructs 
alongside the wild type enabled the examination of how these XYl changes might 
change the in vivo Ca2+ oscillation-inducing. Consistent with an auto-inhibition 
mechanism, the deletion of the XYl from PLCδ1 resulted in a 2-fold increase in Ca2+ 
oscillation-inducing activity in eggs relative to wild-type PLCδ1 (Fig. 4.8 and Table 4.5). 
In contrast, with PLCζ, the deletion of the XYl resulted in ~7-fold reduction in Ca2+ 
oscillation-inducing activity in eggs (Table 4.5). Significantly, the replacement of only the 
PLCζ XYl cluster of basic residues (overall charge +7) by the homologous 12 amino 
acids of the XYl region of PLCδ1 (overall charge +1) also resulted in 5-fold reduction in 
Ca2+ oscillation-inducing activity in eggs (Table 4.5). 
These findings suggest that the XYl of PLCζ serves a completely different regulatory 
role to that of the XYl in PLCδ1. It could be the high density of basic amino acids in the 
XYl of PLCζ that causes this disparity since it is absent from PLCδ1 and other somatic 
PLC isoforms. In this case the XYl cluster of positively charged residues may perform a 
central role in the interaction of PLCζ with the substrate PIP2. The presence of positively 
charged residues in XYl is a common feature in the PLCζ sequences across species. 
However, the specific sequence of the XYl in PLCζ is poorly conserved. This diversity 
sequence might explain the difference in PLCζ potencies from different species in 
regard to inducing Ca2+-oscillations. For further understanding of XYl regulatory role 
across species we created three constructs using human PLCζ as a template. These 
included hPLCζWT, hPLCζmXYl and hPLCζrXYl. Interestingly the microinjection of 
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hPLCζmXYl demonstrates a total loss of the Ca2+-inducing activity, whereas the 
microinjection of hPLCζrXYl shows a significant but not complete loss of the enzyme 
activity comparable to wild type hPLCζ (Fig. 4.9 and Table 4.6). Not only the enzyme 
activity was affected but also there was a dramatic decline in the protein expression 
levels in both generated constructs, for reasons that are not clear. Nevertheless, these 
results confirm the importance of the specific amino acid sequence of the XYl within the 
PLCζ of specific species.  
Similar results were also obtained from in vitro study work by collaboration group. They 
examined the effect of these generated constructs (i.e. PLCζΔXYl, PLCδ1ΔXYl and 
PLCζ/XYlδ1480–491) on the in vitro PIP2 hydrolysis activity of PLCζ or PLCδ1 constructs 
(Nomickos et al., 2011c).  
4.8.4 PLCζ domain(s) abolish PLCδ1 catalytic activity 
 
PLCδ1 has the closest homology to PLCζ among all the mammalian PLCs. We created 
three chimaeric constructs using PLCδ1 as a template. This was done after removal of 
the PH domains, and replacing different domain(s) with their analogous from PLCζ i.e. 
PLCδ1PH-zEF&XYl, PLCδ1PH-zEF&C2 and PLCδ1PH-zXYl (Fig. 4.10). We proposed these 
experiments to enable an understanding of the specificity of PLCζ domains 
Interestingly, the microinjection of all these construct PLCδ1PH-zEF&XYl, PLCδ1PH-zEF&C2 
and PLCδ1PH-zXYl individually into unfertilized mouse eggs failed to initiate any cytosolic 
Ca2+ changes despite a very high protein expression in all these newly generated 
constructs (Fig. 4.11 and Table 4.7).  
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These finding suggest that the enzymatic activity of PLCζ and PLCδ1 are require a 
specific set of domains acting together to enable full functionality. It was not considered 
necessary to carryout in vitro studies to investigate the effect of these constructs on 
PIP2 hydrolysis to compare that with my in vivo study. The reason was because the in 
vivo study shows a complete lack of PLCδ1 enzymatic activity.  
4.8.5 PLCζ species chimeras 
 
Among the mammalian PLCζs, the human hPLCζ
WT
 (608aa) is the smallest in regard to 
the number of amino acids. The next smallest is the mouse PLCζ (mPLCζ
WT
) (647aa) 
and for this reason we made six different swapping chimeras between the two, i.e. for 
mouse (mPLCζ
WT
, mPLCζ
hXYl
, mPLCζ
hEF
 and mPLCζ
hC2
) and for human (hPLCζWT, 
hPLCζmXYl, hPLCζmEF and hPLCζmC2). All these constructs were tested in vivo by 
microinjection into mouse eggs to monitor their ability to trigger Ca2+-release in 
comparison with their correspondent wild type. It was expected from the previous work 
that any changes in the amino acid sequence in any domain in PLCs would lead to a 
significant drop in the enzymatic activity of that particular PLC. The individual micro-
injection of these constructs either from human or mouse showed either a complete (as 
in case of hPLCζmXYl) or else a significant decline in activity as in case of hPLCζmEF (Fig. 
4.13 and Table 4.9) and in all mPLCζ originated constructs (Fig. 4.12 and Table 4.8). 
The exception was with the apparently positive results for activity augmentation noted in 
the case of hPLCζ
mC2
, but even in this case the chimera does not initiate Ca2+-
oscillations until the luminescence has reached nearly 2-fold the wild type level of 
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hPLCζ (0.32 c.p.s/egg vs 0.17 c.p.s/egg) respectively (Fig. 4.13; Table 4.9). These 
findings suggest that the enzymatic activity of the wild type PLCζ of any species is 
superior to any newly created constructs. 
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Chapter 5 
 
Ca
2+
-OSCILLATIONS IN HUMAN EGGS 
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5.1 Introduction  
 
Nowadays the importance of Ca2+ oscillations during mammalian fertilization has been 
established. Based on parthenogenetic activation studies from different stimuli, the free 
cytoplasmic Ca2+ increase has been shown to be a sufficient trigger for development in 
mouse, pig and hamster eggs (Steinhardt et al., 1974; Fulton and Whittingham, 1978; 
Sun et al, 1992). In human eggs, Ca2+ ionophores have also been shown to be an 
effective parthenogenetic trigger (Winston et al., 1991). However, almost all 
parthenogenetic activation protocols used are only trigger a monotonic increases in free 
Ca2+, which is unlike fertilization where there are repetitive Ca2+ increases (Homa et al., 
1993). These monotonic increases produce significantly lower activation rates (Fulton 
and Whittingham, 1978; Vincent et al., 1992). This is not the case with Sr2+, where Sr2+ 
not only stimulates repeated Ca2+-oscillations (Kline and Kline, 1992), but can also 
activate most of the freshly ovulated mouse eggs (Homa et al., 1993).  
One of the concerns facing human IVF programmes is the underlying reasons of failed 
fertilization. Although ICSI has overcome most of male infertility problem (Palermo et al., 
1992), this technique does not work in every single case (Yoon et al., 2012). In the 
literature, several clinical reports have suggested that, in cases of repeated failed ICSI, 
the application of assisted oocyte activation,  such as Sr2+ treatment or other stimuli 
such as Ca2+ ionophore, post ICSI might improve the ICSI outcome (Yanagida et al., 
2006; Kyono et al., 2008; Chen et al., 2010; Borges et al., 2009; Taylor et al., 2010; 
Check et al., 2010). Taking these studies into account, it appears that assisted egg 
activation procedures could help some infertile patients where the sperm may lack the 
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ability to triggers Ca2+ signal (Chen et al., 2010; Nasr-Esfahani et al., 2010). 
Unfortunately, the safety of such pharmacological agents has not been fully tested, and 
there is not a single report showing Ca2+ oscillations in human eggs triggered by Sr2+. 
Theoretically, once we understand the molecular mechanisms that are involved in 
successful fertilization, then we might be able to begin to tackle this issue of failed 
activation. Fertilization normally occurs when the egg is meiotically mature, and is 
initiated after the spermatozoon fuses with the plasma membrane of the egg. We now 
consider that upon sperm-egg fusion, sperm delivers sperm-specific phospholipase C 
(PLCζ) (Saunders et al., 2002; Swann et al., 2006), that persistently activating the 
phosphoinositide pathway and results in the IP3  production, which then activate IP3R 
located on ER and causing repeated episodes of Ca2+ release (Swann, 1990; Stricker, 
1999; Rice et al., 2000). It has been shown that PLCζ not only activate eggs but also 
enhances embryo development up to the morula and blastocyst stages in mouse (Yu et 
al., 2008), porcine (Yoneda et al., 2006), cow (Ross et al., 2008) and human oocytes 
(Rogers et al., 2004).  
Consequently, the most convenient human egg activator may well be sperm PLCζ. This 
notion has been further supported recently by two studies on hPLCζ from sperm of 
patient who had repeated failed ICSI. These studies suggested that sperm with low 
quantity (Yoon et al. 2008) or mutated (maternally inherited point mutation) hPLCζ 
(Heytens et al., 2009) are unable to induce Ca2+-oscillations and fertilize the human 
eggs. Moreover, using mouse PLCζ, we have shown that injection of mRNA encoding 
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this mutation abolishs its ability to induce Ca2+-oscillations and this further supports  the 
suggestion that this is the cause of the infertility (Nomikos et al., 2011a).  
PLCζ is known to be an effective egg activator in mammals. However, the most 
available form of this artificial human egg activator, and one that can cause fertilization-
like Ca2+ oscillations, is the complementary RNA of sperm PLCζ (Kouchi et al., 2004). 
Experimentally, once PLCζ cRNA introduced into eggs by the direct cytoplasmic 
microinjection it starts to translate into PLCζ protein that continues over a several hours 
period (Yu et al., 2008), and in turn this PLCζ protein causes prolonged Ca2+-
oscillations.   
However, there are legal issues with regards to the use of cRNA in human eggs. In 
addition the precise quantification and the translation ability of the injected cRNA is 
difficult in human eggs. For both of these reasons the use of cRNA in IVF clinics is 
unlikely. These obstacles have led researchers to look for a more usable and natural 
human egg activator, and this is recombinant PLCζ protein. Several attempts have been 
reported to find a way to prepare recombinant hPLCζ, but the purity and stability of the 
PLCζ protein are still unresolved. Recently, one report has been published on potential 
successful synthesis and purification of recombinant human PLCζ (hPLCζ) protein, 
which was shown to induce Ca2+-oscillations in mouse and human eggs (Yoon et al., 
2012).  
The human eggs used in this study were donated by patients attending the IVF Wales 
clinic at the University Hospital of Wales, Cardiff, UK. The current project and all 
associated procedures were approved by the local South East Wales Research Ethics 
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Committee and also by the UK Human Fertilisation and Embryology Authority (HFEA) 
(R0161). In this chapter I will show how human eggs respond to the Sr2+ protocols that 
were successfully applied on mouse eggs, and I show under which circumstances Sr2+ 
might trigger Ca2+-oscillations in human eggs. In addition, I will demonstrate to what 
extend our research group has achieved the synthesis of active hPLCζ recombinant 
protein.  In this regard, we have succeeded in producing a very stable partially purified 
recombinant hPLCζ protein that could be stored in fridge or in -80C freezer. The 
microinjection of either of these stored recombinant hPLCζ proteins has Ca2+ inducing 
activity in both mouse and human eggs. Finally, briefly some preliminary studies 
monitoring cytoplamic movements during human egg activation using hPLCζ cRNA. 
 
5.2 Direct intra-cytoplasmic Sr
2+
 injection may not trigger 
Ca
2+
 release in human eggs  
 
After the results of my experiments on Sr2+ injection in mouse eggs, I tried to apply the 
same protocol to human eggs done by injecting human eggs with the Ca2+ dye OGBD 
then transferred to the inverted fluorescent microscope for the next injection with 
100mM Sr2+ (pipette concentration). This does not mean that cytoplasmic Sr2+ 
concentration is 100mM since it leaks slowly and dilutes within the egg. Due to the 
shortage in the human eggs, I ended up using only 5 human eggs for the Sr2+ injection 
protocol. Those eggs were from three different patients, 3 from failed IVF/ICSI (old 
eggs) and the other two were from follicular reduction (fresh eggs). After monitoring 
fluorescence for over five minutes, the injection pipette was introduced into the human 
egg and Sr2+ started to leak directly into the egg with continuous florescence (Ca2+) 
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monitoring. Sr2+ injection was continued for over half an hour by process called 
ionotophoresis (see material and methods chapter) and in some eggs the injection cycle 
was repeated twice with a new injection pipette. My results shows that none of those 
eggs demonstrate any Ca2+ rises in response to Sr2+ injection (Fig 5.1).  The main 
obstacle for this experiment was the poor availability of human eggs. Hence, it is difficult 
to give a final conclusion for this kind of experiments, but it does suggest that human 
eggs may be less sensitive to Sr2+ even when it is present in the cytoplasm. 
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Figure  5.1 Schematic diagram of Sr
2+ 
injection and example of Ca
2+ 
trace in human eggs in response to 
injected Sr
2+
 
 
5.2.1 Do human eggs need enhancement to respond to Sr
2+
? 
 
Based on these similarities between the human and mouse egg IP3R type, and after the 
negative results with Sr2+ injection, a modified technique was tried to try and enhance 
Ca2+-oscillations. In brief, I thought if I could sensitize the human egg IP3R with a small 
dose of the agonist adenophostine, that only triggers few Ca2+ spikes and then treat 
those eggs with Sr2+, this could induce the egg to respond to Sr2+. The injection protocol 
was carried out by mixing adenophostine with the Ca2+ dye RhD (50:50). Then the 
injected eggs were transferred to a prepared dish for recording on the florescent 
inverted microscope. In this experiment I used a total of 11 eggs, 5 were failed IVF from 
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one patient, and 6 eggs from another patient, 3 of them were fresh eggs and other 3 
were failed ICSI. I injected the failed ICSI eggs with final concentration of 0.5µM 
adenophostine.  
With continuous Ca2+ monitoring, the results was that no Ca2+ oscillations occurred  
even after co-treating  eggs with 20mM Sr2+ 0Na+ high K+ media (Fig 5.2A). I then 
increased the adenophostine concentration to 1µM and I injected those IVF failed and 
the fresh eggs with the new higher concentration of adenophostine.  
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Figure  5.2 Human egg response to adenophostine and 20mM Sr
2+ 
media (0 Na
+
& high K
+
). A) 
Representative figure of a failed ICSI human egg in response to the injection of 0.5mM adenophostine 
followed by 20mM Sr
2+
 media. B) Representative figure of failed IVF/ fresh human eggs in response to 
the injection of 1.0mM adenophostine followed by 20mM Sr
2+
 media  
 
The results showed that all injected eggs responded to adenophostine with Ca2+ 
increases for around 20 minutes, and when I transferred them to 20mM Sr2+ media, no 
further Ca2+ oscillations were detected (Fig 5.2B). These results suggest that a 
difference in degree of IP3R sensitization to Sr
2+ between mouse and human eggs is not 
likely to account for the lack of response to the Sr2+ protocol in human eggs.  
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5.2.2 Sr
2+
 may trigger Ca
2+
-oscillations in human eggs under 
certain conditions   
 
It is been well known that Sr2+ works reliably in rodent eggs but not in human and 
domestic animals, and the reason behind this is still unclear, despite several clinical 
studies that reported higher rate of ICSI outcome after Sr2+ exposure of ICSI eggs 
(Yanagida et al., 2006; Kyono et al., 2008; Chen et al., 2010). The results on Sr2+ influx 
mechanisms in mouse eggs suggested that Sr2+ influx may occur mainly via the reverse 
NCX. Consequently in this study, I tried to activate the reverse mode of NCX using 
similar protocols that I used on mouse eggs. One of the most successful protocols is the 
totally Na+ free HKSOM media with high K+ i.e. 0Na+ with 10mM Sr2+ for 2-3 hours (see 
chapter 2). This was the most extreme media I prepared to activate the reverse NCX.  
When I used this protocol on human eggs, there were no Ca2+ rises in all of the eggs 
tested (10/10), from 5 patients (failed IVF/fresh eggs) (Fig 5.3A). Then I adjusted the 
protocol by increasing the time of exposure for up to 5 hrs and increasing the Sr2+ 
concentration to 20mM. Unfortunately, the results were still the same with no response 
in all tested eggs (16/16) (Fig 5.3 B), the eggs where donated from different patients 
that varies between fresh and failed IVF/ICSI.  
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Figure  5.3 Human eggs response to two protocols of Sr
2+
 activation in NCX reversal media.  
A) Represent the human egg response to 10mM Sr
2+ 
for 2-3 hours. B) represents the response of human 
eggs to a higher Sr
2+
 concentration (20mM) with longer exposure time (5 hrs). 
  204 
Unexpectedly, when I kept the human eggs overnight on the recording dish in the Sr2+ 
20mM NCX reversal media (0mM Na+ & high K+), the results were encouraging and 
showed that most surviving eggs responded to Sr2+ by showing repetitive Ca2+ rises.  
5 hrs
Florescence Ca2+ (a.u)
egg died
n = 6/10
n = 1/10
n = 3/10
 
Figure  5.4 Ca2+-oscillations in human (failed ICSI) eggs in response to overnight incubation in 20mM 
Sr
2+ 
, 0Na
+ 
& high K
+ 
media 
 
The interesting point is that all tested eggs were failed ICSI eggs. In total I tested 10 
eggs, 7 from one patient, and 3 eggs from two other patients. From the 10 tested eggs, 
7 survived eggs, and amongst them 6 displayed Ca2+-oscillations (6/7) 85.7% (Fig. 5.4). 
However, the starting time and the oscillations frequencies were very variable. The 
earliest an egg that started oscillating was 10 hrs after recording. These data suggest 
that prolonged incubation in some Sr2+ media can cause some Ca2+-oscillations in 
human eggs. However, all responded eggs looked unhealthy by the next morning, they 
never underwent pronuclear formation and eventually all died.  
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5.3 Recombinant PLCζ-protein and human eggs 
 
It has been shown that all mammalian eggs including, those of humans, respond 
reliably to sperm specific PLC (PLCζ). However, due to the nature of the cRNA 
encoding PLCζ, and the difficulty to control the injection amount of the cRNA, the 
production of recombinant PLCζ protein has become desirable. In this regard Michael 
Nomikos from our group has succeeded in producing stable and partially purified (with 
NusA) human recombinant PLCζ protein (Nomikos et al., 2013). This recombinant 
human PLCζ was expressed as a NusA hexahistidine fusion protein in E. coli and then 
purified by Ni-NTA affinity chromatography. Due to the potential inactivation issues, our 
human recombinant PLCζ protein was kept with the attached NusA, and tested in 
mouse as well as in human eggs (Nomikos et al., 2013). Our results showed the 
presence of prompt Ca2+ oscillations in response to the injected recombinant hPLCζ 
protein in both mouse and human eggs indicate that we have made potent recombinant 
hPLCζ protein. We have also showed that purified recombinant human PLCζ protein is 
capable of hydrolyzing PIP2 with a similar Ca
2+ dependence to mouse PLCζ, and 
enhance early embryonic development in mouse eggs (Nomikos et al., 2013).  
Figure 5.5A, shows failed IVF human eggs from same patient showed Ca2+-oscillations 
triggered by injected fresh partially purified hPLCζ recombinant protein with NusA 
attached. This stock was then divided and kept in two different conditions i.e. in fridge 
~4C° and in -80C° freezer for over 10 months period.  The injection of this concentrated 
stock, that was stored in -80C° freezer,  into failed ICSI human eggs triggered Ca2+-
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oscillations for  around 1 hour (5/5) (Fig. 5.5B). The injection of the concentrated stock, 
that was stored in fridge, into a (failed ICSI) human egg failed to trigger Ca2+ oscillations 
in 3 hours. However, the oscillations stimulated after re-injecting this egg with the (- 
80C°) freezer stock (1/1) (Fig. 5.5C).  
* the time bare is 1 hr
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Figure  5.5 hPLCζ‎recombinant‎protein‎into‎failed‎IVF‎and failed ICSI human eggs                             
A) These eggs are from a failed IVF and they were injected with freshly partially purified recombinant 
hPLCζ protein. B) These eggs are failed ICSI and were injected with hPLCζ protein that was kept in -80C 
freezer for > 10 months .The oscillations starts after nearly 1 hr of recording. There is ~10 minutes gap. 
C) This egg was a failed ICSI case and was injected with hPLCζ protein that was kept in the fridge for >10 
months and it showed, no oscillations for almost 3 hrs, but then when re-injected with the same 
preparation that was kept in -80C freezer for > 10 months, the oscillations started and continued for 
nearly another 3 hours of recording. There is 20 minutes gap (time to check the response of eggs) 
 
Figure 5.6, is an illustrative trace  showing Ca2+-oscillations in mouse eggs in response 
to injected hPLCζ recombinant protein that was treated in different ways. The traces in 
(Fig. 5.6 A&B), shows prompt Ca2+-oscillations in mouse eggs triggered by crude (with 
out purification) fresh, as well as 1week old (fridge stored) recombinant hPLCζ protein. 
There were 6/6 and 7/7 eggs respectively. However, the frequency of Ca2+-oscillations 
is higher in the protein stored in the fridge by over 60% (24 spikes/1hr versus 15 
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spikes/1hr). The injection of partially purified hPLCζ recombinant protein into mouse 
eggs showed around a 50% reduction in the hPLCζ protein activity that was 
represented with lower frequency oscillations (13 spikes/1hr) (15/15) (Fig. 5.6C) 
compared to (24 spikes/1hr) that triggered by crude hPLCζ recombinant protein (7/7) 
(Fig.  5.6B).  
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Figure  5.6 The effect of hPLCζ recombinant protein injection into mouse eggs.                       
A) Ca
2+
-oscillations in mouse eggs in response to fresh crude hPLCζ recombinant protein B) Ca
2+
-
oscillations triggered by 1 week old (in fridge) crude hPLCζ recombinant protein In C) 1 week (in fridge) 
partially purified hPLCζ recombinant protein. In D) 10 months old (in fridge) partially purified hPLCζ 
recombinant protein. In E) >10 months old (in -80C) partially purified hPLCζ recombinant protein. In F) 
NusA purified hPLCζ recombinant protein into mouse eggs 
 
Interestingly, after 10 months storage of this partially purified protein in the fridge or in -
80C° freezer, the injection of this protein into mouse eggs still showed a significant Ca2+ 
releasing activity that looks similar to the activity of the one week old un-purified stock in 
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Figure 5.6B [21 spikes/1hr (25/25)] (Fig. 5.6D) & [19.5 spikes/1hr (22/22)] (Fig. 5.6E) 
respectively. However, further purification that removed the NusA completely abolished 
the protein enzymatic activity and showed completely flat traces in all injected mouse 
eggs (12/12) Fig.5.6F. 
These data might be interpreted to suggest that the freshly made hPLCζ recombinant 
protein is less active than the stored protein. This in turn may lead to a concept that 
hPLCζ recombinant protein requires a period of time to 'mature' in order to get the 
highest PIP2 hydrolytic activity. These data also suggest that preserving the NusA 
attached on the hPLCζ protein stabilizes the protein activity for longer periods.  
 
5.4 A potential non-invasive method of calcium monitoring 
and possible predictive method for embryo selection  
 
The importance Ca2+-oscillations during fertilization in mammalian eggs are well known 
and extensively studied. Until recently, the usual method to detect Ca2+ changes is by 
using an invasive Ca2+-sensitive fluorescent dye and then exposes eggs to excitation 
light at specific wavelengths. This light and dye combination can cause damage to the 
egg that consequently might interfere with the later development of the resulting embryo 
(Nematollahi-mahani  et al., 2009). It has been reported previously that during 
fertilization in mouse eggs the first few Ca2+ spikes are simultaneously accompanied by 
sudden cytoplasmic-movements (Deguchi et al. 2000). By using advanced image 
analysis based on particle image velocimetry (PIV) analysis, these cytoplasmic 
movements have been detected in fertilizing mouse zygotes (Ajduk et al., 2011). This 
could be used as non-invasive technique to monitor the occurrence of Ca2+ oscillations 
  209 
in the absence of fluorescent dyes. These cytoplasmic-movements have not been 
reported in any other mammalian species. In this study I was involved in a study of this 
phenomenon in human eggs. I co-injected human eggs that failed to fertilize after ICSI 
eggs with cRNA PLCζ mixed with Ca2+ sensitive dye (OGBD). These eggs were then 
monitored for both Ca2+-oscillations and cytoplasmic-movements with PIV 
simultaneously. The PIV analysis was carried out in collaboration with Dr Chris Graham 
in Oxford University Department of Zoology where the PIV image analysis was carried 
out. In total, from 10 different zygotes a range between 95 and 102 cytoplasmic-
movements were detected. After analyzing the results of the injected human eggs with 
cRNA PLCζ, it was clearly seen that Ca2+ oscillations were easily detectable with low 
and then higher frequency. In the meantime, cytoplasmic-movements accompanied the 
oscillations.  They were more clearly detected after the first 1 or 2 Ca2+ spikes. Our 
study shows that small abrupt cytoplasmic-movements can be detected simultaneously 
with each Ca2+ transient in human failed ICSI eggs (Fig. 5.7).  
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Figure  5.7 PLCζ- and ICSI-induced Ca
2+
 oscillations in human oocytes are accompanied by 
coincident transient movements in the oocyte cytoplasm. Recording of intracellular Ca
2+
 increases 
measured by OGBD fluorescence and the corresponding cytoplasmic movements as measured with PIV  
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We carried out a similar analysis of PLCζ cRNA-induced Ca2+-oscillations and 
cytoplasmic-movements in seven unfertilized eggs that were obtained after follicle 
reduction mainly from women undergoing intra-uterine insemenation (IUI). Notably, we 
failed to detect any movements associated with the 41 Ca2+ spikes observed in these 
follicle reduction-derived eggs. This method can be regarded as potential non-invasive 
way for monitoring Ca2+-oscillations occurrence and their patterns in human eggs in the 
absence of Ca2+ dyes and high intensity excitation light. 
 
5.5 Discussion  
 
5.5.1 Sr
2+
 injection may not provoke Ca
2+
 release in human eggs  
 
Although it has previously been reported that Sr2+ can be injected into mammalian eggs 
(Georgiou et al., 1987 and Okada et al., 2003), these reports did not keep the injection 
pipette in the egg for prolonged times. Hence they did not see if oscillations in Ca2+ 
could be generated. The Sr2+ injection experiments were the most challenging 
experiments with regards to the survival of the injected egg. My protocol was planned 
using repeated electrical pulses to ensure continuous leaking of Sr2+ from the injection 
pipette that was kept in for long times (~30minutes) before withdrawal from the egg. It 
has been reported previously that Sr2+ works by activating the Ca2+ binding stimulatory 
site of the IP3R (Marshall and Taylor, 1994). Amongst the three types of IP3R that have 
been reported in mammalian cells 1, 2 and 3 (Patterson et al., 2004), the IP3R1 is the 
predominant type in mammalian eggs and is highly expressed  at the MII stage in 
mouse (Mehlmann et al., 1996) and human eggs (Goud et al., 1999; Mann et al., 2010). 
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The IP3R1 has also been reported to be the receptor responsible for all of the of Ca
2+ 
increases after fertilization or IP3 injection in rodent (Xu et al., 1994; Mehlmann and 
Kline, 1994; Yoshida et al., 1998) and in human eggs (Goud et al., 2002). In this project 
I ended with only 5 human eggs being injected which is a very small number. However, 
even in this small number of eggs, by bypassing the plasma membrane via direct Sr2+ 
injection, Sr2+ should be able to induce Ca2+ release as it does in mouse eggs. Despite 
this similarity between mouse and human eggs, Sr2+ injection did not show Ca2+ release 
in human eggs. It is difficult to give a reasonable explanation that could clarify this. One 
possibility, considering the egg’s size, is the density of IP3R1 in human egg could be 
less than that in mouse. The other possibility is the threshold sensitivity of IP3R1 to Sr
2+ 
in human eggs could be higher in comparison to that in mouse eggs.  It might be due to 
other modifications of the IP3 receptor such as different phosphorylations. Despite the 
fact that these are preliminary results, I suggest that the Sr2+ injection is not an effective 
way to activate or triggers Ca2+-oscillations in human eggs. Nevertheless further 
injection experiments might still be needed to draw a precise and final conclusion. 
 
5.5.2 Human egg response to Sr
2+
 is conditioned  
 
Previous studies (Yanagida et al., 2006, Kyono et al., 2008 and Chen et al., 2010) 
claimed that 10mM Sr2+ treatment for 1 hr after 30 minutes post ICSI on human eggs 
would be an effective method of assisted oocyte activation. This could improve 
fertilisation, embryo quality, pregnancy rates and successful live births, in cases of 
repeated ICSI failure. This is shorter exposure time than the used protocols in the 
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mouse, where it has been reported that the optimum Sr2+ activation protocol is the 
combination of 10mM Sr2+ for 2.5 hrs in Ca2+ free media (Ma et al., 2005). These 
previous human egg studies have a couple of scientific based deficits. First, they lack 
the inclusion of a control group at the time of the study. Secondly, none of these reports 
has shown or reported Ca2+ monitoring during the activation process. These would be 
expected, since Ca2+-oscillations are a physiological prerequisite step for  human egg 
activation (Taylor et al., 1993).The Ca2+-oscillations in  my  experiments starts very late, 
~10hrs into recording, which is roughly ~ 36 hrs after ICSI. In the end none of the eggs 
in my study showed pronuclear formation and eventually they all died. These results, 
despite being the first reported Ca2+-oscillations in human eggs triggered by Sr2+, is far 
from physiological conditions, and hence cannot be recommended to be used in IVF 
clinics. Hence my current results on Sr2+ treatments suggest it is too early to use Sr2+ is 
an agent for human egg activation.  
One interesting point in my study is that all human eggs that showed some response to 
Sr2+ were failed ICSI eggs (i.e. containing sperm). Therefore, due to the short availability 
of human eggs, this overnight protocol that I used in these experiments should be 
tested in future on fresh and failed IVF human eggs before drawing too many 
conclusions. The other recommendation is with regards to the media used. It would be 
worthy testing the overnight protocol using the regular Ca2+ free Sr2+ media before we 
can say that the oscillations were definitely a result of the special NCX reversal media 
derived from studies in mouse eggs.  
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5.5.3 ICSI failure of male factor origin might be rescued with PLCζ 
recombinant protein 
 
Despite the invention of the ICSI technique as a successful tool to solve most of male 
infertility problems in IVF clinics, there are still some cases of repeated failure in ICSI. 
The majority of these cases are caused by egg activation failure (Tesarik et al., 1994; 
Nasr-Esfahani et al., 2010).  Following the identification of PLCζ as the sperm factor in 
mammals, there is a growing interest in the use of recombinant PLCζ protein in IVF 
clinics. This might be a means to solve the egg activation failure after ICSI. In principal 
the co-microinjection of PLCζ cRNA during ICSI could be used to rescue egg activation 
failure due to sperm PLCζ dysfunction.  
 In this study, I have focused on the fact that our lab has made an active recombinant 
hPLCζ protein. We prepared recombinant human PLCζ protein fused to NusA (Nomikos 
et al., 2013). NusA is a fusion protein known to greatly enhance the stability and 
solubility of recombinant proteins (De Marco et al., 2004). Our study has now showed 
that the microinjection of wild-type recombinant human PLCζ protein induced Ca2+-
oscillations in both human and mouse eggs. In the extension on this study my colleague 
(Yuansong Yu) has succeeded in successfully activating mouse early embryo 
development up to the blastocyst stage using recombinant human PLCζ protein 
(Nomikos et al., 2013). The micro injection of recombinant human PLCζ protein into 
mouse eggs alone, without the fusion protein NusA showed a dramatic loss of PLCζ 
activity as represented by very poor Ca2+-oscillations. This indicates the importance of 
the accompanying the fusion protein in stabilizing the recombinant PLCζ protein.  The 
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production of active purified recombinant PLCζ protein promotes its potential application 
in IVF clinics as a therapeutic option for egg activation following failure caused by male 
factor related to PLCζ dysfunction. 
 
5.5.4 Possible non-invasive method of Ca
2+
 monitoring and 
embryo selection  
 
Cytoplasmic movement have been reported in mouse eggs after sperm entry (Ajduk et 
al., 2011). In addition, the point of sperm entry in mammalian eggs is known to be linked 
the organization of the cytoplamic components (Ajduk et al., 2011). In our studies the 
cytoplasmic movements were observed in 10 failed ICSI human eggs i.e. containing 
sperm, but not in the 7 follicular reduction or ‘fresh’ human eggs (Swann et al., 2012). 
This suggests that the presence of the sperm is important for the effective observation 
of cytoplasmic movements in human eggs during fertilization. 
To use this technique as a potential indicator of successful fertilization or embryo 
development, it is worthwhile to know to what extend the human embryo can tolerate 
light exposure. Previous studies have suggested that we can predict the ability of 
developing human embryo to the blastocyst by monitoring group of human IVF zygotes 
from day 2 after fertilization by automated image analysis system (Wong et al., 2010). 
These and other studies reported that the exposing of light for <1 second every couple 
of minutes for several days on human embryos showed no harmful effect upon 
development (Nakahara et al., 2010). Our method for monitoring the cytoplasmic 
movements was programmed to expose human eggs to light for <1 second every 10 
seconds for several hours. It is unclear whether or not this level of light exposure will 
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have any damaging effect upon human embryo later development. However (Adjuk et 
al., 2011) reported that there is no harmful effect upon mouse embryo development to 
term. 
Previous mouse embryo studies results indicated that the pattern of cytoplasmic 
movements, that mirroring the Ca2+-oscillations, provide a powerful indicator of embryo 
quality,  and consequently provide a predictive measure of the quality of the pre-
implantation embryo (Ajduk et al., 2011). Extrapolating these finding to our study we can 
expect that this technique could be a novel, early and non-invasive method to determine 
the viability and potential for later human embryo development. This could then be 
helpful in raising the implantation success in IVF clinics.  
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Chapter 6 
 
GENERAL DISCUSSION 
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6.1 Overview 
 
In this Thesis I have presented data from several studies that have investigated the 
optimal mechanisms of triggering Ca2+-oscillations artificially in mouse and human eggs. 
Several scientific facts have resulted from this work. I have shown that Sr2+-triggers 
Ca2+-oscillations in mouse eggs by an influx mechanism, in which the NCX seems to 
play the major role. I have also shown that human eggs, that had failed fertilization post 
ICSI, can respond to Sr2+. However, this response is conditional and only occurs in 
particular circumstances, such as in a special media (0 Na+ and high K+) and with a long 
Sr2+ exposure period.  
The other part of my research concerned sperm specific PLCζ. In this I showed the 
impacts of some sequence mutations on PLCζ functional activity. Moreover, we have 
investigated the regulatory mechanism of PLCζ.  Finally, we succeeded in making an 
active recombinant PLCζ protein. PLCζ is thought to be the sperm factor in all 
mammals.  Following on the results from previous studies on human PLCζ (Yoon et al., 
2008; Heytens et al., 2009), I have shown that the H398P single site mutations seen in 
human PLCζ works in exactly the same in mouse PLCζ in abolishing all PLCζ activity. 
This mutation is special since I showed also that the H398A mutation enables mPLCζ 
to retain most of its catalytic activity (Nomikos et al., 2011a). I also showed that the 
PLCζ XYl region has a special cluster of amino acids that enables PLCζ to target PIP2 
(Nomikos et al., 2011b). Beside the PIP2 targeting role of the XYl in PLCζ, I have shown 
also that PLCζ is regulated by its XYl in a different way from the mechanism in somatic 
PLCs (Nomikos et al., 2011c). A number of experiments on PLCs mutation chimeras 
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and their effect on Ca2+ release activity were also carried out and they are included in 
this Thesis. These experiments are mainly comparisons between PLCζ and its closest 
homolog PLCδ1, and with sperm specific PLCζ between species; mainly human and 
mouse. These PLCζstudies, including the chimeras work, suggest that any change in 
the nature of the domain structure of PLCζ will result in a significant impact on 
PLCζCa2+-releasing activity. In this chapter I will discuss the pathenogenetic stimuli 
causing Ca2+ release in mammalian eggs, including mouse and human, for a general 
comparison. Similarly I will include in my discussion other PLCs (somatic), and compare 
them with the sperm specific PLCζ. 
 
6.2 Parthenogenetic mammalian egg activation via Sr
2+
 
application  
 
For decades it is been known that egg activation can be achieved even in absence of 
sperm (Swann and Ozil., 1994). Previously the lack of knowledge that surrounds egg 
activation events presented challenges for artificial oocyte activation methods. Many 
approaches been used to artificially induce oocyte activation and they have focused on 
triggering in intracellular Ca2+ increases (Loren and Lacham-Kaplan, 2006). A few 
successful candidates have been shown to release the MII arrested eggs from the 
meiotic arrest by promoting of extracelluar Ca2+ entry or release to increase free 
intracellular Ca2+. These include Ca2+ ionophores, 7% ethanol (Cuthbertson & Cobbold 
1985), and the divalent cation strontium (Sr2+) (Kline & Kline 1992). While these 
methods may be credible for artificial egg activation, none are is able to achieve the 
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efficiency provided by spermatozoa. For example, Ca2+ ionophores (A23187) have been 
reported in several studies to activate mammalian eggs including those of humans 
(Borges et al., 2009; Nasr-Esfahani et al., 2010). However only Sr2+  has the ability to 
produce Ca2+-oscillations and it appears to be most  physiological compared with 
methods of egg activation that  trigger a monotonic rise in cytosolic Ca2+. The optimum 
parthenogenetic stimulus in rodent eggs is Sr2+ and it has been successfully employed 
in many studies (Miyazaki and Ito, 2006; Loren and Lacham-Kaplan, 2006; Kyono et al., 
2008). In fact Sr2+ is widely used in research labs as an egg activator in rodent eggs as 
it is the only cation that provokes Ca2+ oscillations that are similar to those seen in 
normal fertilization (Kono et al., 1996).   
Sr2+ exposure times have been shown to support and influence blastocyst composition 
and early embryonic development (Bos-Mikich et al., 1997; Lacham-Kaplan et al., 
2003). However, Sr2+ alone cannot produce live offspring since there are imprinted 
genes that are switched off in the egg and only switched on in sperm. A single report 
has shown that Sr2+ can lead to production of normal mice offspring in conjunction with 
ICSI of sperm collected from male mice treated with alkylated iminosugars (Suganuma 
et al., 2005). Alkylated iminosugars act as reversible male infertility-inducing agents 
during short-term treatment by inducing sperm deformities that include irregular 
mitochondrial sheaths, aberrant attachment of tails, and deviant head shapes that 
impair sperm fertilization ability (Van der Spoel et al., 2002). They do this without 
altering the genetic integrity of male mouse germ cells. When mouse eggs were treated 
with Sr2+ as per their protocol after ICSI of misshapen epididymal spermatozoa, the 
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majority of these eggs were activated and a normal generation of mice produced 
(Suganuma et al., 2005). 
In humans, a few clinical reports have shown that Sr2+ may enhance IVF and ICSI 
success rates in cases of repeated IVF/ICSI failure (Yanagida et al., 2006; Kyono et al., 
2008). In large mammals like bovine eggs, the combination of electrical and chemical 
‘Sr2+’ parthenogenetic activation protocols  have been shown to be able to compete with 
the rate of development seen in IVF/ICSI at the early cleavage stage, but not at the  
blastocyst stage (Hosseini et al., 2008). However, other studies have failed to show 
Ca2+ transients in human eggs treated with Sr2+ (Rogers et al., 2004; Heindryckx et al., 
2009). It is of note that no other groups are using Sr2+ to activate human, pig or cow 
eggs. So it is has remained unclear why Sr2+ only works reliably in rodent eggs, but not 
in eggs of other species including human.  
It has been suggested that Sr2+ works through the IP3R to release Ca
2+ from the internal 
stores, so the IP3R is the likely mediator of Sr
2+ effects on eggs (Zhang et al., 2005). 
These IP3R are well known to be present in all mammalian eggs. Sr
2+ is divalent cation 
that is very similar to Ca2+ (Whittingham and Siracusa, 1978; Kline and Kline 1992; 
Swann and Ozil, 1994; Rogers et al., 2004). To this end, I have worked on the 
hypothesis that Sr2+ needs to cross the plasma membrane to triggers the IP3R on 
internal store ‘ER’ and to commence Ca2+-oscillations. In doing so, and due to the 
similarity between Sr2+ and Ca2+ ions, Sr2+ might use the same channels that Ca2+ 
normally use to enter the egg. This idea was supported with Sr2+ injection experiments 
in which I have shown that by bypassing the plasma membrane, Sr2+ is able to induce 
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Ca2+ rises in mouse eggs in normal Ca2+ free media (Fig 3.3A). In mammals, this is the 
first successful study to show Ca2+-oscillations triggered by Sr2+ injection in mouse 
eggs. Although, it has been reported previously in two different studies that Sr2+ can be 
injected into mammalian eggs such as in hamster eggs (Georgiou et al., 1987) and in 
pig eggs (Okada et al., 2003). Interestingly both reports showed a single Ca2+ transient 
that is different from the physiological pattern of Ca2+ changes during fertilizations. In my 
protocol in which Sr2+ injected directly into the mouse egg cytoplasm using micropipette 
with sequential electrical pulses (see material and methods) to ensure a continuous 
leaking of Sr2+ from the injection pipette. The results were interesting and showed a 
succession of Ca2+-oscillations within the first few minutes in all tested eggs. These 
Ca2+-oscillations were promptly stopped after Sr2+ leakage was ceased and further 
resumed by resuming the Sr2+ injection (Fig. 3.3A). Egg survival was a challenging point 
here since the injection pipette has to be kept in continuously during the injection 
protocol running time. The overall results of this experiment favour the influx theory and 
suggest that Sr2+ has no particular interaction with plasma membrane except to cross it. 
The question remains about the nature and the type of the mediators that Sr2+ uses to 
cross the PM and reach the IP3R on ER and subsequently provoke Ca
2+-oscillations. 
Different kinds of mediators of Ca2+ influx, including the NCX, have been expressed in 
mammalian eggs.  Any cytosolic Ca2+ load can be removed from the cytosol by using 
two main transport processes, the Ca2+-ATPase (that actively pumps Ca2+ against its 
gradient mainly into internal store) and the NCX. The later has been found in many 
mammalian tissues including eggs in hamster (Igusa and Miyazaki, 1983; Georgiou et 
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al., 1988) and mouse (Pepperell et al., 1999). NCX can lead to changes in membrane 
potential (electrogenic) due to the cytosolic accumulation of the positive charges (Na+) 
(Carroll, 2000). The NCX is driven by the electrochemical gradient, therefore, any 
manoeuvres that would minimise the extracellular Na+ would activate the reverse mode 
and promote Ca2+ influx and in my experiments’ protocol these should promote Sr2+ 
influx in exchange with Na+ extrusion.  
In my  experiments I used either a low or zero Na+ media to enhance the reverse NCX 
using as an osmolarity stabilizer either choline or K+.  Based upon my results of Sr2+ 
experiments on mouse eggs, I found out that NCX is the main Sr2+ influx mediator. This 
is because the activation of the reverse mode of NCX in normal osmolarity Sr2+ media 
allowed even 0.5mM Sr2+ to trigger Ca2+ oscillations in mouse eggs. This is bearing in 
mind that this Sr2+ concentration is unable to produce Ca2+ rises in normal situation. 
Interestingly, these Ca2+-oscillations are completely and reversibly abolished by using 
20µM of specific NCX reverse mode inhibitor (KB-R7943) see Fig. 3.21. This suggests 
the importance of the NCX in Sr2+ influx and could explain how Sr2+ cross the membrane 
to triggers Ca2+ release.  
The effect of Na+ on the direction of NCX was also further examined using the Na+ 
ionophore (monensin). The addition of monensin to eggs placed in low Na+ (~30mM) 
and low Sr2+ (0.5mM) media, demonstrated that Sr2+ able to triggered Ca2+-oscillations 
in non-oscillating eggs (>50%) and  increased the frequency of oscillating ones (>45%), 
see Fig. 3.23. These findings are consistent with the results from previous study on 
mouse eggs (Carroll, 2000). This again suggests that Sr2+ most likely substitutes for 
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Ca2+ in the reverse mode of NCX. Whilst clear cut these results cannot exclude the idea 
that other channels might also be involved in Sr2+ influx, such as SAC and TRPC 
channels. However, it give a firm hypotheses of how Sr2+ influx through the plasma 
membrane. 
A previous study reported the potential mechanism of NCX switching between the two 
modes by manipulating the Na+ gradient. The reverse mode is more likely to take place 
if the reversal potential of the NCX is similar to the resting membrane potential (Carroll, 
2000). In order to measure the reversal potential of the NCX accurately, a calculation of 
the intracellular Na+ is required. Estimated values for the reversal potential can be 
obtained using the equation ER = (nENa – 2ECa)/(n – 2) (Carroll, 2000) full details in 
page 53. Carroll (2000) estimated that the ER for eggs is around –40 mV. This value is 
close to reports that showed the resting membrane potential of the mouse egg is around 
(- 30 to - 40mV) (Peres, 1986 and Carroll, 2000). At this level the reverse NCX is 
activated which should lead to Ca2+ influx into the egg. In my experiment Sr2+ is used 
instead of Ca2+. However, it should be recognized that this type of calculation has to 
make an assumption about the intracellular free Na+ concentration, and the behaviour of 
the NCX is very sensitive to the value of this parameter.  Any minimal increase in the 
Na+ concentration gradient across the plasma membrane, which largely driven by the 
intracellular values, will be enough to promote the reversal of the NCX.  I used mainly 
two different concentrations of Sr2+ (10mM and 0.5mM) and have used the previous 
equation to calculate the effects of different values of intracellular Na+ from 0 to 25mM. 
The results are summarised in the graph below that showed two curves that represent 
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the relation between the reversal potential of the NCX with different concentrations of 
intracellular Na+. This is compared to the membrane potential of the egg, which is taken 
as – 40 mV (Fig. 6.1). I have assumed that Sr2+ and Ca2+ are equivalent to each other 
as divalent ions. The interpretation of this figure is that when the reversal potential value 
is above the membrane potential (taken as -40mV) the NCX works in forward direction 
to pump Ca2+, or Sr2+ in case of Sr2+ media, out of the egg. However, when the NCX 
reversal potential value is equal to or less than the membrane potential the NCX will 
switch into the reverse mode and brings Sr2+ into the egg. 
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Figure  6.1 The relation between the Sr
2+
 influx and intracellular Na
+
 concentration in correlation 
with the membrane reversal potential. Each curve represents the relation between the reversal 
potential of the NCX and the intracellular Na
+
 concentration. This relationship is plotted for either 0.5mM 
or 10mM extracellular Sr
2+
 ions.  
 
It is notable  from the figure above that in the case of 10mM Sr2+ the NCX works 
normally in forward direction at any intracellular Na+ level below 5mM, and will switch to 
the reverse mode when the reversal potential equal to or less that -40mV which is when 
the intracellular Na+ increases over 5mM. So the Na+ concentration only has to be over 
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5mM for Sr2+ to enter the egg. However, in the case of 0.5mM Sr2+ the forward mode 
NCX continues until intracellular Na+ level increases and reaches over 12mM. Only at 
that point will Sr2+ enter the eggs, and this is why 0.5mM Sr2+ does not cause Ca2+ 
oscillations unless the Na+ is manipulated. Notably, the Na+ concentration in cells is 
thought to be in the range from 4 to 12mM (Sonn and Lee, 1988; Johnson et al., 1991), 
hence the NCX is carefully balanced between its two modes of action. It has been 
reported previously that the membrane potential in human eggs is ~ -30 mV (Feichtinger 
et al., 1988). Using this value in the (Fig. 6.1) might help understand one of the reasons 
for the inability of Sr2+ to trigger Ca2+ releases in human eggs. It could possibly be that 
in human eggs the intracellular Na+ concentration is maintained in very low (< 4mM) 
levels compared with that in rodent eggs. This would make the NCX always works in the 
forward direction in human eggs. 
 
6.3 Can Sr
2+
 induce Ca
2+
-oscillations in human eggs? 
 
Taking the protocols that I used on mouse eggs, I applied these to human (failed ICSI) 
eggs donated from couples who treated in IVF Wales. I have found that there is still little 
ability to trigger either Ca2+ oscillations or egg activation. I have also tried the Sr2+ 
injection protocol on human eggs, unfortunately none of the injected eggs responded to 
Sr2+ leakage. In addition, treating human eggs with Sr2+ media in different 
circumstances by changing media osmolarity, Sr2+ concentration and time exposure, 
shows that human eggs may only respond to Sr2+ in very extreme situations. This 
involves overnight 20mM Sr2+ exposure in media that was prepared to maximize the 
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reverse mode of NCX. Interestingly, when failed ICSI human eggs were kept overnight 
in 20mM Sr2+ and 0Na+ media, despite a long delay of >10 hrs, there was clear Ca2+ 
oscillations in the majority of those eggs (7/10). Unfortunately, none of these eggs 
developed further, or even formed pronuclei, and eventually all died within next few 
hours. These results are interesting in showing that even human eggs can respond to 
Sr2+ and generate Ca2+ oscillations activations given that the appropriate conditions are 
provided. 
Therefore, the unsolved question is why Sr2+ works reliably in rodent eggs, such as 
those of mouse, but not in eggs of humans and domestic mammals. One part of the 
explanation could be related to the intracellular Na+ level which could behave in a similar 
way to that found in cardiac cells. It has been suggested previously that in cardiac cells 
the intracellular Na+ ([Na+]in) is maintained at lower levels in larger mammals than  that 
in the smaller mammals (Pieske and Houser, 2003). If this is the case in mammalian 
eggs, Na+ could be maintained at lower levels in the large eggs from large mammals 
such as human and pigs, compared to the Na+ values in smaller mammalian eggs such 
as mouse and rat. In this case the forward direction of NCX would dominate in the large 
mammalian eggs, which makes Sr2+ influx unlikely to happen in situations of the Sr2+ 
triggers egg activation protocols. Still, why Sr2+ does not work in human eggs? 
Gathering this with the previous assumption from Pieske and Houser (2003) regarding 
the intracellular Na+ in human eggs, the only possibility is that the intracellular Na+ in 
human eggs is maintained in its lowest values (i.e. below 4mM). This suggests that the 
forward NCX would dominate the situation. This consequently could partially explain 
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why Sr2+ unable to trigger Ca2+ release in human eggs at normal Sr2+ activation 
conditions.  
Nevertheless, my experiments using 0Na+, high K+ media with 20mM Sr2+ have also 
failed to provoke Ca2+ release in human eggs. Significantly, by applying the same 
components’ concentration in the Sr2+ activation media but using an overnight exposure 
I finally succeeded in stimulating Ca2+-oscillations in failed ICSI human eggs. However, 
despite these promising results, which involve the first reported Ca2+-oscillations in 
human eggs triggered by Sr2+, it is far from the physiological conditions, and is 
apparently toxic to eggs. Therefore we cannot yet recommend a media to be used in 
IVF clinics.  It is also difficult to draw a final conclusion not least because of the limited 
availability of the human eggs which meant that all tested eggs were from failed ICSI 
group. Because of this, a full comprehensive study is recommended to examine the 
overnight protocol on the fresh and failed IVF eggs in the extreme media, as well as in 
normal Ca2+-free Sr2+-media, that is routinely used for mouse eggs. Only then we can 
reach a final conclusion in this matter.  It may be of interest to try some of the low Na+ 
protocols I used in eggs of domestic animals, such as pigs and cows, since they have 
also proved difficult to activate with normal containing Sr2+ media. They are also 
available for experiments in larger numbers than human eggs.   
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6.4 Sperm specific PLCζ 
 
It has been suggested that during fertilization sperm convey a message to the fertilized 
egg in order to provoke the egg activation events. Later it was suggested that this 
message has to be introduced into the egg, since the injection of sperm extracts can 
trigger Ca2+ oscillations and egg activation events in mouse, hamster and human eggs 
(Swann, 1990; Swann, 1994; Homa and Swann 1994). Substantial evidence suggests 
that the Ca2+ oscillations at fertilization are triggered after the sperm fuses with the egg, 
and this leads to the introduction of a sperm-specific phospholipase C (PLCζ) into the 
oocyte (Saunders et al., 2002; Swann et al., 2006; Yu et la., 2008). PLCζ then 
generates repeated cycles of IP3 production within the ooplasm that cause the repetitive 
Ca2+ release phenomenon of Ca2+-oscillations (Swann et al., 2006; Yu et al., 2008). 
However, a recent report criticised this and showed through IVF with indirect 
immunofluorescence analysis study that PLCζ is no longer detectable after sperm-egg 
membrane fusion (Aarabi et al., 2012). They also showed evidence suggesting that 
PLCζ is produced during, and involved in, spermatogeneses in human and mouse and it 
is reduced in levels after acrosomal formation (Aarabi et al., 2012).  The specificity of 
the PLCζ antibody used in this study is, however, dubious.   
An interesting study by (Borges et al., 2009) suggests that it is most probably that PLCζ 
is expressed only in epididymal sperm and not in testicular correspondents, since they 
found that the artificial egg activation improves only ICSI cases with epididymal sperm 
injection and not those injected with testicular retrieved sperm (Borges et al., 2009). 
This study is consistent with previous work that found out by reverse transcriptase PCR 
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(rtPCR) experiments that PLCζ appears only in spermatids but not in the earlier steps of 
spermatogeneses (Saunders et al., 2002). 
 Sperm PLCζ is most conveniently introduced into oocytes by microinjection of its 
complementary RNA (cRNA) which is translated into PLCζ protein within the oocytes 
over a period of several hours until pronucleus formation (Jones et al. 1995). Hence, the 
injection of PLCζ cRNA into oocytes produces the PLCζ protein that causes prolonged 
Ca2+ oscillations, and in parallel experiments PLCζ has been shown to activate 
embryonic development of mouse, pig, cow and human oocytes up to the morula and 
blastocyst stages (Rogers et al., 2004; Yu et al., 2008). 
In this thesis I reported several studies on different aspects of the structural point of 
view and their effects on the functional activities of PLCζ. In addition, I reported 
differences in PLCζregulation compared to other PLCs. I started with mutations studies 
and compared their effects on the Ca2+ releasing potency with that of the wild type 
PLCζ. It has been suggested that even though the sperm contains PLCζ, it is inactive 
until it is introduced into the egg cytoplasm (Swann et al., 2004). Consequently, this 
could mean that there is some unrevealed intrinsic mechanism within the egg that 
switches on the activity of PLCζ.  
In principle, any disruption of the PLCζ code of amino acids sequence could alter the 
protein structure and subsequent functional activity. The first direct link between male 
infertility and a defective PLCζ gene was made after identification of a PLCζ point 
mutation in an infertile oligospermic patient after ICSI treatment that had repeated failed 
fertilization due to egg activation failure. The problem with PLCζ was reported to involve 
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a single point mutation (i.e PLCζH398P) found after a genomic search of PLCζ sequence 
in this patient. This proline residue, which in protein structure prediction is known to 
have helix-destabilizing ability, specifically causes a perturbation of the catalytic Y 
domain that annuls PLCζ enzymatic activity. We studied this mutation using an 
equivalent site in mouse PLCζ (i.e. PLCζH435P). This could then be the monitoring for its 
ability to cause Ca2+-oscillations after PLCζ expression in individual mouse eggs. Our 
study ‘Nomikos et al., 2011a’ showed  a complete abolishing effect of this mutation on 
the mouse PLCζ activity, despite high expression values of this mutated PLCζThis 
provides a clear evidence of the effect of this mutation This could be due to the 
introduction of major protein structural changes, consistent with that proposed 
previously (Heytens et al., 2009). For a comparative study, we employed an additional 
PLCζ mutant (i.e. PLCζH435A) in which a histidine residue was replaced with a neutral 
non-helix-destabilizing amino acid, alanine. This mutation does not abolish PLCζ activity 
but reduces its catalytic activity by 20-30% (Nomikos et al., 2011a). This H398P 
infertility linked point mutation was also examined for in vitro enzymatic properties of a 
closely related PLC isoform PLCδ1 (PLCδ1H542P). Very similar results were observed in 
which only 16% of the PIP2 hydrolysis activity of the PLCδ1
WT was retained at high Ca2+ 
levels, in which PLCδ1WT is known to be fully enzymatically active (Nomikos et al., 
2005). 
To determine whether an equivalent or excess level of PLCζH435P protein expressed in 
mouse eggs can block the Ca2+ oscillation-inducing activity of PLCζWT, as suggested by 
a previous study (Heytens et al., 2009), we examined the dominant-negative effect of 
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PLCζH435P on PLCζWT. Our results on cRNA PLCζWT and in mouse IVF (on sperm PLCζ) 
suggest that mouse PLCζH435P does not appear to operate on a dominant negative 
manner. Our results that argued against the previous assumption of a dominant 
negative effect were later explained by the discovery of another point mutation within 
the PLCζ sequence from the same patient that was firstly found to have the PLCζH435P 
mutation. The newer mutation was found with a substitution of histidine with lucine a.a. 
in different ‘mother-inherited’ allele at position 233 in the PLCζ sequence (PLCζH233L). 
This mutation was found to dramatically reduce PLCζ activity (Kashir et al., 2012). 
Despite the basic knowledge of PIP2 hydrolysis by PLCζ at fertilization, the exact 
mechanism by which PLCζ locates and binds the substrate in eggs remains unclear. It 
has been suggested that electrostatic interactions the positively charged PLCζ residues 
might interact with the negatively charged PIP2 (Nomikos et al., 2007). Experiments 
using a synthetic peptide corresponding to a portion of the XYl in a fluorescence 
resonance energy transfer (FRET) assay have suggested that basic amino acids could 
help anchor PLCζ to the membrane and facilitate local PIP2 concentration adjacent to 
the catalytic domain.  
There are also promising results from protein-lipid overlay and liposome-binding assay 
experiments on the ability of the mouse PLCζ XYl and C2 domain to interact with 
membrane PIP2. These data suggest that only the XYl and not the C2 domain interact 
preferably with PIP2 (Nomikos et al., 2011b). We aimed to rule out any additional role of 
other PLCζ domains on this interaction by preparing sequential mutations using site-
directed mutagenesis on positively charged region of the mouse PLCζ XYl. This 
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resulted in the generation of three cumulative mutations; single (K374A), double 
(K374,375AA) and triple (K374,375,377AAA) mutant constructs of PLCζ. The selection 
of lysine to alanine change was chosen as it is likely to bring about relatively small 
changes compared with charge-reversed amino acid substitution effects on PLCζ 
structure. In this study it was clearly reported that both PLCζ activity and expression 
levels declined by sequential increase numbers of the mutated lysine to alanine. 
However, the enzymatic properties of PLCζ were not clearly affected with these 
mutations (Nomikos et al., 2011b). This result suggests that the sequential cumulative 
neutralization of these basic residues within the XYl region substantially reduces the in 
vitro affinity of PLCζ for PIP2 without affecting the Ca
2+ sensitivity of this enzyme.  
All somatic PLCs such as PLCβ, δ and ε have highly negatively charged X-Y linker. 
Interestingly PLCζ is the only mammalian PLC that possesses a highly positively 
charged XYl region. It has been proposed that these XYls might mediate auto-inhibition 
of PLC activity (Hicks et al., 2008). This was suggested after results that showed that 
the deletion of the XYl from PLCβ2 consistently increases PLCβ2 activity in vitro and in 
vivo (cells). Similar results were detected by the deletion of the XYl from PLCβ1, δ1, 
and ε. This suggests a common auto-inhibition mechanism for PLCs regulation (Hicks et 
al., 2008). The suggested mechanism of this action is by prevention of PIP2 gaining 
access to the active site by a combination of steric exclusion and electrostatic repulsion 
of negatively charged membranes with the negatively charged XYls of these PLCs 
(Hicks et al., 2008). Beside the tyrosine phosphorylation activation process of XYl 
region, PLC is regulated by additional regulatory domains: a PH domain, two SH2 
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domains and an SH3 domain (Rodriguez et al., 2001; Ozdener et al., 2002; Sekiya et 
al., 2004). Recently it was suggested that the auto-inhibition mediated by the XYl region 
also applies to the PLC isozyme. However, the crucial determinant for the auto-
inhibition is the C-terminal SH2 domain (Gresset et al., 2010). In contrast, the XYls of 
PLCη isozymes are not negatively charged overall but contain clusters of acidic 
residues near their ends. It is unclear whether there is a role of this region in the 
regulation of PLCη activity (Fukami et al., 2010). By comparing the structural amino acid 
sequence of different domains amongst all PLCs, the XYl region sequence is clearly the 
most divergent. Herein, and as a consequent of this study we have tested the effects of 
XYl region deletion on PLCζ in vitro and in vivo (in eggs) in comparison with PLCδ1 as a 
control (Nomikos et al., 2011c). As mentioned previously PLCδ1 was chosen based on 
its closer similarity with PLCζ and because it has been shown to trigger infrequent Ca2+-
oscillations in mouse eggs with high doses. Significantly, the important and unique 
functional feature of PLCζ is the relatively high Ca2+ sensitivity that results in ~100-fold 
higher Ca2+ sensitivity than PLCδ1. In other words, low Ca2+ concentrations (nanomolar) 
are needed for enzymatic activity of PLCζ compared to micromolar Ca2+ concentrations 
for optimal PIP2 hydrolysis with the PLCδ1 isoform. Therefore, within eggs, with a basal 
cytosolic Ca2+ concentration of 50-100 nM, PLCζ but not PLCδ1 would be strongly 
activated.  
Although previous studies suggest that EF hand domains are required for a functional 
PLCζ in the egg (Nomikos et al., 2005). The molecular determinants that confer the high 
Ca2+ sensitivity of PLCζ were unknown. A recent study in our lab by my colleague Dr Yu 
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on the localization of PLCζ and whether and how PLCζ can bind to the plasma 
membrane, has showed that PLCζ targets PIP2 on intracellular vesicles and not the 
plasma membrane PIP2 (Yu et al., 2012). This idea was based on several results.  
Firstly, yellow fluorescent protein (YFP)-tagged constructs of PLCζWT, the PLCζD210R, 
the XYl, the XY domain, and the C2 domain were all expressed in mouse eggs. Re-
gardless of the stage that eggs were held in, a uniform fluorescence in the cytoplasm 
was noted in all. The only exception was the localization of PLCζ in the nucleus of the 
second polar body. This finding of unspecific localization of none of these PLCζ 
constructs was totally the opposite to that seen with distinctive plasma membrane lo-
calization of PLCδ1 using GFP-tagged PH domain (Yu et al., 2012). Secondly, the 
changes in plasma membrane PIP2 using GFP-tagged PH were used to record the 
relative changes of PIP2 in the fertilizing mouse eggs (Halet et al., 2002). This showed 
even though PLCζ is far more potent ‘at causing Ca2+ oscillations’ than PLCδ1, the de-
creases in plasma membrane PIP2 was only recorded after PLCδ1 injection and not 
after PLCζ injection. Finally, it was found that by using PLCζ antibodies and 
immunocytochemistry PLCζ could be localized to small vesicles in the egg cytoplasm. It 
remains to be shown which PLCζ domains might be involved in binding to such vesicles 
(Yu et al., 2012).  
It was worth examining the general auto inhibitory mechanism of somatic PLCs 
regulation on sperm specific PLCζ. This is because PLCζ is very distinct from somatic 
PLCs in possessing a positively charged XYl region. In order to enable us to understand 
the regulatory role of the short linker region separating the catalytic X and Y domain,  
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the XYl of both PLCζ (amino acids 308–385) and PLCδ1 (amino acids 441-490) were 
excised from both PLCζWT and PLCδ1WT respectively to create PLCζΔXYl and PLCδ1ΔXYl 
(Nomikos et al., 2011c). Interestingly, the deletion of the XYl from PLCζ negatively 
affected the in vivo enzymatic activity, which translated into an observed 7-fold 
reduction in Ca2+-oscillation-inducing activity in mouse eggs. In contrast, deletion of the 
XYl from PLCδ1 resulted in a 2-fold increase in Ca2+-oscillation-inducing activity in eggs. 
These results clearly support the general autoinhibitory mechanism suggested for 
somatic PLCs like PLCδ1. This result also correlates with the in vitro PIP2 hydrolysis 
assays showing an ~2.3-fold increased enzymatic activity relative to wild-type PLCδ1 
(Nomikos et al., 2011c). Finally, the replacement of only the PLCζ XYl cluster of basic 
residues (12 a.a) by its homologous XYl region of PLCδ1 also resulted in 5-fold 
reduction in Ca2+-oscillation-inducing activity in eggs with this chimeric PLCζ. The 
potential interpretation of our findings in these experiments is that the XYl of PLCζ has 
the opposite regulatory role to that of the XYl in PLCδ1. This could be due to the high 
density of basic amino acids (positively charged) in the XYl of PLCζ that is absent from 
PLCδ1 and other somatic PLC isoforms. These results are consisted with our previous 
findings on the sequential mutations (KA) where we introduced the specific high 
density cluster of positively charged a.a. into the XYl of PLCζ. Both studies suggest the 
important role of XYl in PLCζ regulation and activity. In either case the excision of the 
complete XYl or exchanging positively charged cluster with neutral residues causes a 
significant reduction in PLCζ functional properties regarding PIP2 targeting and 
hydrolysing activity. 
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6.5 Non-invasive potential method for embryo selection  
 
The basic role of Ca2+-oscillations during egg activation in mammals suggests the 
importance of developing a potential non-invasive monitoring technique of these 
cytoplasmic Ca2+ changes. Any success in this direction might be implemented in future 
for embryo selection techniques in IVF clinics. In this regard, our studies investigated 
monitoring the cytoplasmic movements in human eggs during activation that was 
previously first noticed in mouse eggs (Deguchi et al., 2000). They were also reported in 
fertilizing mouse eggs using PIV analysis (Ajduk et al., 2011). The  implementation of 
this technique on activating human eggs injected by cRNA encoding hPLCζ, showed 
significant cytoplasmic-movements that correlated with each Ca2+ spike. The degree of 
synchrony between Ca2+ elevation and movement was the common finding in all of 
these human eggs. This suggests that the cytoplasmic-movements in human eggs are 
directly induced by elevated free Ca2+ ions. On detailed analysis of this relation, we 
found that distinct cytoplasmic movements occurred just after each Ca2+ transient, or 
within the same 10-second interval. In addition, we noticed either coincidence between 
the maximum mean PIV speed with the maximum of the Ca2+ spike or it occurred within 
the 50 seconds after the maximum of the Ca2+ transient. In a total from 10 different 
zygotes, 95/102 cytoplasmic-movements were detected within this range. The mean lag 
of the PIV speed peak was 18 seconds after the Ca2+ peak (with a range of 10-50 sec). 
In mouse eggs it was suggested that such cytoplasmic-movements are dependent on 
the actin cytoskeleton and are greatly influenced by the presence of the sperm and 
fertilization cone ‘zygote shape changes’ (Ajduk et al., 2011). Since we recruited only 
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failed ICSI human eggs for this study, it was difficult to identify the fertilization cone or 
region that exhibit shape changes, although there were slow progressive changes of 
cell profile detected during the recordings. However, in some records it was possible to 
notice a thick granular crescent formed beneath the cell membrane, which moved 
towards the position of the first polar body. The presence of sperm in these eggs could 
play a specific role in cytoplasmic-movements, as suggested in mouse zygotes. 
Moreover, the failure to detect any cytoplasmic-movement on 7 follicular reduction 
human eggs that were injected with cRNA encoded PLCζ to induce Ca2+-oscillations, 
further suggest the important role of sperm presence for optimum fertilization in 
mammals.  
 
6.6 Recombinant hPLCζ protein is a potential solution in 
some ICSI failure cases of paternal cause 
 
One of the main goals of this particular research is to find an acceptable, optimum and 
ethically approvable way to activate human eggs that can be used safely in repeated 
male factor related IVF/ICSI failure. Recombinant PLCζ might represent a potential 
alternative physiological therapeutic agent that can overcome certain cases of failed 
fertilization after ICSI. 
Our success in producing human recombinant PLCζ protein came from the expression 
of this protein as a NusA-hexa-histidine fusion protein in E. coli that was purified by 
affinity chromatography on Ni-NTA resin. The eluted proteins were dialyzed overnight 
and concentrated with centrifugal concentrators (Nomikos et al., 2013). The selection of 
a fusion protein with NusA was chosen after instability issues with previous constructs in 
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our laboratory. One of these earlier studies used a hexa-histidine tag, and even though 
we succeeded in obtaining expression of some recombinant PLCζ protein, the product 
was functionally inactive. Recently, a promising study was reported that showed active 
recombinant hPLCζ protein with a hexa-histidine tag (Yoon et al., 2012). Looking into 
this report, it is noticeable that it was consistent with our lab previous studies using 
expression of recombinant hPLCζ without a fusion protein partner. This is because their 
hPLCζ protein was of very low activity and in order to show some activity for this protein 
they have to inject as much as 5,000 to 10,000 fg into a an egg to  cause Ca2+-
oscillations. Moreover, it did not result in further embryo development to the blastocyst 
stage. On contrary, in our study a significant expression of soluble NusA-PLCζ was 
observed, and displayed the predicted ~130 kDa molecular mass (70 kDa hPLCζ & 
NusA ~60 kDa) (NomiKos et al., 2013). Prompt fertilization like pattern of Ca2+-
oscillations were observed after the microinjection of recombinant wild-type human 
PLCζ into mouse and partially delayed ones in human eggs. In addition, the estimated 
amount of human PLCζ protein in mouse eggs that was required to efficiently induce 
Ca2+-oscillations and embryogenesis was ~80 fg/egg compare to 5,000 to 10,000 fg/egg 
in the previous report (Yoon et al., 2012).  This means our activity is about 100 times 
stronger than the recently published report. To rule out the possible effect of NusA tag, 
this protein was microinjected alone and failed to cause any Ca2+ changes. This 
revealed that the expressed recombinant PLCζ protein possesses a potent ability to 
hydrolyse PIP2. Not only that, but it triggered, with high efficiency, early embryo 
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development, from pronuclei formation up to the multicellular blastocyst stage (Nomikos 
et al., 2013).  
The activity of our recombinant PLCζ protein was further tested by my colleagues in 
order to investigate whether injection of recombinant human PLCζ protein would be able 
to rescue the failed egg activation caused by infertility-linked PLCζ mutants. They 
produced two mutants of PLCζ encoding the two novel point mutations that previously 
reported so far in the PLCζ gene and linked specifically to male infertility PLCζH398P and 
PLCζH233L mutations (Heytens et al., 2009; Kashir et al., 2012) respectively. Both of 
these mutations have been found to dramatically abolish PLCζ activity and were unable 
to produce Ca2+-oscillations in mouse eggs (Nomikos et al., 2011a; Nomikos et al., 
2013). When they microinjected the wild-type human PLCζ protein into mouse eggs that 
were expressing these infertility-linked PLCζ mutants (H398P and H233L), the results 
demonstrate an effectively rescue the failure of egg activation by inducing a normal 
pattern of Ca2+-oscillations. This finally led to successful early embryo development up 
to the blastocyst stage. These findings promote the potential application of PLCζ protein 
into IVF clinics as an effective therapeutic option for egg activation failure due to male 
factor deficiencies related to PLCζ dysfunction.  
 
6.7 Clinical implications 
 
Infertility is a major issue that faces many couples who want to start a family.   
Tremendous improves designed to tackle this issue have been made in the past few 
decades. Firstly the invention of conventional IVF solved a significant percentage of 
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both maternal and paternal sub-fertility dilemmas. This success was however followed 
by more advanced technique i.e. ‘ICSI’ which is predominantly used to treat male factor 
infertility problems following failure of conventional IVF. It is a highly successful 
technique that, on average, results in normal fertilization in 70% of cases (Nasr-
Esfahani et al., 2010). Although, these techniques and their derivatives have benefited a 
large number of infertile couples, there are still between 2% to 3% of infertile couples 
who have not benefited from these contemporary solutions in their infertility treatment 
(Nasr-Esfahani et al., 2010; Vanden et al., 2012). Another review study found out 
between 1 - 5% with complete or virtually complete fertilization failure still occurs after 
ICSI cycles (Kashir et al., 2010). ART now accounts for 7% of all births in some 
developed countries (Nasr-Esfahani et al., 2010). Scientists and clinicians have looked 
at this issue and found out that some cases of failed fertilization can be because of egg 
activation failure. This can be the case for approximately 70-80% of cases after ICSI 
(Tesarik et al., 1994; Palermo et al., 2009; Nasr-Esfahani et al., 2010; Kashir et al., 
2010). For this reasons researchers have focused on solving this issue by finding an 
artificial way, by any possible means, to activate human eggs that have failed to fertilize 
after ICSI. Ca2+ ionophore has been reported to improve the fertilization and embryo 
quality after ICSI in human eggs, mainly if epidydemal sperm was injected compare to 
testicular sperm (Borges et al., 2009). Amongst the  same number of human eggs (n = 
49) injected with epididymal sperm only, or injected with epididymal sperm and then 
treated with Ca2+ ionophore, the fertilization, high-quality embryo, implantation and 
pregnancy rates rose by 3.2%, 16.8%, 5.2% and 6.8% respectively. The interesting 
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point here is the increase in the high-quality embryos by nearly 17%, which suggests 
the beneficial effect of Ca2+ ionophores on development after activation. However, this 
was not the case with testicular sperm origin since no significant difference reported. 
More recent report showed that although the artificial egg activation is highly efficient 
(74.2% compare with 43.7%) in patients with a suspected egg related activation 
deficiency with previous ‘post ICSI’ total fertilization failure,  it is not always beneficial 
(75.0% compared with 60.4%) for patients with previous low conventional fertilization 
rates and a suspected egg-related activation deficiency (Vanden et al., 2012). A recent 
interesting study looked at whether PLCζ levels from fertile men sperm (control group) 
are similar, and whether a predominant localization pattern of PLCζ within sperm is 
related to better egg activation rates. The results showed marked variance in both, the 
PLCζ levels within the control group and in the predominant pattern of PLCζ localization 
in relation to normal egg activation. The diagnostic application of quantitative PLCζ 
immunofluorescent analysis might be prevented with such variability (Kashir et al., 
2013). 
My study on Sr2+ activation protocols on human eggs may be one of the first serious 
attempts to activate human egg with Sr2+. The safety of Sr2+ usage might be not present 
major issues since it has already been used in human ICSI in several clinical reports 
(Kashir et al., 2010). For example, a previous report with low fertilization rate (17%) 
couples with no pregnancy in eight cycles was successfully treated in with Sr2+ post 
ICSI. This resulted in a 100% fertilization rate, with pregnancies from fresh and frozen 
embryos (Yanagida et al., 2006). Similarly, the fertilization and pregnancy rates were 
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reported markedly improved following Sr2+ use (22%-65% and 0%-40%) respectively 
(Kyono et al. 2008). However, these studies lack the evidence to reveal whether the 
previous low fertilization rates were sperm related activation deficiencies or not. There 
were no controls done alongside the S2+ activation treatments. In addition, there is no 
clear evidence confirming Sr2+ action in these reports by showing Ca2+-oscillations. The 
issue here is the mechanism by which of Sr2+ can work on human eggs, and the 
scientific proof of an effective action. As I reported in the human egg’s results chapter, 
Sr2+ may only provoke Ca2+ release in human eggs in special conditions. These 
conditions were not provided in the previous reported clinical studies. It has yet to be 
elucidated whether Sr2+ is an efficient candidate for artificial human egg activation since 
my results are not yet conclusive and my protocol cannot be recommended for 
application in those cases with repeated failed ICSI. However, my results might be the 
preliminary steps towards future protocols.   
PLCζ identification is a novel discovery that has implications in infertility and is a 
possible treatment option in future. Principally, the potential application, by co-
microinjection, of PLCζ cRNA during ICSI could be used to rescue egg activation failure 
due to PLCζ-deficient/mutated sperm.  Yoon et al., (2008) demonstrate this by rescuing 
the egg activating capability of globozoospermic sperm by the co-injection of PLCζ 
cRNA into mouse eggs. However, some basic ethical and practical difficulties would 
face this application. These include the safety, the nature of cRNA PLCζ since the RNA 
would be regarded as a genetic material and hence its injection could be seen as a 
genetic modification that could incorporate into the embryo genome (Kashir et al., 
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2010), and inability to control the bolus size of microinjected cRNA. The latter would 
affect significantly the rate of PLCζ protein synthesis and the total amount expressed 
within the egg. However, even if the same amount of cRNA was injected the protein 
synthesis can vary from one egg to another. This then leads to inappropriate condition 
for further embryo development. In this regard, previous report suggested that for a 
successful embryo development, PLCζ has to be available within a narrow window of 
relatively precise concentration range in the egg. That is closely similar to the 
physiologically relevant amount of PLCζ that would be provided by a single mature 
sperm at fertilization (Yu et al., 2008). The availability of purified, active recombinant 
human PLCζ protein appears to represent both a highly practical and the most 
physiologic therapeutic agent for overcoming failed ICSI cases resulting from aberrant 
sperm PLCζ. In other words, artificial activation by recombinant protein may be useful 
when there is no or low fertilization potential in male patient such as globozoospermia, 
severe teratozoospermia, and nonobstructive azoospermia. Recombinant human PLCζ 
protein could potentially also be used in regenerative medicine approaches to aid the 
generation of parthenogenetic embryos and blastocysts that may facilitate stem cell 
derivation. 
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